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Summary 
Spinocerebellar ataxias (SCA) are a group of cerebellar diseases characterized by 
progressive ataxia and cerebellar atrophy accompanied by a loss of Purkinje cells. 
Within SCA, Spinocerebellar ataxia type 14 (SCA14) is a subtype inherited in an 
autosomal dominant fashion and caused by missense, deletion or splice site mutations 
in the PRKCG gene, which is coding for protein kinase C (PKC) gamma (γ) (Yabe et 
al., 2003).  Previous studies in our lab have shown that chronic activation of PKC with 
the PKC activator phorbol-12-myristate-13-acetate (PMA) in organotypic cerebellar 
slice cultures drastically inhibits the growth and development of the Purkinje cell 
dendritic tree (Metzger et al., 2000). This result is intriguing and could mean that the 
degeneration of the Purkinje cell dendritic tree in SCA14 may be caused by the 
increased activity of PKC. Another study has shown most SCA14 mutations in PKCγ 
showed an increased activity of PKCγ in transfected cells (Adachi et al., 2008). These 
findings raise the possibility that SCA14 might be related to increased PKC activity. 
The mechanisms by which increased PKC activity may lead to inhibition of Purkinje 
cell dendritic growth and perhaps even to degeneration are not known and it is not 
clear which proteins are involved in PKC signalling related to dendritic growth in 
Purkinje cells.  
In this project, we took advantage of a mouse model for SCA14, which was developed 
in our lab. In S361G mutated PKC gamma (mPKCγ) transgenic mice carrying a PKCγ 
transgene with a mutation from a human SCA14 allele we have shown that PKC activity 
is increased and Purkinje cell dendritic growth is strongly inhibited in slice cultures. We 
then tested whether other SCA14 mutations, in particular located in the C1 domain, 
would show similar effects on Purkinje cell dendritic development as the S361G 
mutation. We constructed several PKCγ mutants carrying mutations from human 
SCA14 patients and transfected them to Purkinje cells. We found that mutations in the 
catalytic domain caused severe inhibition of Purkinje cell dendritic development. In 
contrast, mutations in the C1 domain didn’t show this effect. Our findings suggest that 
mutations in the PKCγ gene causing SCA14 can have different effects on PKC 
biological activity in Purkinje cells and that multiple mechanism may be involved in the 
pathogenesis of SCA14. In order to search for molecules involved in signal 
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transduction of mPKCγ, we performed a gene chip microarray analysis using mPKCγ 
transgenic mice and identified Carbonic anhydrase 8 (Car8) and type 1 inositol 1, 4, 5-
trisphosphate receptor (IP3R1) as mRNAs and proteins being upregulated in mPKCγ 
transgenic mice. Furthermore, Car8 over-expression in Purkinje cells resulted in the 
formation of small, stunted dendritic trees in Purkinje cell similar to those after PKCγ 
activation implying that Car8 negatively regulates dendritic development. On the other 
hand, Car8 knocked down failed to rescue the morphology of the dendritic tree in 
Purkinje cells from mPKCγ transgenic mice or after pharmacological PKC activation. 
This indicates that Car8 is not directly downstream of mPKCγ signalling for Purkinje 
cell dendritic development but is likely to be part of a larger signalling network including 
PKCγ and IP3R1 which controls dendritic growth of Purkinje cells.  
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1. Introduction 
  Cerebellum and Purkinje cells 
  Cerebellum  
The meaning of cerebellum is ‘‘little brain’’ because of its volume and its separation 
from the main brain. Indeed the cerebellum is much smaller compared to the cerebrum 
in mammalian species, which located dorsal to brain stem and is partially hidden by 
the large occipital lobes of the cortex. However, the surface area of the cerebellar 
cortex is larger as expected because of the complex folding. The area of the cerebellar 
cortex in humans is 1,128 cm2, whereas that of the neocortex is 1,900 cm2 . The large 
area of cerebellum indicates that the cerebellum has important functions. It is well 
known that the cerebellum plays important roles in coordinated movement and motor 
learning. In addition, recent investigations have shown that the cerebellum is also 
involved in higher cognitive functions and mental health (Tanaka et al., 2009). 
 
 
Fig. 1 Cerebellar layers and cell types. 
(A) Cell types and their location across the cerebellar cortical layers. (B) The different 
layers can be easily discriminated. P - the Purkinje layer; G - the granular layer; M - 
the molecular layer; W - the white matter. Figure from (Kirsch et al., 2012). 
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Furthermore, human neuroimaging and animal behaviour studies have recently 
implicated that the cerebellum might have important roles in the processing of signals 
for perception and emotion (Bastian et al., 2011; D'Angelo et al., 2012; Schmahmann 
et al., 2010), particularly in circumstances involving predictions or timing. From those 
finding, the cerebellum is now recognized as an important part of brain for both motor 
and non-motor function.  
Histologically, the cerebellar cortex consists of three layers (molecular layer, Purkinje 
cell layer and internal granular layer) and contains five major types of neurons 
(Purkinje, granule, basket, stellate and Golgi cells), which form a relatively simple and 
well characterized neuronal circuitry (Fig. 1). Within cerebellar cells, Purkinje cell 
integrate the signals from the all other neurons and are the only cell projecting outside 
the cerebellar cortex (Fig. 2)  
 
 
Fig. 2 Cytoarchitecture and connectivity in the cerebellum.  
(A) Mouse brain shown from a lateral view with the cerebellum highlighted in color. (B) 
The basic cerebellar circuit is comprised of granule cells, Purkinje cells, stellate and 
basket cell interneurons, and deep nuclei. Afferent information is delivered to the 
cerebellum by climbing fibers and mossy fibers. The plus and minus signs indicate 
whether each synapse is excitatory or inhibitory. Note that inhibitory connections 
between the cerebellar nuclei and inferior olive complete the olivo-cortico-nuclear loop 
and excitatory projections from the cerebellar nuclei loop back to the cerebellar cortex. 
Panel (B) was modified from (Reeber et al., 2013). For simplicity we have not shown 
Golgi cells, unipolar brush cells, Lugaro cells, and candelabrum cells. Figure from 
(Reeber et al., 2013) 
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The Purkinje cell axons actually leave the cerebellar cortex and they synapse on deep 
cerebellar nucleus neurons where neurons represent virtually all of the output from the 
cerebellum, and there Purkinje cells inhibit neurons through secretion of γ-amino 
butyric acid (GABA). Therefore Purkinje cells are key neuron which connect cerebellar 
cortex and outside. Furthermore Purkinje cells have highly elaborate dendritic arbors 
and receive two types of excitatory inputs: parallel fibers (PFs) forming around 
100,000-200,000 contacts on one Purkinje cell dendritic arbor and a single climbing 
fiber (CF) which makes around 500 climbing fiber synapses (Kitamura et al., 2012). 
The parallel fiber input is determined by mossy fibers, which originate from over two-
dozen brain and spinal cord nuclei (Reeber et al., 2013). Approximately 25 million 
mossy fibers enter the cerebellum and synapse on approximately 50 billion granule 
cells (Andersen et al., 1992). Granule cells then converge massively (100,000 to 1) 
onto the dendrites of Purkinje cells. This striking expansion from mossy fibers to 
granule cells and the equally striking convergence from granule cells onto the Purkinje 
cells is believed to provide a computational benefit, that means the ability of the 
cerebellum to discriminate a large number of different patterns (Brunel et al., 2004). It 
is true that the major information flow in the cerebellum is mossy fibers-granule cells-
Purkinje cells-cerebellar and vestibular nuclear neurons while it is also important flow 
that a climbing fiber codes an error signal reflecting the motor performance failure. 
When a motor performance comes up in failure, the excitatory signal conveyed by a 
climbing fiber works to depress the synaptic transmission between parallel fibers and 
a Purkinje cell, the phenomenon is called long term depression (LTD). Not only the 
excitatory inputs but also various inhibitory interneurons regulate the excitatory inputs 
onto Purkinje cells and specialized astrocytes called Bergmann glia maintain efficient 
synaptic signalling. Altogether Purkinje cells send inhibitory signals to the deep 
cerebellar nuclei, which control the final output of the cerebellum (White et al., 2013). 
An excitatory feedback projection terminating in mossy fiber-like endings exists 
between the deep cerebellar nuclei and the granule cell layer, and an inhibitory 
feedback connection is made from the cerebellar nuclei to the inferior olive. These two 
connections form parts of the nucleo-cortical and olivo-cortico-nuclear loops 
respectively (Chaumont et al., 2013). This canonical cerebellar circuit, which was once 
thought to be simple and synonymous with motor signalling, is now thought to have 
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underlying complexities that also mediate non-motor brain behaviours (Timmann et al., 
2010). 
 
  Dendritic growth of Purkinje cells 
Purkinje cells  are one of the best known neurons in the cerebellar cortex due to their 
large somata and elaborated dendritic trees (Tanaka et al., 2009). Jan Evangelista 
Purkinje described Purkinje cells in 1837 and they were the first cerebellar neurons to 
be discovered. After his discovery, introduction of novel staining procedures such as 
Golgi techniques revealed the elaborated dendritic trees of Purkinje cells. Due to their 
unique features, Purkinje cells are an important model for searching mechanisms 
underlying neuronal development and degeneration. There are two important points. 
First, Purkinje cells develop their elaborate dendritic trees postnatally in the human and 
rodent brain (Kapfhammer et al., 2004). Second, Purkinje cells are critically affected in 
various neurological diseases ranging from genetic defects to acquired injury or 
poisoning (Sarna et al., 2003). These two points are shown below in detail. 
 
Purkinje cells development can be divided into four stages (Fig. 3, next page).  
a) First, in midgestation, Purkinje cells are produced in the mouse from E11-E13 
in the ventricular zone (Wang et al., 2001) and then migrate and position 
beneath the external granular layer. 
b) Second, in the neonatal period, the primitive processes of the Purkinje cell 
change to Purkinje cell with numerous thin perisomatic extensions develop.  
c) Third, in the second and third postnatal weeks, Purkinje cells form a primary 
dendrite and undergo rapid dendritic elongation and branching in the sagittal 
plane to elaborate their typical dendritic tree (Sotelo et al., 2009). 
d) Finally, as Purkinje cell dendrites branch, climbing fibers and parallel fibers 
contact specific sets of dendritic spines (Rossi et al., 1995). 
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Fig. 3 Dendrite formation of cerebellar Purkinje cells, postnatal development of 
the cerebellar cortex.  
Slices of mice on postnatal day (P) 7 (A), 14 (B) and 21 (C). (A) In the first postnatal 
week, there is little total dendritic expansion. (B and C) In the second and third 
postnatal weeks, Purkinje cells form a primary dendrite and undergo rapid dendritic 
elongation and branching. Pictures are from (Tanaka et al., 2009). 
 
 
As for Purkinje cells dendritic development, most Purkinje cells have a single primary 
dendrite, whereas a few have two or more primary dendrites. During dendritic 
development, Primary dendrites extend toward the molecular layer (ML) and branch 
extensively to form secondary and tertiary dendrites. A large number of synapses are 
made between spines on tertiary dendrites and parallel fibers, which are the axons 
from granule cells and are the most numerous neurons in the central nervous system 
(CNS). In addition, as mentioned above Purkinje cells are innervated by climbing fibers 
which are axons from inferior olive neurons and also innervated by inhibitory 
interneurons (basket and stellate cells). Purkinje cell dendrites develop in a planar form 
and the plane is oriented perpendicular to the long axis of the cerebellum (Tanaka et 
al., 2009).  
 
Purkinje cells related diseases  
As mentioned, Purkinje cells dysfunction results in multiple cerebellar diseases. Ataxia 
is a classical sign of cerebellar dysfunction. A unifying cellular phenotype observed in 
the nervous system of ataxic mice and humans, regardless of the type of ataxia, is 
extensive Purkinje cell degeneration. More details of cerebellar disease are given in 
the spinocerebellar ataxia chapter. 
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  Spinocerebellar ataxia 
  Overview  
The word “ataxia” is from Greek meaning “loss of order,” it is used clinically to describe 
an aberrant regulation of limb movements with poor coordination between limbs. 
Cerebellar ataxia is the most common form of ataxia and is caused by dysfunction 
either within the cerebellum or in its afferent and efferent pathways. Spinocerebellar 
ataxia (SCA) is caused by anomalous function of the spinocerebellum, the part of the 
cerebellar cortex that receives somatosensory input from the spinal cord (Carlson et 
al., 2009). Although there are sporadic forms of SCA, the term is most often used to 
refer to the hereditary forms, and in particular the autosomal dominant forms. The 
autosomal dominant SCAs are typically late-onset, progressive, and often fatal 
neurodegenerative disorders. They are characterized by cerebellar ataxia and 
frequently other symptoms related to dysfunction of additional neural pathways 
(Duenas et al., 2006).  
Currently 42 SCA types are known (the number is continuously increasing), which are 
numbered from SCA1 to SCA42 (SCA9 is unassigned, SCA15 and SCA16 were linked 
to the same chromosomal locus, SCA24 proved to be recessively inherited, SCA33 
has not been published). Their prevalence in Europe is estimated at approximately 
3:100,000, whereby SCA1, SCA2, SCA3 and SCA6 represent the most frequent SCAs 
worldwide (Kay et al., 2012). It is also known that prevalence of different SCAs shows 
a regional difference, for example SCA1 is the dominant SCA in Italy, SCA3 in 
Germany, and SCA6 in Japan. 
The clinical picture of SCAs is heterogeneous with various symptoms. The common 
symptoms of the SCAs result from damage to the cerebellum and/or its neuronal 
connections: ataxia of the limbs, head and trunk, dysarthria and cerebellar oculomotor 
disorders (Paulson, 2009: Soong et al., 2007). These are often accompanied by 
extracerebellar symptoms, which sometimes may be characteristic for a given SCA 
and thus may help in differential diagnosis. They can also include Parkinsonism, retinal 
degeneration, aspiration, psychiatric symptoms, as well as dysfunction of touch, sight, 
hearing and proprioception and are accompanied by diverse extracerebellar 
neurodegeneration patterns (Scho¨ls et al., 2004). 
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  Spinocerebellar ataxia 14 
SCA14 is a rare spinocerebellar ataxia which is inherited in an autosomal dominant 
fashion. It is caused by missense point mutations, deletions or splice site mutations in 
the PRKCG gene (Yamashita et al., 2000), coding for protein kinase C gamma (PKCγ). 
Now more than 30 types of missense mutations or deletions in PRKCG gene are found 
as SCA14 related mutations (Fig. 4, next page). PKCγ is primarily expressed in CNS 
and dominantly expressed in cerebellar Purkinje cells, which is an important factor in 
cerebellar development (Yabe et al., 2003). General clinical manifestations of SCA14 
usually include ataxia, dysarthria, oculomotor disturbance, vertigo, facial myokymia 
and myoclonus. Less frequent symptoms are a decreased vibration sense, depression, 
psychosis as well as cognitive decline and, in younger patients, tremor and chorea 
(Vlak et al., 2006). SCA14 begins in childhood to late adulthood and the lifespan is 
normally not shortened. In clinics, no features of SCA14 are pathognomonic; therefore, 
diagnosis depends on molecular genetic testing (Chen et al., 2005). In vivo brain MRI 
scans showed primarily vermal cerebellar degeneration and post-mortem neuro-
histological-pathological studies have demonstrated a pronounced loss of cerebellar 
Purkinje cells in SCA14 patients (Brkanac et al., 2002). 
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Fig. 4 SCA14 mutations found in human patients. 
Illustrations of each domain mutations in PKCγ protein. PKCγ consists of an N-
terminal regulatory and a C-terminal catalytic kinase domain. The regulatory domain 
of PKCγ contains two conserved domains, the diacylglycerol (DAG) binding C1 
domain and the Ca2+ binding C2 domain. The C1 domain is subdivided into the C1A 
and C1B domains having six conserved cysteines and two histidines in the typical 
core structure that coordinates two zinc ions. So far thirty two point mutations and 
deletions were found in SCA14 families. 
 
Mutant PKCγ Pathogenesis 
As mentioned, more than 30 types of mutations or deletions in PRKCG gene cause 
SCA14 (Fig. 4). It is not known in which way the different mutations of PKCγ cause 
SCA14. Remarkably, PKCγ-deficient mice show only mild ataxia and no gross 
morphological abnormalities in the cerebellum (Chen et al., 1995; Kano et al., 1995), 
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indicating  that a toxic gain of function, dominant negative function or gain of function, 
rather than loss of function of PKCγ causes SCA14. One possibility is toxic function of 
PKCγ  due to PKCγ protein  aggregation. It was reported that mutant PKCγ protein 
aggregates in the cytoplasm of cultured cells transfected with mutant PKCγ expression 
vectors (Doran et al., 2008; Lin et al., 2007; Seki et al., 2007) but the role of these 
aggregates in the pathogenesis of SCA14 is still not clear. When mutant PKCγ 
transfected cells are treated with an inducer of autophagy, cultured cells demonstrated 
an accelerated clearance of aggregates, indicating that autophagy contributes to the 
degradation of mutant PKCγ (Yamamoto et al., 2010). However, in primary cultures of 
Purkinje cells transfected with mutant PKCγ, abnormal dendritic development of 
Purkinje cells also occurred independent of aggregation (Seki et al., 2009). There is 
another report that amyloid-like oligomers and fibril formation of mutant PKCγ may 
contribute to SCA14 pathogenesis (Takahashi et al., 2015). But they mentioned 
endogenous PKCγ itself may form amyloid-like aggregates to amplify their local signals 
in some physiological PKC-dependent pathways, so PKCγ protein aggregation thus 
might partially contribute to SCA14 but the mechanism is unclear and it’s not only the 
reason of SCA14 pathogenesis.  
Another possibility is a dominant negative activity of PKCγ or gain of function of PKCγ. 
PKCγ is a serine-threonine kinase and it is well known that some mutant kinases have 
dominant negative activities. Studies of the effect of SCA14 related mutations on 
kinase activity have been in several groups, but a dominant negative effect has not 
been shown (Lin and Takemoto, 2007; Seki et al., 2005; Verbeek et al., 2005).  
On the other hand, two PKCγ mutations were characterized functionally in vitro and 
were shown to increase PKCγ catalytic activity, linking Purkinje cell degeneration to a 
potential gain of function phenotype of PKCγ (Verbeek et al., 2005). Subsequently, 
Adachi et al. found that 19 out of the 20 tested mutations showed an increased 
constitutive activity of PKC and increased Ca2+ levels in the cytoplasm, which suggests 
that a gain of function, rather than toxic or dominant negative of function, of PKCγ could 
underlay the pathology of SCA14 (2008). 
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Molecular Genetic Pathogenesis 
Several groups are searching for proteins interacting with mutant PKCγ because PKCγ 
is a well-known signaling kinase and key protein for several kinase signaling cascades. 
However it has been found that many PKCγ substrates proteins are not directly 
associated with ataxia or Purkinje cell loss, such as metabotropic glutamate receptor 
5, non-muscle myosin heavy chain II-B, Myristoylated alanine-rich C kinase substrate 
(MARCKS), GSP43/B-50, HMG-I, RC3/neurogranin and glycogen synthetase (Xiao et 
al., 2000). Later, Aprataxin (APTX) which is  a DNA repair protein and associated with 
autosomal recessive ataxia with oculomotor apraxia type 1 (AOA1) (Moreira et al., 
2001), was found to be a preferential substrate of mutant PKCγ which inhibited nuclear 
import of APTX, and thus sensitized cells to oxidative stress-induced DNA damage, 
leading to cell death (Asai et al., 2009). This observation suggests that the 
pathogenesis of SCA14 may involve altered phosphorylation of proteins in PKCγ 
dependent pathways and show one path mechanisms that phosphorylated PKCγ 
increased oxidative stress-induced DNA damage which cause cell death (Asai et al., 
2009; Doran et al., 2008). The ubiquitin-proteasome pathway has been implicated in 
this process (Seki et al., 2007). Furthermore, the observation that mutant PKCγ fails to 
phosphorylate TRPC channels resulting in sustained Ca2+ entry into the cells indicates 
that altered phosphorylation of substrates proteins of PKCγ links to a role for abnormal 
Ca2+-mediated signaling in neurodegeneration (Adachi et al., 2008). Most of these 
studies were done in cultured cells with transient overexpression of mutant PKCγ and 
the detailed molecular mechanisms leading to SCA14 in Purkinje cells expressing 
mutant PKCγ are still unclear. There is one report of a transgenic mouse model of 
SCA14 which ubiquitously express human mutant cDNA with the p.His101Tyr-PKCγ 
mutation, showing loss of Purkinje cells at the age of four weeks and stereotypic 
clasping responses in the hind limbs (Zhang et al., 2009). Previous work showed that 
His101Tyr-PKCγ mutation has dominant negative effects on endogenous wild type 
PKCγ enzyme activity which leads to uncontrolled, open gap junctions in cells 
overexpressing His101Tyr-PKCγ mutation (Lin et al., 2007). They suggested that loss 
of control of gap junctions may further propagate ER stress-linked cell death signals in 
Purkinje cells (Zhang et al., 2009). But this study is not completed and further 
investigations are needed. 
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  PKC gamma and Purkinje cell dendritic tree development 
  Overview 
The Protein Kinase C (PKC) family was discovered by Yasutomi Nishizuka in 1977 
(Inoue et al.,1977). After this finding, numerous signalling cascades were discovered 
and PKC was recognized as one of the important kinase for regulation of other 
signaling pathways, gene expression, secretion, and modulation of ion channels as 
well as cell growth, stress, autophagy, which related to many diseases. 
PKC occupies the tip of a branch of the AGC kinases from which the related kinases 
protein kinase N (PKN), Akt/PKB, p70 S6 kinase, and the phosphoinositide-dependent 
kinase-1 (PDK1) diverge (Newton,1995) (Fig. 5A, next page). 
PKCs are actually a family of serine/threonine kinases with at least ten different 
isoforms being identified by now. The isoforms can be split into three families according 
to their requirement for different co-factors (Fig. 5B, next page):   
1. The conventional, or classical (c) PKCs: α , βI, βII and γ ,  
2. The  novel (n) PKCs: δ, ε, η and, θ 
3. The atypical (a) PKCs: ζ and ι (referred to as PKCι in murine systems).  
Differential splicing gives rise to the two forms of β: βI and βII, which differ only in their 
extreme C-terminal end, while a constitutively active form of PKCζ is expressed from 
an internal promoter within the PKCζ gene and is known as PKMζ. A further isoform, 
PKCμ , was originally thought to belong to the PKC family but is now referred to as 
protein kinase D (PKD) (Rozengurt, 2011). PKD is serine/threonine protein kinases 
and the initial description of PKD as an atypical isoform of PKC contributed to a 
perception that PKD belongs to a subfamily of PKC. However, it was found that the 
catalytic domain of PKD has highest sequence homology with myosin light chain 
kinase and CAMKs and now PKD1, 2 and 3 are classified as a new protein kinase 
family within the CAMK group, separate from the AGC group (Rozengurt, 2011).  
Within the PKC family, PKCγ is a member of the classical PKCs (cPKC) which was 
first isolated as one of more than 10 PKC cDNAs from a brain cDNA library. The cPKCs 
(PKCα, PKCβ, and PKCγ) are activated by diacylglycerol (DAG) and Ca2+ in the 
presence of phosphatydylserine (Nishizuka et al.,1995). The function of the different 
domains is explained in the next chapter. 
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Fig. 5 Protein kinase C (PKC) family members, showing position on branch of 
AGC kinome, domain composition, and cofactor dependence.  
(A)  Human kinome, showing the position of the AGC kinases (bottom right). PKC 
isozymes (enlarged on right) are poised on a branch that includes Akt, p70 S6 
kinase, and PDK1 (phosphoinositide-dependent kinase 1). The PKN family diverges, 
then the atypical PKC isozymes, the novel PKC isozymes, and finally, most 
divergent, the conventional PKC isozymes. (B) Domain composition of PKC family 
members, showing pseudosubstrate (green rectangle), C1 domain [orange rectangle; 
Y/W switch that dictates affinity for diacylglycerol (DAG)-containing membranes 
indicated by circle in C1B domain], C2 domain [yellow rectangle; basic patch that 
drives binding to PIP2 (phosphatidylinositol-4,5-bisphosphate), indicated by oval with 
++], connecting hinge segment, kinase domain (cyan), and carboxyl-terminal tail (CT; 
dark blue rectangle). Also shown are the 3 priming phosphorylations in the kinase 
domain and CT, with numbering indicated for PKCβII, PKCε, and PKCζ (note atypical 
PKC isozymes have Glu at phospho-acceptor position of hydrophobic motif).  
(C) Table showing dependence of each family cofactors, diacylglycerol (DAG), and 
phosphatidylserine (PS) in C1 domain and Ca2+ and PIP2 in C2 domain. Picture from 
(Newton, 2010) 
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  PKC Domain Function 
In the following I will present the most important aspects of the different PKC domains 
(Zeng et al., 2012). The major domain structure was already shown in Fig. 4 and Fig. 
5. 
 
PS: Pseudosubstrate Domain 
The pseudosubstrate region interacts with its kinase domain, forming a hairpin 
structure which maintains the enzyme in a closed/inactive conformation, therefore this 
domain functions is a suppressor of its kinase activity. The pseudosubstrate site is 
resembles a PKC substrate with an alanine substitution at the phosphoacceptor site 
therefore it cannot be phosphorylated. The blocking property of the pseudosubstrate 
domain for kinase activity has been exploited in the development of specific PKC 
inhibitors (Kirwan et al., 2003). The PKMζ form of PKCζ lacks this pseudosubstrate 
domain, which is thought to be in a constitutively active formation (Hernandez et al., 
2003). 
 
C1: DAG/Phorbol Ester Binding Domain  
For cPKCs and nPKCs this domain confer upon the ability to bind DAG/phorbol esters, 
within the C1 domain the C1b region is thought to be critical for this function. These 
domains were originally discovered in PKCs itself but are now known to be found in 
multiple other DAG-binding proteins (Colon-Gonzalez et al., 2006). In typical PKC 
(cPKCs and in nPKCs), the C1 domain is present as a tandem repeat (C1a and C1b) 
which is a cysteine-rich zinc finger structure. The DAG-binding site is a hydrophilic cleft 
formed from two pulled apart β-sheets, whereas the C1 domain surface surrounding 
the binding cleft is hydrophobic. Once DAG binds to DAG-binding site, the hydrophobic 
surface is completed which drives conformational change in the overall protein 
structure. In the atypical PKC isozymes (aPKCζ and aPKCι), the ligand-binding pocket 
of the C1 domain does not allow the entry of DAG nor phorbol esters (Kazanietz et 
al.,1994; Pu et al., 2006). C1b is also found to be the key region involved in the 
stereospecific interaction of PKC with phosphatydylserine (PS) (Johnson et al., 2000), 
although the C2 domain interacts with anionic phospholipids in a Ca2+ dependent 
manner. In PKCε, there is a 22 amino acid actin-binding sequence located between 
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the C1a and C1b domains that is unique to this PKC isoform, while the C2 domain 
appears to play an important role in the interaction of cPKC-α, -βI and -βII with F-actin  
(Slater et al., 2000). 
 
C2: Binds Ca2+ and phospholipids 
The presence of aspartate residues in the C2 domain of cPKCs confers upon them the 
ability to bind Ca2+, which is then crucial for activation of the kinase. nPKC isozymes 
do not have a Ca2+-regulated C2 domain therefore their activation only by DAG is 
possible because of a single residue change in their C1B domain that allows them to 
bind DAG-containing membranes with two-fold greater affinity for DAG than cPKCs 
(Giorgione et al., 2006). In cPKCs both the C2 and C1 domains are involved in the 
interaction of activated PKC with the plasma membrane: C1 in a DAG/PMA and 
phospholipid dependent manner and C2 in a Ca2+ dependent manner. aPKCs do not 
have a C2 domain but have a PB1 domain.  
 
Phox/Bem1 (PB1): a Distinctive Characteristic of the aPKCs 
This scaffolding domain of approximately 80 amino acids is found in many different 
proteins and are grouped into three types: type I (or type A), type II (or type B), and 
type I/II (or type AB). The type I domain group contains a conserved OPCA motif that 
interacts with a conserved lysine residue from a type II domain. The type I/II PB1 
domain, containing both the OPCA motif and the invariant lysine, is present in the 
aPKCs (Moscat et al., 2009). This domain is important for interaction with other 
proteins. 
 
V3: Hinge Region  
The third variable region (V3) region forms the “hinge” of the molecule, allowing the 
pseudosubstrate to interact with the kinase domain (see above). The V3 region is 
susceptible to proteolytic cleavage (Liu et al.,1998), which allow the catalytic domain 
to be free and generates a constitutively active form of the kinase in some PKC 
isoforms (Steinberg, 2008). The V3 region might also be important region for the 
translocation of some PKC isoforms but so far very little is still known about the function 
of this region. (Quittau-Prevostel et al., 2004).  
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Catalytic Domain 
This domain is highly conserved between the PKCs, and it is also highly conserved 
between many families of kinases and well conserved over the species, meaning this 
region is of course crucial and also implying poor specificity over isoforms and the 
species. There are two or three major conserved kinase domains and it is optimal when 
the kinase domain is appropriately phosphorylated on at least two (ζ and ι) or three (α, 
β, γ, δ, ɛ, η and θ) sites. These phosphorylations play important role for stabilising the 
active catalytic conformation (Newton, 2010). 
 
Control of PKC activation by membrane-targeting following binding of second 
messengers 
Activation of cPKC requires the binding of second messengers to the C2 and C1 
regulatory domains. External stimuli acting upon membrane receptors (i.e. G-protein-
coupled receptors or receptor tyrosine kinases) initiate a cascade of events that 
includes the hydrolysis of phosphatidylinositol 4, 5-bisphosphate (PIP2) into the C2+ -
mobilizing messenger inositol 1, 4, 5-trisphosphate (IP3) and DAG. An increase in the 
intracellular Ca2+ concentration after IP3 production which bind to IP3 receptor and 
increase cytoplasm Ca2+ induces Ca2+ binding to the C2 domain of the cytosolic PKC. 
The C2 domain serves as a membrane-targeting molecule that binds anionic 
phospholipids in a Ca2+ dependent fashion (Mellor and Parker,1998). Therefore, cPKC 
with bound Ca2+ moving by diffusion in the cytoplasm will associate to the plasma 
membrane (Schaefer et al., 2001). It will then diffuse in the plane of the membrane 
until it encounters a DAG molecule. Its C1 domain will bind DAG, establishing a high-
affinity interaction between cPKC and the plasma membrane. This interaction induces 
release of the auto-inhibitory pseudosubstrate domain from catalytic domain, switching 
cPKC to the open conformation. cPKC is then a mature active enzyme that is able to 
interact with its substrate and initiate the signal transduction processes.  
 
Control of PKC activation by phosphorylation 
In addition to allosteric activation, phosphorylations of Serine/Threonine or Tyrosine 
residues in distinct PKC isoforms control kinase activity, cellular localisation and 
function. First evidence that PKC is phosphorylated in vivo appeared in 1985 (Fry et 
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al., 1985). PKC is first synthesized as an inactive state, dephosphorylated precursor 
with an apparent molecular weight of 74 kDa; this was chased to a transient 77 kDa 
phosphorylated form and then to the final 80 kDa mature form (Dutil et al., 1994). In 
the cPKCs, three priming phosphorylation sites were identified and phosphorylation of 
the activation loop site was shown to be essential for cPKCs catalytic activity 
(Cazaubon et al., 1994). Phosphorylation of the two carboxyl-terminal sites plays a 
more complex role in the control of cPKC phosphorylation rate and important for 
keeping the kinase in a phosphatase resistant state (Bornancin and Parker, 1996). 
 
Control of PKC activation by desensitization mechanisms 
Down-regulation of cPKC activity and the consequent termination of signalling are 
achieved by several mechanisms. Activation of cPKCs and nPKCs with their agonists, 
such as phorbol esters, eventually leads to their dephosphorylation and subsequently 
rapid degradation, which is mainly thought via the ubiquitin-proteasome pathway. PKC 
is ubiquitinated after the treatment of cells with their agonists, phorbol esters or 
bryostatin, although the precise compartment where PKC is dephosphorylated remains 
to be determined (Hansra et al., 1999). 
Dephosphorylated cPKCs can be also rescued from degradation. Heat-shock protein 
70 (Hsp70) binds dephosphorylated PKCβII at its turn motif preventing its degradation. 
PKCβII can be then re-phosphorylated and cycled back into the pool of functional 
enzymes (Gao et al., 2002) (Fig. 6, next page).  
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Fig. 6 Model for the life cycle of PKC, from biosynthesis to degradation.  
Newly synthesized PKC associates with a membrane fraction, where it is processed 
by a series of ordered and tightly coupled phosphorylations. Heat shock protein-90 
(HSP90) binds to the PXXP clamp in the kinase domain, an event required for priming 
phosphorylations. Two upstream kinases control priming phosphorylations: PDK-1, 
bound to the exposed carboxyl terminus of newly synthesized PKC, phosphorylates 
the activation loop (pink circle); this step appears to be first, and necessary for the 
processing PKC. The mTORC2 complex promotes the phosphorylation of the turn 
motif (orange circle), second phosphorylation event, and hydrophobic motif (green 
circle), the final phosphorylation event. The fully phosphorylated mature PKC localizes 
to the cytosol with the pseudosubstrate (green rectangle) occupying the substrate-
binding cavity. Signals that cause lipid hydrolysis recruit PKC to membranes. For 
conventional PKC isozymes, binding of Ca2+ to the C2 domain recruits them to the 
plasma membrane via interaction with PIP2, an event that allows efficient binding of 
the membrane-embedded ligand DAG. For novel PKC isozymes, the intrinsic affinity 
of the C1 domain is sufficiently high to allow direct recruitment to membranes by 
agonist-evoked levels of DAG. Membrane-bound PKC adopts an open conformation, 
in which the pseudosubstrate is released from the kinase domain, allowing 
downstream signals. This open conformation is sensitive to dephosphorylation: the 
phosphatase (PH domain leucine-rich repeat protein phosphatase) dephosphorylates 
the hydrophobic motif, an event that shunts PKC to the detergent-insoluble fraction 
where it is further dephosphorylated and degraded (bottom right species). Figure from 
(Newton, 2010)  
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In a rat intestinal cell line, two distinct mechanisms of PKCα down-regulation have 
been shown to co-exist (Leontieva and Black, 2004). One mechanism is ubiquitin–
proteasome-dependent mechanism. Exposure to the PKC agonist PMA induced 
desensitization by ubiquitination of the fully phosphorylated enzyme at the plasma 
membrane and subsequent degradation at the proteasome. Interestingly, in the same 
intestinal cell line, exposure to a different PKC agonist, bryostatin 1, induced PKCα 
desensitization not only by the ubiquitin–proteasome-dependent mechanism just 
mentioned, but also through a caveolae-dependent internalization of the active enzyme 
followed by dephosphorylation and degradation. Corinne et al. showed that the PKCα 
associated endosomes co-localize with caveolin and that cholesterol binding drugs 
could inhibit PKCα downregulation, leads to the conclusion that PKCα has been 
degradated through a caveolae-mediated process (2000). It was also shown in other 
cell types, such as MCF7, to be trafficked from the plasma membrane to an endosomal 
compartment through caveolae in its active phosphorylated form (Prevostel et al., 
2000). Active PKCα is found to be sorted to a Rab-11-positive perinuclear 
compartment (Becker et al., 2003), where finally PKCα is thought to be 
dephosphorylated and degradation. Ubiquitination of fully phosphorylated active PKCα 
followed by degradation, as described above, is unusual in this case. Indeed, 
dephosphorylation appears to precede degradation, which can then proceed through 
the ubiquitin–proteasome degradation mechanism (Lee et al., 1996). 
 
General PKC signal transduction 
cPKC is expressed universally in every tissue but expression levels of the isoforms of 
cPKC are different throughout tissues and cells. PKC typically phosphorylates serine 
or threonine residues in basic sequences but displays significantly less specificity 
compare to protein kinase A (Kennelly et al., 1991). There are several well-known 
substrates such as Myristoylated alanine-rich C kinase substrate (MARCKS) protein, 
MAP kinase, translation inhibitor protein IκB, Vitamin D kinase receptor (VDR), Raf 
kinase and the EGFR. In addition, activated PKC was shown to regulate transcription, 
and to be involved in learning and memory in neural cells as well as many other 
functions. It is evident from these findings that PKC has a central role in intracellular 
signal transduction (Newton, 1995).  
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  Protein kinase C gamma  
Overview 
Among PKC subtypes, the γ isoform of PKC (PKCγ) is specifically expressed in the 
CNS and is especially abundant in cerebellar Purkinje cells (Saito et al., 1988; Saito 
and Shirai, 2002). In the spinal cord, PKCγ is an important intracellular signalling 
kinase found in a specific subset of excitatory interneurons in the inner region of lamina 
II and in axons of the corticospinal tract (Malmberg et al., 1997; Mori et al., 1990; Polgár 
et al., 1999). In the Purkinje cells of the cerebellum, PKCγ is involved in modulation of 
synaptic plasticity for long term potentiation and depression (Saito and Shirai, 2002). 
PKCγ-deficient mice showed that the developmental elimination of multiple CF 
innervation of Purkinje cells is impaired, which suggests that PKCγ is involved in the 
process of pruning CF synapses from developing Purkinje cells (Kano et al.,1995). 
Moreover, the PKCγ signalling in Purkinje cells negatively regulate the nonselective 
transient receptor potential cation channel type 3 (TRPC3), the opening of which elicits 
slow excitatory postsynaptic potentials at CF-Purkinje cells synapses (Shuvaev et al., 
2011). 
 
PKC gamma genomic and protein structure 
The cDNA for PKCγ was sequenced in 1986 together with those of PKCα and PKCβ, 
then the genomic structure of PKCγ and its chromosomal mapping were analysed. The 
human and mouse PKCγ genes are localized on chromosomes 17ql3.4 and 7, 
respectively. The PKCγ gene is approximately 24.4 kb long and composed of 18 small 
exons varying between 32 and 406 bp in size (Kofler et al., 2002). The AUG translation 
initiation site for open reading frames of PKCγ is localized in exon 1 as for other cPKCs. 
The 5'- flanking region of the mouse PKCγ gene lacks TATA and CAAT boxes but 
contains binding sites for several transcription factors (Takanaga et al., 1995) which 
indicates expression level of PKCγ is regulated by these transcription factors.  
PKCγ has C1 and C2 domains which bind DAG and Ca2+, respectively as mentioned 
above (Bittova et al., 2001). Both second messengers are necessary for the activation 
of cPKCs (Nishizuka et al., 1995). The C1 domain of PKCγ consists of C1A and C1B, 
both of which bind DAG or its agonist with high affinity (Irie et al., 2002). The structures 
of the PKCα, PKCβ. and PKCγ C1 domains are very similar and show high homology, 
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on the other hand, C2 domains which bind to Ca2+ show quite low homology. The 
functional differences resulting from this low homology are unclear, but it is shown that 
PKCγ have higher affinity to Ca2+ than the other isoforms in the presence of 
phosphatydylserine (Saito and Shirai, 2002). 
 
PKC gamma specific functions in nervous system 
The generation of PKCγ knockout mice was reported in 1993 by Abeliovich et al. 
(1993). The PKCγ deficient mice are viable and their brain anatomy is rather normal 
when they are observed by light microscopy. Behaviours such as grooming, feeding 
and mating seem normal, although the mutant mice moved with a mild ataxic gait. It 
was also examined whether lack of PKCγ effected for long term potentiation (LTP) in 
the CA1 region of the hippocampus (Abeliovich et al., 1993). Although synaptic 
transmission evoked by stimulating hippocampal axons in PKC gamma deficient mice 
is indistinguishable from the wildtype mice, LTP is rarely induced by the commonly 
used high frequency stimulation in PKCγ deficient mice. While, the knockout mice can 
learn to carry out hippocampus-dependent tasks, although they exhibit mild deficits in 
spatial and contextual learning (Abeliovich et al., 1993). On the other hand, the 
involvement of PKCγ in long term depression (LTD) induction is strongly suggested by 
reports which show that 1) LTD is blocked by PKC inhibitors, 2) PKC activators such 
as phorbol ester induced depression of synaptic transmission, and 3) PKCγ is the 
major PKC isotype in Purkinje cells (Saito and Shirai, 2002). Thus, the deletion of PKCγ 
would be predicted to abolish LTD. It was also reported that in the L7-PKCI transgenic 
model in which the pseudosubstrate PKC inhibitor was selectively expressed in 
Purkinje cells under the control of the pcp-2 (L7) gene promoter therefore the PKC 
activity is specifically inhibited in the Purkinje cells, result that establishment of LTD at 
the parallel fiber-Purkinje cell synapses was impaired (Lefort et al., 2015). However, 
LTD is fully inducible in cerebellar slices of the PKCγ deficient mice (Chen et al.,1995). 
It is noteworthy that a PKC inhibitor peptide (PKC 19-36) completely blocks LTD in 
wild-type mice but does not abolish LTD in PKCγ deficient mice (Hémart et al., 1995). 
This suggests that PKCγ plays a crucial role in LTD in normal condition or wild type of 
mice but once PKCγ is not available in cells, other isotypes of PKC or other kinases 
can compensate for the PKCγ deficiency. This compensation for the lack of PKCγ by 
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other isotypes of PKC or other kinases makes it difficult to elucidate the specific 
function of PKCγ in PKCγ deficient mice. PKCγ deficient mice exhibit impaired motor 
coordination but are fully capable of discrete motor learning (Kano et al., 1995). In 
mature PKCγ deficient mice, 40% of Purkinje cells remain innervated by multiple CFs, 
while normally these multiple innervations are eliminated during the 3rd week after birth 
in wild-type mice, which result in one-to-one innervation between the Purkinje cells and 
CFs. This result suggest that PKCγ is also crucial for one-to-one innervation between 
the Purkinje cells and CFs. There are several reports of other knockout mice which 
exhibit this persistent multiple innervation of Purkinje cells by CFs. Mice deficient in 
metabotropic receptor 1 (mGluRl) (Kano et al., 1997) or phospholipase C (PLC) (Kano 
et al., 1998) show a similar phenotype of multiple CFs innervation and motor 
discoordination. Taken together, the results from PKCγ deficient mice as well as 
mGluRl or PLC deficient mice suggest that an mGluR1-PLC-PKCγ signaling pathway 
in cerebellar Purkinje cells is involved in the elimination of CFs and play important role 
for motor coordination with persistent multiple innervation of Purkinje cells by CFs. 
 
Modulation of receptor function 
As mentioned above, PKCγ is specifically expressed in CNS and abundantly 
expressed in Purkinje cells. It is also reported that PKCγ is abundant in the dorsal horn 
of the spinal cord and has been suggested to be important in sensory signal processing 
including pain. Several studies have shown that activation of μ-opioid receptors in the 
spinal cord induce prolonged PKC translocation (Narita et al., 1994) and that inhibition 
of PKC prevents the development of anti-nociceptive tolerance to μ-opioid agonists 
(Narita et al., 2001). Within PKC isotypes, the evidence that selective μ-opioid receptor 
agonists increase the amount of membrane-associated PKCγ but no other PKC 
isotypes, and desensitize μ-opioid receptor mediated G-protein activation has been 
reported (Narita et al., 2001). This showed the involvement of PKCγ signaling for pain. 
Using PKCγ deficient mice, it has been demonstrated that activation of PKCγ is critical 
for the development of morphine induced reinforcing and enhancement of nociceptive 
responses (Martin et al., 1999). Also the result from PKC inhibitor, Gö6976 treatment, 
showed that PKC is involved in morphine mediated c-Jun N-Terminal Kinase activation, 
which lead G protein-coupled receptor desensitization (Kuhar et al., 2015). 
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Furthermore, PKCγ deficient mice failed to develop a neuropathic pain syndrome after 
partial nerve section (Malmberg et al., 1997). These findings suggest that PKCγ has 
crucial role for induction of the psychological dependence on morphine and the 
development of a PKCγ-specific inhibitor may enable us to alleviate pain by protecting 
the tolerance. It is also interesting that epinephrine-induced hyperalgesia is also 
attenuated in mice lacking PKCε, a presynaptic localized isotype of nPKC (Khasar et 
al., 1999). Later study showed that epinephrine induces short-term hyperalgesia, which 
depends on protein kinase A (PKA) and PKCε activity (Wei-Yu et al., 2015). Although 
both PKCγ and PKCε act at different levels, both isotypes play an important role in pain 
responses.  
The modulation of GABAA receptors by PKC was also reported (Krishek et al., 1994 
and Lin et al., 1994). It is shown that PKCβ, PKCγ, and PKCε are associated with 
GABAA receptors (Brandon et al., 1999; Kumar et al., 2002). There are controversial 
reports upon the role of PKC for GABAA receptors. The response of GABAA receptors 
expressed in Xenopus oocytes is inhibited by PKC activator, phorbol esters and the 
mutation of the GABAA receptor in a possible PKC phosphorylation site, Ser343, 
reduced the effect of PKC activation (Krishek et al., 1994). In contrast, the activity of 
GABAA receptors expressed in fibroblasts is enhanced by active PKC (Lin et al., 1994). 
Taken together PKC has crucial role for GABAA receptors modulation negatively or 
positively depending on cells. 
Ethanol and benzodiazepines are known to enhance the function of GABAA receptors 
and the effect of ethanol on GABAA receptor α1 subunit surface expression is PKC-
dependent (Kumer et al., 2010). The mutation of Ser343 in the gamma 2L subunit 
which is a possible PKC phosphorylation site prevented ethanol potentiation but not 
benzodiazepine potentiation. GABAA receptors isolated from brain membranes of 
PKCγ deficient mice do not respond to ethanol (Harris et al., 1995). Behaviourally, 
PKCγ deficient mice show reduced sensitivity to the acute effects of ethanol on righting 
reflex and body temperature, but show normal responses to pentobarbital. PKCγ 
deficient mice display decreased tolerance development to the sedative hypotonic and 
hypothermic effects of ethanol (Bowers et al., 2001), suggesting that these PKCγ 
deficient mice may be a good model for the study of alcoholism. In contrast to PKCγ 
deficient mice, PKCε deficient mice show hypersensitivity to allosteric activation by 
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ethanol and fluinitrazepam and exhibit reduced ethanol self-administration (Hodge et 
al., 1999). These findings suggest that two PKC isotypes, PKCγ and PKCε, modulate 
the sensitivity of GABAA receptors to ethanol but have opposite actions on GABAA 
receptor activity. 
 
  Mutations of the PKC gamma gene related to disease 
Genomic mapping was performed in order to search for functional PKC mutations 
associated with familial genetic abnormalities and revealed that a major locus of 
retinitis pigmentosa (RP) exists at chromosome position 19q, which includes the PKCγ 
gene. Additionally, a point mutation in PKCγ that segregates with RP was found in two 
RP families. The mutation is in the catalytic domain of PKCγ (Osborne et al., 1992), in 
which the effect on the kinase activity of PKCγ is unclear, but it is possible that this 
mutation affects PKCγ kinase activity because this point mutation is present between 
the turn motif (Thr655) and the hydrophobic motif (Thr674) (Newton, 1997) which are 
important conserved kinase domains.  
Another report suggests that PKCγ is a candidate gene for Parkinson syndrome. The 
AS/AGU rat, which has a nonsense mutation in PKCγ, exhibits altered behaviour and 
brain pathology like progressive dopaminergic neuronal degeneration in the substantia 
nigra, and lower extracellular levels of dopamine in the striatum, which resembling 
Parkinson syndrome (Shirafuji et al., 2014). It has been shown that this mutation in 
PKCγ leads to the early termination at the C2 domain without possessing the catalytic 
domain (Craig et al., 2001). This new stop codon would truncate the PKCγ protein at 
280 amino acids, resulting in expression of truncated PKCγ. At an early age in the 
AS/AGU rat, the extracellular dopamine levels are markedly decreased and later loss 
of dopaminergic cells in the substantia nigra and dysfunction of movement are reported 
(Campbell et al., 2000). It is also noteworthy that LTP in the CA1 region of the 
hippocampus from AS/AGU rats is normal (Shahraki et al., 2002), while LTP in PKCγ 
deficient mice is impaired under the conventional condition described above. These 
results indicated C1 domain of PKCγ has crucial role for LTP and truncated PKCγ in 
AS/AGU rats still has function for LTP.  
Overall, functional PKCγ is crucial for memory and motor coordination as well as 
neuronal development.  
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2. Aims of the project  
   Estimation of the amount of mutant PKC gamma protein expression in 
mPKCγ transgenic mice 
 
Previously it was shown that chronic activation of PKC in organotypic slice cultures 
strongly inhibits Purkinje cell dendritic growth (Schrenk et al., 2002). The question 
arises weather mPKCγ has an increased PKC activity and therefore may cause 
inhibition of Purkinje cell dendritic growth.  
In order to search for mechanisms of Purkinje cell dysfunction, our laboratory has 
established mutant PKCγ transgenic mice as a model for SCA14. These transgenic 
mice are carrying a mutation from a human SCA14 allele in the catalytic domain of 
PKC gamma in Purkinje cells. They show a mild ataxic phenotype and abnormal 
Purkinje cell morphology in organotypic slice culture while Purkinje cell morphology in 
vivo is mostly normal. One reason for the rather mild phenotype could be that the 
transgenic expression of the mutated PKCγ may be rather weak and could be 
balanced by the presence of the normal PKCγ protein expressed from the 
endogenous alleles. In order to be able to evaluate the proportion of mutated mRNA 
and protein present in Purkinje cells of S361G transgenic mice I have analysed 
transgene expression level in these mice with real time quantitative PCR and 
Western blot analysis. 
 
  Will mutations from SCA14 patients located in different domains PKCγ 
have similar effects on Purkinje cell dendritic development? 
 
We have previously shown that mutant PKCγ transgenic mice carrying a mutation 
from a human SCA14 allele located in the kinase activity had abnormal Purkinje cell 
dendritic growth and development (Ji et al., 2014). These results indicate that S361G 
mutant PKCγ has an increased biological activity, which results in inhibition of 
Purkinje cell development. This finding raises the question whether or not other 
SCA14 mutations will also negatively regulate Purkinje cell dendritic growth. In this 
project I constructed vectors carrying mutations located in different protein domains 
of PKCγ and transfected them to Purkinje cells in dissociated cerebellar cultures. 
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Then I analysed whether SCA14 mutations from different domains of PKCγ will show 
the same effect on Purkinje cell development and morphology. 
 
  Search for molecules involved in signalling of mutant PKC gamma in 
Purkinje cells 
 
The major project of my thesis was to search for potential signalling molecules 
downstream of mutant PKCγ which might be related to dendritic growth inhibition of 
Purkinje cells. As mentioned, in the S361G mutant PKCγ transgenic mice which 
served as a SCA14 model it was found that mutant PKCγ has an increased PKC 
biological activity evident by Purkinje cell dendritic growth inhibition in organotypic 
slice cultures. This finding suggests that in the SCA 14 mutation there is constitutive 
activation of PKC which causes inhibition of Purkinje cell dendritic growth. But the 
intermediate steps of the PKCγ signalling cascade eventually leading to the inhibition 
of dendritic growth are still unknown. The aim of this project was to search for 
signalling targets of activated PKCγ related to Purkinje cell morphology. 
In order to search for such molecules I performed a gene chip assay searching for 
mRNAs with an increased expression in cerebellar slice cultures from mutant PKCγ 
mice compared to slice cultures from control mice. In a second step I identified and 
further studied potential candidate molecules with an increased expression in 
Purkinje cells from S361G mutant mice with the aim of confirming or excluding a role 
of these molecules for the PKCγ-mediated inhibition of dendritic growth. 
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3. Materials and Methods  
  Plasmids construction 
  Plasmids pCMV6-XL4- PKCγ-S361G 
Materials 
• Primers were generated by Microsynth 
• Pfu DNA polymerase (Invitrogen) 
• QIAquick Gel Extraction Kit (Qiagen, Ca No. 28704) 
• QIAprep Spin Miniprep Kit (Qiagen, Ca No. 27104) 
• EndoFree Plasmid Maxi prep kit (QIAGEN, Ca No.12362) 
• Human PKCγ gene in pCMV6-XL4 (Origene). 
 
Insert point mutation 
• Mutated PKCγ genes were produced by site-directed mutagenesis PCR with 
the pCMV6-XL4-PKCγ. PCR was performed with the Pfu DNA polymerase 
(Invitrogen, Carlsbad, CA, USA) for 30 cycles (30 sec at 95°C, 45 sec at 57°C, 
and 8 min at 68°C), using the following primers:  
S361G forward primer: 5’- gttctaggaaaaggcggttttgggaaggtgatgctg -3’,  
S361G reverse primer: 5’- catgaggaagctgaagtcggagatg -3’.  
• The PCR products were then incubated with DpnI which only digests the 
parental methylated cDNA and the constructed mutated expression vectors 
were confirmed by DNA sequencing (Microsynth, Balgach, Switzerland).  
• After transformation, Plasmids were obtained with EndoFree Plasmid Maxi prep 
kit (QIAGEN). 
 
  Plasmids pL7-Car8-GFP and pL7-PKCγ-GFP 
Materials 
• Primers were generated by Microsynth 
• PrimeSTAR® Max Premix Polymerase (Clontech, Ca No. R045A) 
• In-Fusion® HD Cloning Kit (Clontech, Ca No. 638912) 
• QIAquick Gel Extraction Kit (Qiagen, Ca No. 28704) 
• QIAprep Spin Miniprep Kit (Qiagen, Ca No. 27104) 
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• EndoFree Plasmid Maxi prep kit (QIAGEN, Ca No.12362) 
• Car8 and PKCγ plasmids (Origene) 
• pL7 GFP vector (Dr. Wolfgang Wagner University Medical Center Hamburg-
Eppendorf Center for Molecular Neurobiology Hamburg (ZMNH) Department of 
Molecular Neurogenetics). The structure of this vector is shown in Fig. 7. 
• Ampicillin (100 mg/ml stock)  
• LB (Luria-Bertani) medium (pH 7.0) 
• LB / Ampicillin plates 
• Agarose (SIGMA, Ca No. A9539) 
• TBE buffer (89 mM Tris-borate / 2 mM EDTA) 
• Ethidium bromid (MERCK) 
Restriction sites were added to the Car8 and PKCγ genes by polymerase chain 
reaction (PCR) using the following primers.  
CA8 F primer: 5’- cag gat cca gcg gcc gca tgg ctg acc tga gct tc -3’,  
CA8 R primer: 5’- ccc ttg ctc acc atg gcc tga aag gcc gct cgg a -3’,  
PKCγ F primer: 5’- cag gat cca gcg gcc gca tgg ctg gtc tgg gcc cc -3’,  
PKCγ R primer: 5’- ccc ttg ctc acc atg gcc atg acg ggc aca ggc a -3’.  
 
Methods 
Amplification of the DNA inserts was done according to the following protocol. 
The insert DNA PCR reaction was set up as followed. 
• PrimeSTAR® Max Premix (2×)   12.5 μl 
• Forward Primer, 5 μM        1 μl 
• Reverse Primer, 5 μM          1 μl 
• Template 200 ng               1 μl 
• Sterile deionized H2O up to 25 μl   9.5 μl  
PCR reaction was performed as following protocol. 
• 98°C    10 sec 
• 55°C    5 sec 
• 72°C   30 sec/kb 
The reaction was done for 35 cycles and PCR products were stored at 4°C. 
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Fig. 7 Structure of plasmid pL7 
(A) Schematic of plasmid pL7. The L7 DNA fragment (shown in blue) contains a 
promoter sequence, as well as all of the exons (dark blue) and introns that comprise 
the small L7 structural gene. All of the AUG codons present in exons 1A, 1B, 2, 3, 
and 4 were mutated (Serinagaoglu et al., 2007) to ensure that translation starts within 
the cDNA inserted into the multiple cloning site (MCS; red). The indicated restriction 
sites are present only once in the vector (except for BamHI). (B) Schematic maps of 
plasmids pL7-mGFP. (C) DNA sequences immediately upstream and downstream of 
the fluorescent protein cDNAs. Restriction sites that occur only once in these 
plasmids are shown in red. (Wagner et al., 2011) 
In order to add the expressing genes at the N terminal of mGFP, Not1 and Nco1 
restriction sites in MCS were used for cloning. 
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Gel purification of the PCR products: To get the purified DNA fragment from the PCR 
product mixture, an Agarose gel was prepared as followed. 
• Agarose        1.3 g 
• 1 × TBE       130 ml 
• Ethidium bromid      6.5 μl 
PCR products were mixed with 5 × Sample buffer.  
• 5 × Sample buffer 5 μl 
• Marker or Sample   20 μl 
Agarose Gel electrophoresis was done with 150 V for 1 hour. 
After Agarose Gel electrophoresis, purification of DNA fragments from gels were done 
with QIAquick Gel Extraction Kit (Qiagen). 
These purified PCR products and L7-GFP vector were then incubated together in the 
presence of the restriction enzymes, NotI and NcoI (New England BioLabs, 
Massachusetts, USA) in New England CutSmart buffer. After 30-60 min incubation at 
37°C, DNA fragment and linearized vector were fused using in-Fusion HD Cloning Kits 
(Clontech) as following reaction. 
• 5 × In-Fusion® HD Enzyme Premix    2 μl  
• Vector            1 μl 
• PCR fragment      2 μl 
• H2O up to      10 μl 
The aluminum seals were peeled back from the tubes. 
The 10 μl volume of the mixture was adeded to HD EcoDry pellet and then mixed well 
by pipetting up and down.  
The reactions were incubated for 15 min at 37°C, followed by 15 min at 50°C, then 
tubes were placed on ice.  
Reactions were continued to the transformation procedure. 
Transformation: 
• DH5𝛼𝛼 competent cells (In-Fusion® HD Cloning Kits) were taken from -70°C and 
put on ice. 
• DH5𝛼𝛼 competent cells were put on benchtop to thaw and then put on ice. 
• After mixing gently, 1.25 μl ligated DNA was added to each tube.  
• Then tubes were incubated on ice for 30 min.  
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• Tubes were placed for heat shock in 42°C water bath for 45 sec without shaking. 
• Tubes were put on ice for 2 min.  
• 900 μl S.O.C. medium (2% Tryptone, 0.5% Yeast Extract, 0.4% glucose, 10 mM 
NaCl, 2.5 mM KCl, 10 mM MgCl2, & MgSO4) was added to each tube. 
• Tubes were gently shaken and incubated at 200 rpm for 30-60 min at 37°C. 
• Cells were spread on LB agar plates containing 100 μg/mL ampicillin as 
antibiotic. 
• Plates were placed in the 37°C incubator with the agar side up and the lid side 
down.    
• Next day, Plates were collected and several colonies were picked up. 
• Using QIAprep Spin Miniprep Kit (Qiagen), Plasmids were extracted. 
The constructed expression vectors were confirmed by DNA sequencing (Microsynth).  
• After conformation of sequence, plasmid were were obtained with EndoFree 
Plasmid Maxi prep kit (QIAGEN). 
 
  Mutated or deleted PKCγ-GFP 
Materials 
• Primers were generated by Microsynth 
• GENEART® Site-Directed Mutagenesis System (Invitrogen, Ca No. A13282) 
• AccuPrime™ Pfx DNA Polymerase (Invitrogen, Ca No. 12344-024)  
• QIAprep Spin Miniprep Kit (Qiagen, Ca No. 27104) 
• EndoFree Plasmid Maxi prep kit (QIAGEN, Ca No.12362) 
• pL7 GFP vector (Dr. Wolfgang Wagner University Medical Center Hamburg-
Eppendorf Center for Molecular Neurobiology Hamburg (ZMNH) Department of 
Molecular Neurogenetics) 
• Ampicillin (100 mg/ml stock)  
• LB (Luria-Bertani) medium (pH 7.0) 
• LB/ Ampicillin plates 
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Primers 
G118D F primer: 5’ -ctgcgaccactgtgactccctcctctacgggctt -3’,  
G118D R primer: 5’-aaggtg gggctgctgtagctatgc a -3’;  
Deletion260-280 F primer: 5’ -gaggagggcgagtattacaatgtgc -3’,  
Deletion260-280 R primer: 5’-catggcccccatgaagtcgttgcg -3’;  
S361G F primer: 5’ – gttctaggaaaaggcggttttgggaaggtgatgct g -3’,  
S361G R primer: 5’-catgaggaagctgaagtcggagatg -3’,  
S119P F primer: 5’- ttctgcgaccactgtggcttcctcctctacgggcttgt -3’,  
S119P R primer: 5’- acaagcccgtagaggaggaagccacagtggtcgcagaa -3’,  
V138E F primer: 5’- cctgctgcgagatgaacgagcaccggcgctgtgtgcgt -3’,  
V138E R primer: 5’- acgcacacagcgccggtgctcgttcatctcgcagcagg -3’, 
F643L F primer: 5’- gcagcggcgagaacttagacaagttcttcacgc -3’,  
F643L R primer: 5’- gcgtgaagaacttgtctaagttctcgccgctgc-3’. 
 
Methods 
Mutated or deleted PKCγ were produced by site-directed mutagenesis PCR with the 
pCMV6-XL4-PRKCG. Using the following reaction mixture PCR was performed with 
AccuPrime™ Pfx DNA Polymerase (Invitrogen). 
• 10 × AccuPrime™ Pfx Reaction mix  5 μl  
• 10 × Enhancer     5 μl  
• Primer mix (10 μM each)    1.5 μl (0.3 μM each) 
• Plasmid DNA (20 ng/μl)    1 μl (20 ng) 
• DNA Methylase (4 U/μl)    1 μl (4 units) 
• 25 × SAM      2 μl  
• AccuPrime™ Pfx (2.5 U/μl)  0.4 μl (1 unit) 
• H2O      32.6 μl 
PCR reaction was performed with following protocol. 
(1) 37ºC  20 min 
(2) 94ºC  2 min  
(3) 94ºC  20 sec 
(4) 57ºC 30 sec 
(5) 68ºC  2 min and 18 cycles (3)-(5)  
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(6) 68ºC  5 min  
The PCR products were stored at 4°C. 
The reactions were continued to the transformation procedure as mentioned. 
The constructed expression vectors were confirmed by DNA sequencing (Microsynth).  
 
  pcDNA™6.2-GW/miR and pL7-Car8 miRNA-GFP 
Materials  
• Primers were generated by Microsynth 
• the BLOCK-iT™ Pol II miR RNAi expression vector (Invitrogen, Ca No.K4935-
00)  
• QIAprep Spin Miniprep Kit (Qiagen, Ca No. 27104)  
• EndoFree Plasmid Maxi prep kit (QIAGEN, Ca No.12362) 
• pL7 GFP vector (Dr. Wolfgang Wagner University Medical Center Hamburg-
Eppendorf Center for Molecular Neurobiology Hamburg (ZMNH) Department of 
Molecular Neurogenetics) 
• Ampicillin (100 mg/ml stock)  
• Spectinomycin (50 mg/ml stock) 
• LB (Luria-Bertani) medium (pH 7.0)  
• LB/spectinomycine plates  
• LB/ Ampicillin plates 
• Agarose (SIGMA, Ca No. A9539) 
• TBE buffer (89 mM Tris-borate / 2 mM EDTA) 
• Ethidium bromid (MERCK) 
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miRNAs were designed and generated using the online tool by Life Technologies to 
target Car8. 
miRNA Oligo Sequence (5'-3') 
mi327 mi327-
Top 
TGC TGA CTT CAT ACA GCT CAA ACT CCG TTT TGG 
CCA CTG ACT GAC GGA GTT TGC TGT ATG AAG T 
mi327-
Bottom 
CCT GAC TTC ATA CAG CAA ACT CCG TCA GTC AGT 
GGC CAA AAC GGA GTT TGA GCT GTA TGA AGT C 
mi616 mi616-
Top 
TGC TGA AGA GGG TCT GGT AAT AAA GTG TTT TGG 
CCA CTG ACT GAC ACT TTA TTC AGA CCC TCT T 
mi616-
Bottom 
CCT GAA GAG GGT CTG AAT AAA GTG TCA GTC AGT 
GGC CAA AAC ACT TTA TTA CCA GAC CCT CTT C 
mi686 mi686-
Top 
TGC TGA TAT CCA GGT AAC TCC TTC GCG TTT TGG 
CCA CTG ACT GAC GCG AAG GAT ACC TGG ATA T 
mi686-
Bottom 
CCT GAT ATC CAG GTA TCC TTC GCG TCA GTC AGT 
GGC CAA AAC GCG AAG GAG TTA CCT GGA TAT C 
  
Methods 
Each miRNA was generated by Microsynth and cloned into the BLOCK-iT™ Pol II miR 
RNAi expression vector (Invitrogen) according to the instructions of the manufacturer, 
briefly shown below. 
• 5 μl Top strand DNA oligo (200 μM), 5 μl Bottom strand DNA oligo (200 μM), 2 
μl 10 × Oligo Annealing Buffer and 8 μl DNase/RNase-Free Water were added 
in 1.5 ml tube. 
• The mixture tubes were incubated at 95°C for 4 min. 
• The tubes containing the annealing reaction were removed from the heat block 
and set on bench. 
• To complete annealing, the reaction mixtures were put on the bench to cool to 
room temperature for 10 min.  
• Reaction mixtures were centrifuged for 5 sec. 
• 1 μl of the annealing mixture was removed and diluted 100-fold into 
DNase/RNase-free water to obtain a final concentration of 500 nM of ds oligo.  
• Then vortexed to mix thoroughly. 
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• 500 nM ds oligo mixture was diluted 50-fold into Oligo Annealing Buffer as 
follows to obtain a final concentration of 10 nM. Then annealing was checked 
with Agarose Gel electrophoresis. 
• To obtain the miRNA plasmid, set up a 20 μl ligation reaction at room 
temperature using the following reagents. 
• The mixtures were incubated for 5 min at room temperature. 
• The reaction tubes were placed on ice and proceeded to transforming to One 
Shot® TOP10 Competent E. coli and then sequenced (Microsynth).  
 
Then pcDNA6.2-GW/miRNA expression vectors containing Car8 miRNAs were user 
for transfection to Hela cells. After choosing the best miRNAs with Hela transfection,  
 
pcDNA6.2-GW/miRNA expression vectors containing Car8 miRNAs were sub cloned 
to pL7 in order to transfect miRNA to Purkinje cells. 
Restriction sites were added to the miRNA ds F primer and R primer, then proceeded 
as mentioned above.  
Insert miRNA PCR (mi327 and mi616) 
• PrimeSTAR® Max Premix (2×)   12.5 μl 
• Forward Primer, 5 μM        1.0 μl 
• Reverse Primer, 5 μM          1.0 μl 
• Template 200 ng               1.0 μl 
• Sterile deionized H2O up to 25 μl   9.5 μl  
PCR reaction was performed as following protocol. 
• 98°C  10 sec 
 sample control 
5 × Ligation Buffer 4 μl 4 μl 
pcDNA™6.2-GW/miR, linearized (5 ng/μl) 2 μl 2 μl 
miR-ds oligo or miR-lacZ positive ds control oligo miR-ds oligo 4 μl miR-lacZ 4 μl 
DNase/RNase-Free Water 9 μl  9 μl  
T4 DNA Ligase (1 U/μl) 1 μl 1 μl 
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• 55°C   5 sec  
• 72°C  30 sec/kb 
The reaction was done for 35 cycles and PCR products were stored at 4°C. 
Gel purification of the PCR products: To get the purified DNA fragment from the PCR 
product mixture, an Agarose gel was prepared as followed. 
• Agarose        1.3 g 
• 1 × TBE       130 ml 
• Ethidium bromid      6.5 μl 
PCR products were mixed with 5 × Sample buffer.  
• 5 × Sample buffer 5 μl 
• Marker or Sample   20 μl 
Agarose Gel electrophoresis was done with 150 V for 1 hour. 
After Agarose Gel electrophoresis, purification of DNA fragments from gels were done 
with QIAquick Gel Extraction Kit (Qiagen). 
These purified PCR products and L7-GFP vector were then incubated in the presence 
of the restriction enzymes, bgl2 (New England BioLabs) in New England 3.1 buffer. 
After 30 min incubation at 37°C, DNA fragment and linearized vector were fused with 
T4 ligase (New England BioLabs). 
 
T4 ligase reaction: The following reaction was set up in a microcentrifuge tube on ice. 
COMPONENT  
10 × T4 DNA Ligase Buffer 2 μl 
Vector DNA 1 μl 
Insert DNA 3 μl 
DNase/RNase-Free Water 13 μl 
T4 DNA Ligase 1 μl 
 
• The reaction components were gently mixed by pipetting up and down followed 
by brief microcentrifuge.  
• Tubes were incubated for 2 hours on bench.  
• Heat inactivation was done at 65°C for 10 min.  
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• Tubes were placed on ice and proceeded to transforming One Shot® TOP10 
Competent E. coli. Then sequenced (Microsynth).   
 
Plasmid containing miRNA were amplified using E.coli and purified with QIAGEN 
Endfree Maxiprep (Qiagen), then they were used for transfection. 
The structure of the plasmid pL7 with miRNA is shown in Fig. 8. 
 
 
 
Fig. 8 Structure of plasmid pL7 with miRNA  
Schematic of plasmid pL7-mGFP with miRNA. The L7 DNA fragment (shown in pink) 
contains a promoter sequence, as well as all of the exons and introns that comprise 
the small L7 structural gene. miRNA (miCont, mi327 and mi616) were inserted 
downstream of mGFP in order to ensure that transfection is visualize with 
fluorescence.  
 
 Plasmid transfection to Hela cells 
In order to test the knockdown efficacy, three type of miRNA vectors (mi327, mi616, 
mi686) were transfected into HeLa cells together with a Car8 expression vector using 
Lipofectamin 2000 (Life Technologies, Zug, Switzerland).  
mGFP 2702..3436
pUC ori 4357..5024
L7/PCP2 3607..3915
mi327 3445..3587
AmpR 5872..5172
pL7-GFP mi327
6849 bp
L7/PCP2 1..2660
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  Materials 
Ingredients for 200 ml culture medium 
• 180 ml Dulbecco’s modified Eagle medium (Gibco) 
• 20 ml FBS (GIBCO) 
• 1N NaOH or 1N HCl to adjust pH to 7.2-7.4 
75 cm2 flask (FALCON, Ca No. 353136) 
6 well cell culture plate (FALCON, Ca No. 353046) 
Tripsin 
Lipofectamine™ 2000 (Life Technologies) 
Plasmid (mentioned above) 
 
  Procedure 
• HeLa cells were cultured with 10% FBS containing culture medium. 
• The day before transfection, 2.5 × 105 HeLa cells were plated in 2.5 ml of 
growth medium without antibiotics so that cells will be 90-95% confluent atthe 
time of transfection.  
• Hela wells in a 6-well plate were transfected using Lipofectamine™ 2000 
reagent with 100 ng Car8-GFP plasmid and co-transfected with 100 ng of 
miRNA expression vectors.  
• Cell lysates were prepared 48 hours after transfection and assayed by 
Western Blotting and immunostaining.  
 
 Real time qPCR 
  cDNA reverse transcription 
Total RNA was extracted as described. 
Template for cDNA reverse transcription is showed below. 
1 μg total RNA 1.0 μl 
H2O 12.2 μl 
10 × randam hexmer 2.0 μl 
10 × Buffer 2.0 μl 
Protector RNase Inhibitor, 40 U/μl 1.0 μl 
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25 ×  dNTP 10 mM 0.8 μl 
TranscriptorReverse Transcriptase 10 U/tube 1.0 μl 
Final volume 20.0 μl 
 
PCR reactions were run on PCR cycler (Mastercycler gradient, Eppendorf) under the 
following reaction conditions. 
25°C 10 min→ 37°C 120 min→ 85°C 5 min 
 
  Quantitative real-time PCR 
Quantitative real-time PCR reactions were conducted in a total volume of 20 μl as 
described. 
cDNA, 100 ng/μl  0.3 μl 
F primer, 5 μM 0.5 μl 
R primer, 5 μM 0.5 μl 
Mastermix with SYBR green 10.0 μl 
ultrapure water 8.5 μl 
 
Real-time PCR reactions were run on a 48-well format with One step real-time detector 
(Applied Biosystems) under the following reaction conditions. 
• 1 cycle 95°C for 10 min 
• 40 cycles of 94°C for 15 sec → 65°C for 60  sec 
• 1 cycle of 95°C for 15  sec → 72°C for 30  sec → 95°C for 15  sec 
 
Oligonucleotide primers were designed using the Primer 3 software 
(http://frodo.wi.mit.edu/primer3/).  
Primer sequences were described in Plasmid construction part. 
 
  SDS-PAGE 
  Materials 
Tris (AppliChem, Ca No. A1086) 
Glycine (SIGMA, Ca No. G7126) 
SDS (BIORAD, Ca No. 161-0301) 
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TritonX-100 was from (Fluka, Ca No. 93148) 
Electrophoretic apparatus was from BIORAD 
10 × RIPA buffer 
• 0.5 M Tris-HCl, pH 7.4 
• 1.5 M NaCl 
•  2.5% Sodium Deoxycholate 
• 10% NP-40 
• 10 mM EDTA 
After making 1 × RIPA buffer, add following inhibitors 
• phosphatase inhibitor (phosphor STOP, Roche) 
• protease inhibitor (complete, Roche , Ca No. 11697498001) 
Running gel solution (10% Acrylamide) 
• 7.5 ml 1.5 M Tris-HCl, pH 8.8 
• 0.15 ml 20% (w/v) SDS 
• 9.9 ml Acrylamide/Bis-acrylamide (30%/0.8% w/v) 
• 12.3 ml H2O 
• 0.15 ml 10% (w/v) ammonium persulfate (APS) (BIORAD, Ca No. 161-0700 ) 
• 0.02 ml TEMED (AppliChem, Ca No. A1148) 
Stacking gel solution (4% Acrylamide) 
• 1.25 ml 0.5 M Tris-HCl, pH 6.8 
• 0.025 ml 20% (w/v) SDS 
• 0.67 ml Acrylamide/Bis-acrylamide (30%/0.8% w/v) 
• 3.075 ml H2O 
• 0.025 ml 10% (w/v) ammonium persulfate (APS) 
• 0.005 ml TEMED 
1 × Running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) 
• 3.02 g Tris 
• 14.4 g glycine 
• 1 g SDS 
• 1000 ml H2O 
1 × Transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol) 
50 
 
 
• 3.02 g Tris 
• 14.4 g glycine 
• 200 ml methanol 
• 800 ml H2O 
1 × TBS solution (10 mM Tris-Cl, pH 7.4-7.6; 150 mM NaCl) 
• 8.76 g NaCl  
• 1.21 g Tris 
• Add HCl and adjust pH to pH 7.4-7.6 
• Add H2O fill to 1000 ml 
Blocking buffer 
• 5% BSA (GIBCO) in TBS 
T-TBS 
• 950 ml 1 x TBS Solution 
• 50 ml 10% TritonX-100  
 
  Procedure 
• Cells were harvested with cell scraper. 
• Samples were then homogenized in RIPA buffer with phosphatase inhibitor 
and protease inhibitor. 
• Homogenates were sonicated for 5 sec a total of 5 times and cleared by 
centrifugation at 14,000 × g for 15 min at 4°C.  
• Protein concentrations were determined with Nano drop or BCA kit (BioRad).  
• 100 µg of each sample mixed with H2O and 2 × sample buffer. 
• Samples were denatured at 95°C for 5 min. 
• Running gel was filled and stacking gel solution was made, and comb was put 
on the Stacking gel.  
• Then the comb was removed and the gel was clamped to the electrophoretic 
apparatus. 
• The electrolyte compartment was filled with running buffer. 
• After checking for leaks the bottom compartment was filled.  
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• With a plastic Pasteur pipette, thoroughly rinse each well in the stacking gel 
with running buffer.  
• The samples were applied by using a micropipette to carefully add 10 µl of 
protein in a well.    
• The electrical connections were checked. 
• Samples were run at 120 V for 2 hours. 
• The gel was carefully removed and was transferred in transfer buffer. 
• Filter papers were placed onto the semi dry blotter.  
• These are then wetted with transfer buffer  
• The gel is put onto the filters and a pre wetted nitrocellulose filter was put on 
top of the gel.  
• Then three more wetted filters should be placed on top of the pile, again taking 
great care not to have any air bubbles in the pile. The top of the apparatus and 
was fixed by tightening the screws. Proteins in transfer buffer were negative in 
charge mostly due to residual SDS. 
• After blotting, membranes were blocked with 5% BSA in TBS for 1 hour and 
incubated with appropriate Primary antibodies.  
• After washing with TBS-T, 3 times for 10 min, membranes were incubated with 
HRP-labelled secondary antibodies for 1 hour. 
• After washing 3 times with TBS-T, the membrane was gently shaken with 
ECL2 Western blotting substrate (PIERCE, 80196). 
• Immunoreactive bands were visualized in X-ray film (FUJI) or C-DiGit Western 
blot scanner and software (LI-COR Biosciences).  
 
 Immunoprecipitation 
  Materials 
• Protein G (Pierce) or Pierce cross link Immunoprecipitation kit (Pierce) 
• Protein samples 
 
  Procedure 
• Cells were harvested in the tubes. 
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• Cells were then homogenized in RIPA buffer with phosphatase inhibitor and 
protease inhibitor. 
• Homogenates were sonicated for 5 sec a total of 5 times and cleared by 
centrifugation at 14,000 x g for 15 min at 4 °C.  
• Protein concentrations were determined with Nano drop.  
• 100 µg of each sample were used for immunoprecipitation. 
For immunoprecipitation with the kit, the following procedure was done 
• Protein G was washed for two times at 12000 x g 10 sec with PBS 
• Lysate was incubated with 50 µl Protein G for 30 min at 4 °C. 
• Lysate was washed twice at 12000 x g 10 sec with PBS 
• 1µg antibody, 50 µl beads and 50 µl PBS were mixed at RT for 1 hour.  
• Mixture was centrifuged 4°C for 2 min at 3000g  
• The antibody binding Protein G was washed with 1ml PBS 4°C for 2 min at 
3000 x g 
• The antibody binding Protein G was washed with 1ml PBS 4°C for 2 min at 
3000 x g 
• 20 µl sample were mixed with 20 µl sample buffer. 
• Samples were denatured at 95°C for 5 min. 
• Then proceeded as the same way as mentioned in SDS-PAGE. 
 
 Cerebellar slice culture  
  Materials  
Ingredients for 200 ml preparation medium 
• 100 ml minimal essential medium (MEM) (Gibco, Ca No. 11012), in twofold 
concentration 
• 98 ml Aqua bidest   
• 1 ml Glutamax  (Gibco, Ca No. 35050) 
• 1 N NaOH or 1 N HCl to adjust pH to pH 7.2-7.4 
Ingredients for 100 ml Incubation medium 
• 25 ml MEM (Gibco, Ca No. 11012), in twofold concentration 
• 23.5 ml Aqua bidest  
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• 25 ml Basal Medium Eagle, with Earl’s salt, without glutamine (Gibco, Ca No. 
21400)  
• 25 ml horse serum, heat-inactivated (Gibco, Ca No. 26050) 
• 1 ml Glutamax (Gibco, Ca No. 35050) 
• 700 µl of a 10% glucose solution 
• 1 N NaOH or 1 N HCl to adjust pH to pH 7.2-7.4 
Ingredients for 100 ml Neurobasal medium 
• 97 ml Neurobasal A medium (Gibco, Ca No. 10888) 
• 2 ml B27 supplement (Gibco, Ca No. 17504) 
• 1 ml Glutamax (Gibco, Ca No. 35050) 
• 1 N NaOH or 1 N HCl to adjust pH to pH 7.2-7.4 
Dishes and plates 
• 6 well plates (BD Falcon, Ca No. 353046) 
• 35 mm dishes (Greiner, Ca No. 627102) 
• Millicell CM tissue culture Inserts (Millipore, Ca No. PICM 03050) 
 
Preparation 
• A sterilized razorblade was installed on a tissue chopper (McIllwain). 
• Petri dishes (Greiner) were half-filled with ice-cold preparation medium and kept 
at 4°C, 2-3 dishes per mouse pup were required. 
• 750μl of incubation medium or Neurobasal medium was pipetted in each well of 
a tissue culture plate (6 well plates). The plate was placed in an incubator 
providing a humidified atmosphere with 5% CO2 at 37°C. One plate holds 
cultures from 3 mice placed on 6 culture inserts.  
• Surgical instruments were sterilized and placed in the working area. 
 
  Procedure 
Animal experiments were carried out in accordance with the EU Directive 2010/63/EU 
for animal experiments and were reviewed and permitted by Swiss authorities. 
Cultures were prepared from CB6 mice or mutant PKCγ transgenic mice at postnatal 
day 8 (P8) as described previously (Metzger and Kapfhammer, 2003; Kapfhammer, 
2005, 2010) and incubated according to the static method (Stoppini et al., 1991). All 
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steps were carried out in the aseptic environment of a horizontal laminar flow 
workbench. 
• A P8 mouse pup was decapitated. 
• The skull was carefully opened in the sterile workbench.  
• The brain was removed from the skull and placed in a 35 mm dish containing 
4◦C cold preparation medium. All further steps were carried out under a 
stereomicroscope (Zeiss, Stemi 2000). 
• The cerebellum was isolated by cutting the cerebellar peduncles and the 
meninges were removed from the surface of the cerebellum. 
• The cerebellum was placed on the tissue chopper and sagittal slices (350 μm) 
were cut. 
• The cerebellar slices were placed in a fresh dish with cold preparation medium 
and the slices were separated from each other.  
• The bottom membranes of two tissue culture inserts (Millipore) were moistened 
with preparation medium. 
• Individual slices were transferred to the cell culture insert and placed on top of 
the membrane. 
• The culture inserts were placed in the pre-arranged tissue culture plate and 
incubated immediately.  
 
Maintenance and experimental treatments of the cultures 
• The medium was changed every 2-3 days. Fresh medium was pre-warmed to 
37°C and the pH was adjusted to 7.2-7.4, if necessary.  
• Pharmacological compounds were added to the culture medium after every 
medium change. (e.g. PMA = Phorbol 12-myristate 13-acetate, Tocris, Ca No. 
1201). Stock solutions were prepared in 50% EtOH / 50% DMSO (EtD) and 
were kept at -20°C.   
 
Immunocytochemistry 
• At the end of the culture period cultures were fixed in 4% paraformaldehyde in 
100 mM phosphate buffer (PB) overnight at 4°C.  
• The slices were washed with PB 3 times for 10 min. 
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• The plastic feet at the culture inserts were cut off to limit the required amount of 
antibody solution to 1000 μl. 
• The 1st antibody solution was prepared in PB as follows: 
o 0.5%  Triton X-100 
o 3% normal goat serum 
o rabbit anti-Calbindin D-28K (Swant) 1:1000 
• The slices were incubated in 1st antibody solution at 4°C overnight. 
• The slices were washed with PB with 0.1 % Triton X-100, 3 × for 10 min. 
• The 2nd  Antibody solution was prepared in PB as follows: 
o 0.1 % Triton X-100 
o goat anti-rabbit Alexa 488  (Molecular Probes, Invitrogen) 1:500 
• The slices were incubated in 2nd antibody solution at room temperature for 2 
hours. 
• The slices were washed with PB for 3 times for 10 min. 
• Stained slices were mounted on glass slides (Thermo Scientific Menzel-Gläser 
Superfrost Plus, Art. No. J1800AMNZ) and coverslipped with Mowiol.  
• Cultures were viewed on an Olympus AX-70 microscope equipped with a Spot 
digital camera.  
• Recorded images were adjusted for brightness and contrast with Photoshop 
image processing software 
 
 Dissociated cerebellar cultures  
  Materials 
Ingredients for 100 ml DFM medium 
• 97 ml 1:1 mixture of Dulbecco’s modified Eagle medium and F–12 nutrients 
(DFM; Gibco, Ca No. 12400) 
• 1 ml N-2 Supplement (100 ×), Liquid (GIBCO, Ca No. 17502-048) 
• 1 ml Glutamax (Gibco, Ca No. 35050) 
• 1 N NaOH or 1 N HCl to adjust pH to 7.2-7.4 
Ingredients for 1000 ml Hank’s Balanced Salt Solution 
• 1000 ml  Aqua bidest   
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• HBSS; 5.333 mM KCl, 0.441 KH2PO4, 137.931 mM NaCl, 0.336 mM 
Na2HPO4•7H2O, and 5.556 mM d-glucose (HBSS, SIGMA, Ca No. H2387) 
• 1 N NaOH or 1 N HCl to adjust pH to pH 7.2-7.4 
Papain solution (HBSS containing 20 U/ml papain) 
• Papain 20 U/ml, 5 ml vial, (Warthington, Ca No. 3176) 
• HBSS, 5 ml 
DNase solution (-20°C stock) 
• DNase1, 0.2 mg (0.2 mg/ml) (0.02%), (SIGMA, Ca No. D5025) 
• MgSO4, 1.43 mg (11.88 mM), (SIGMA, Ca No. M-2643) 
• HBSS, 1 ml 
180 µm filter (Millipore, Ca No. SLGV 025 LS) 
BD Poly-D-Lysine Laminin culture slide (BD, Ca No. 354688) 
 
  Procedure 
• Dissociated cerebellar cultures were prepared from mice essentially as 
described (Linden et al., 1991; Tabata et al., 2000 )  
• The cerebellum from every mouse was treated separately, resulting in one 
culture from one cerebellum. Newborn mouse pups (P0) were obtained from 
CB6 or mPKCγ transgenic mice. 
• Each mouse was then decapitated and the cerebellar primordium was dissected 
free and transferred into a sterile 1.5 ml tube containing 250 µl ice-cold HBSS 
kept on ice.  
• The isolated cerebellar primordia were minced in the tubes to obtain chunks 
of∼1 mm size.  
• Subsequently, the cerebellar tissues were digested by adding 250 µl of freshly 
prepared, ice-cold papain solution (HBSS containing 20 U/ml papain, 
Worthington 3176) to each tube, followed by incubation in a 33°C water bath for 
30 min. 
• To stop the digestion, 1 ml HBSS pre-warmed to room temperature (RT) was 
added to each tube.  
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• After gentle mixing by inverting the tube, the cells were harvested by 
centrifugation at RT for 4 min at 0.6 g. All subsequent steps were carried out at 
RT under the hood.  
• After all supernatants were removed, 300 µl of freshly prepared DNase solution 
was added to each of the harvested cerebellar cell pellets.  
• Each cell pellet was then triturated carefully by pipetting up and down ∼40 times 
using a Gilson Pipetman P1000 equipped with a sterile 1000 µl tip.  
• The triturated cells were then passed through a nylon mesh, collected in a fresh 
1.5 ml tube, and harvested by centrifugation (at RT for 4 min at 0.6 × g).  
• The cells were then washed twice by re-suspending them (via inverting the tube 
several times) in 1 ml of HBSS at RT and harvesting them by centrifugation (at 
RT for 4 min at 0.6 × g). 
• DFM medium with 10% (v/v) fetal bovine serum (FBS) was added to the cells 
and transferred to a 14 mm diameter glass bottom culture dish that had been 
coated with poly-l-ornithine. 
• The dish was then placed in a 37°C incubator (5%CO2, 97% humidity). 
 
Experiments and maintenance of the cultures 
• The medium was changed at the second day after starting culture. Fresh 
medium without serum was pre-warmed to 37°C and the pH was adjusted to 
7.2-7.4, if necessary.  
• Then, every 3-4 days, half of medium was changed. 
• Pharmacological compounds were added to the culture medium after every 
medium change.  
 
Immunocytochemistry 
• At the end of the culture period cultures were fixed in 4% paraformaldehyde in 
100 mM phosphate buffer (PB) for 1 hour at 4°C.  
• The cells were washed with PB for at least 3 times for 10 min. 
• The 1st antibody solution was prepared in PB as follows: 
o 0.5%  Triton X-100,  
o 3% normal goat serum 
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o rabbit anti-Calbindin D-28K (Swant) 1:1000 
• The cells were incubated in 1st antibody solution at RT for 1 hour. 
• The cells were washed with PB containing 0.1% Triton X-100, 3 times for 10 
min. 
• The 2nd  Antibody solution was prepared in PB as follows: 
o 0.1% Triton X-100 
o goat anti-rabbit Alexa 488 or 568  (Molecular Probes, Invitrogen) 1:500 
• The cells were incubated in 2nd antibody solution at room temperature for 1 hour. 
• The cells were washed with PB for 3 times for 10 min. 
• Stained cells on glass slides were covered with Mowiol.  
• Cultures were viewed on an Olympus AX-70 microscope equipped with a Spot 
digital camera.  
• Recorded images were adjusted for brightness and contrast with Photoshop 
image processing software. 
 
  Biolistic transfection 
  Materials  
All ingredients were sterile and mixed in a laminar flow work bench. 
Helios Gene Gun Kit (Biorad): 
• Helios Gene Gun (Biorad, shown in Fig. 9) 
• Tubing Prep Station (Biorad)  
• Gold microcarriers (Biorad) 
• Helium tank 
• Nitrogen tank 
• Nitrogen regulator 
• Polyvinylpyrollidone, MW = 360,000 
• 100% ethanol 
• Spermidine (Sigma, Ca No. S-0266) 
• Calcium chloride (CaCl2) 
• Plasmid DNA 
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Fig.9 Gene gun (from Biorad manual) 
 
The Helios (Bio-Rad) gene gun is a small portable instrument that enables efficient 
transportation of plasmid or dyes into cells. 
 
 Procedure 
Preparation of DNA-Coated gold particles for Slice culture  
• 15 mg gold particles and 30 µl spermidine stock solution were added to a 1.5 
ml microfuge tube. 
• Vortexed for 5 sec. 
• 30 µl of plasmid DNA (0.5 mg/ml) were added to the microfuge tube and 
vortexed for 5 sec. 
• 30 µl of CaCl2 stock solution were added dropwise. 
• Incubate the gold and plasmid DNA at room temperature for 10 min, flicking the 
tube periodically to mix the contents. 
• Then spin the tube for 5 sec at 1,000 rpm to pellet the gold. 
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• The supernatant was removed and stored as a sample. 
• The gold particles were washed three times with 1 ml of 100% EtOH. 
• Then the gold pellet was re-suspended in 200 µl PVP working solution from a 
3.5 ml aliquot, and the suspension was transferred to a 5 ml tube. This transfer 
was repeated with 200 ml aliquots of PVP until all the gold particles had been 
transferred, and then the remaining PVP solution was added. 
Based on this reference (Wellmann et al., 1999), we first set the conditions below and 
changed several factors depending on the results. 
1.6 µm GOLD, 15 mg 
30 µl, 0.05 M Spermidine 
30 µl,  Plasmid (0.5 mg/ml) 
30 µl, 2 M CaCl2 
2 ml, PVP 
 
Tubing Preparation (This step done according the manufacturer’s manual) 
• Tubing was cut to the length of the tubing prep station, then inserted from the 
right end into the tubing prep station, and pushed in until it slipped through the 
O-ring on the left side 
• The tube was dried for 20 min with N2 at 0.3 – 0.4 lpm, then it was taken out 
from the tubing prep station and connected to a syringe with tubing 
• The coated particle solution was sonicated, vortexed and then drawn up, it is 
important to leave some empty space at each end of tubing.  
• Let the solution settle for 5 min, no turning of tubing. 
• The solution was then slowly (1.5-3 cm/sec) withdrawn, leaving the gold 
particles on the bottom of the tubing. 
• Then the tubing was rotated 90°, stopped for 5 sec, rotated for 180°, stopped 
again for 5 sec and rotated for 30 sec. 
• Rotated under N2 flow (0.4 lpm) for 5 min. 
• The tubing was removed from the tubing prep station; the coating could be seen 
as a brownish film. 
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• Finally the coated area of the tubing was cut with the cutting machine to get the 
bullets.  
 
Bombardment 
• Cerebellar slice cultures were prepared as mentioned. 
• Battery was inserted into the Helios Gene Gun. 
• The Helios Gene Gun was connected to a Helium Source. 
• To activate the Gene Gun: turn on the flow of helium to the desired pressure 
and with an empty cartridge holder in place, make 2–3 “pre-shots” by engaging 
the safety interlock and firing the trigger. 
• The cartridges with tubes containing DNA-coated gold particles were prepared 
and cartridges were loaded into the cartridge holder and then placed in the Gene 
Gun. 
• The lid of 6 well culture plate was opened and culture inserts were the target for 
bombardment. 
• For bombardment: engage the safety interlock and press the firing trigger. 
• As soon as possible, slice culture plates were returned to the incubator.  
 
  Magnetofection 
  Materials and Methods 
Ingredients for 100 ml DFM medium 
• 97 ml 1:1 mixture of Dulbecco’s modified Eagle medium and F–12 nutrients 
(DFM; Gibco, Ca No. 12400) 
• 1 ml N-2 Supplement (100 ×), Liquid (GIBCO, Ca No. 17502-048) 
• 1 ml Glutamax (Gibco, Ca No. 35050) 
• 1 N NaOH or 1 N HCl to adjust pH to 7.2-7.4 
Ingredients for 1000 ml Hank’s Balanced Salt Solution 
• 1000 ml  Aqua bidest   
• HBSS; 5.333 mM KCl, 0.441 KH2PO4, 137.931 mM NaCl, 0.336 mM 
Na2HPO4•7H2O, and 5.556 mM d-glucose (HBSS, SIGMA, Ca No. H2387) 
• 1 N NaOH or 1 N HCl to adjust pH to pH 7.2-7.4 
Papain solution (HBSS containing 20 U/ml papain) 
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• Papain 20 U/ml, 5 ml vial, (Warthington, Ca No. 3176) 
• HBSS, 5 ml 
DNase solution (-20°C stock) 
• DNase1, 0.2 mg (0.2 mg/ml) (0.02%), (SIGMA, Ca No. D5025) 
• MgSO4, 1.43 mg (11.88 mM), (SIGMA, Ca No. M-2643) 
• HBSS, 1 ml 
180 µm filter (Millipore, Ca No. SLGV 025 LS) 
BD Poly-D-Lysine Laminin culture slide (BD, Ca No. 354688) 
NeuroMag kit (OZ BIOSCIENCES) 
Plasmid mentioned above. 
 
  Procedure 
Preparation of DNA/NeuroMag complexes  
• The appropriate amount of NeuroMag reagent (4 µg) was vortexed in a 
microtube.  
• For DNA preparation, the indicated quantity of plasmid DNA was diluted in 
200 μl of culture medium without serum and supplement. 
• The DNA solution was added to the NeuroMag solution (4 µg plasmid DNA + 
14 μl Neuromag) and vortexed, then incubated at room temperature for 15 to 
20 min. 
 
Cells 
• Dissociated cerebellar cultures were prepared from mice essentially as 
described (Linden et al., 1991; Schilling et al., 1991; Tabata et al., 2000), and 
explained above. 
 
Transfection 
• NeuroMag / DNA complexes were added onto cells drop by drop and the dish 
was gently rocked to ensure a uniform distribution. The cell culture dishes were 
incubated on the magnetic plate during 15 min. 
• Then the magnetic plate was removed. 
• The dish was then placed in a 37°C incubator (5% CO2, 97% humidity). 
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Maintenance of the cultures 
• Every 3-4 days, half of medium was changed. After one to two weeks cells were 
fixed and stained as described. 
 
  Effectene 
  Materials  
All ingredients were sterile and mixed in a laminar flow work bench. 
Effectene Kit: 
• Buffer EC 
• Enhancer 
Ingredients for 100 ml DFM medium 
• 97 ml 1:1 mixture of Dulbecco’s modified Eagle medium and F–12 nutrients 
(DFM; Gibco, Ca No. 12400) 
• 1 ml N-2 Supplement (100 x), Liquid (GIBCO, Ca No. 17502-048) 
• 1 ml Glutamax (Gibco, Ca No. 35050) 
• 1 N NaOH or 1 N HCl to adjust pH to 7.2-7.4 
Ingredients for 1000 ml Hank’s Balanced Salt Solution 
• 1000 ml  Aqua bidest   
• HBSS; 5.333 mM KCl, 0.441 KH2PO4, 137.931 mM NaCl, 0.336 mM 
Na2HPO4•7H2O, and 5.556 mM d-glucose (HBSS, SIGMA, Ca No. H2387) 
• 1 N NaOH or 1 N HCl to adjust pH to pH 7.2-7.4 
Papain solution (HBSS containing 20 U/ml papain) 
• Papain 20 U/ml, 5 ml vial, (Warthington, Ca No. 3176) 
• HBSS, 5 ml 
DNase solution (-20°C stock) 
• DNase1, 0.2 mg (0.2 mg/ml) (0.02%), (SIGMA, Ca No. D5025) 
• MgSO4, 1.43 mg (11.88 mM), (SIGMA, Ca No. M-2643) 
• HBSS, 1 ml 
180 µm filter (Millipore, Ca No. SLGV 025 LS) 
BD Poly-D-Lysine Laminin culture slide (BD, Ca No. 354688) 
 
Plasmids were mentioned above. 
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  Procedure 
• 0.4 μg plasmid (400 ng/ml plasmid 1 μl), 99 μl Buffer EC and 3.2 μl Enhancer 
were mixed in a 1.5 ml microtube. 
• Vortexed for 1sec. 
• Microtubes were incubated for 5 min at RT. 
• 10 μl Effectene transfection regent was added to the plasmid mixture and 
pipetted up and down 5 times, then incubated for 5 min at RT. 
• During the incubation, the medium of dissociated cerebellar cultures plate was 
changed and replaced with 1.6 ml fresh medium. 
• 600 μl medium was added to the complex, and then the solution was added to 
the cultures.  
• The dish was then placed in a 37 °C incubator (5% CO2, 97% humidity). 
• Cultures were maintained for 24 hours and fixed, stained with anti-GFP and anti-
Calbindin antibody, mentioned above. 
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4. Results 
  Mouse model of spinocerebellar ataxia 14  
 
Increased protein kinase C gamma activity induces Purkinje cell pathology in a 
mouse model of spinocerebellar ataxia 14 
 
Jingmin Ji; Melanie L Hassler; Etsuko Shimobayashi; Nagendher Paka; 
Raphael Streit; Josef P. Kapfhammer 
 
Anatomical Institute, Department of Biomedicine Basel, University of Basel, 
Pestalozzistr. 20, CH - 4056 Basel, Switzerland. 
 
The following section is based on the work published in the Neurobiology of Disease, 
2014, Volume 70, October 2014, Pages 1–11. Figure legend numbering and title 
numbering were modified to fit this thesis. The abstract and the introduction are 
unchanged from the publication, for Materials and methods, Results and Discussion 
the parts shown are limited to the experiments performed by myself. 
 
  Abstract 
Spinocerebellar ataxias (SCA) are hereditary diseases leading to Purkinje cell 
degeneration and cerebellar dysfunction. Most forms of SCA are caused by expansion 
of CAG repeats similar to other polyglutamine disorders like Huntington’s disease. In 
contrast, in the autosomal dominant SCA-14 the disease is caused by mutations in the 
protein kinase C gamma (PKCγ) gene which is a well characterized signaling molecule 
in cerebellar Purkinje cells. The study of SCA-14, therefore, offers the unique 
opportunity to reveal the molecular and pathological mechanism eventually leading to 
Purkinje cell dysfunction and degeneration. We have created a mouse model of SCA-
14 in which PKCγ protein with a mutation found in SCA-14 is specifically expressed in 
cerebellar Purkinje cells. We find that in mice expressing the mutated PKCγ protein 
the morphology of Purkinje cells in cerebellar slice cultures is drastically altered and 
mimics closely the morphology seen after pharmacological PKC activation. Similar 
morphological abnormalities were seen in localized areas of the cerebellum of juvenile 
transgenic mice in vivo. In adult transgenic mice there is evidence for some localized 
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loss of Purkinje cells but there is no overall cerebellar atrophy. Transgenic mice show 
a mild cerebellar ataxia revealed by testing on the rotarod and on the walking beam. 
Our findings provide evidence for both an increased PKCγ activity in Purkinje cells in 
vivo and for pathological changes typical for cerebellar disease thus linking the 
increased and dysregulated activity of PKCγ tightly to the development of cerebellar 
disease in SCA-14 and possibly also in other forms of SCA.  
 
Key words:  
Spinocerebellar ataxia type 14, protein kinase C gamma, Purkinje cell dendritic 
development, transgenic mouse model. 
 
  Introduction 
Spinocerebellar ataxias (SCAs) are hereditary diseases leading to Purkinje cell 
degeneration and cerebellar dysfunction. By now more than 30 different mutations 
have been identified as the underlying cause of this group of diseases (for a recent 
review see Matilla-Dueñas et al 2012). Most forms of SCA are caused by expansion of 
CAG repeats similar to other polyglutamine disorders like Huntington’s disease. In 
contrast, in the autosomal dominant SCA-14 the disease is caused by mutations in the 
protein kinase C gamma (PKCγ) gene which is a well characterized signaling molecule 
in cerebellar Purkinje cells. The study of SCA-14, therefore, offers the unique chance 
to reveal the molecular and pathological mechanism eventually leading to Purkinje cell 
dysfunction and degeneration (Pandolfo and van de Warrenburg 2005). Genetic 
analysis has shown that the disease is caused by different point mutations in the PKCγ 
gene. Many, but not all, of the identified mutations are clustered in the regulatory C1b 
domain of the PKCγ gene (Chen et al., 2012). Clinically, the disease is characterized 
by a slowly progressive pure cerebellar ataxia with the age of onset ranging from 5 – 
60 years. The dominant pathological finding is a mild to moderate cerebellar atrophy 
with a loss of Purkinje cells. Because of the dominant inheritance of the disease it is 
assumed that the mutated PKCγ protein must have a toxic action or may confer a gain 
of function phenotype eventually resulting in Purkinje cell dysfunction and death. When 
two of the mutations causing SCA-14 were characterized functionally by in vitro assays 
it was shown that they resulted in an increase of PKCγ catalytic activity (Verbeek et al. 
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2005) linking Purkinje cell degeneration to a potential gain of function phenotype of 
PKCγ. More recently, Adachi et al. (2008) studied the PKC activity of 20 spontaneous 
mutations found in the PKCγ gene of SCA-14 patients. 19 of the 20 mutations showed 
an increased constitutive activity of PKC and increased calcium levels in the cytoplasm 
when assayed in transfected cells. Furthermore, transfection of mutant PKCγ into 
cultured dissociated Purkinje cells resulted in increased apoptosis and in a reduction 
of dendritic growth (Seki et al., 2009). These findings are consistent with the concept 
that the disease phenotype in SCA-14 is related to increased PKC activity. 
Nevertheless, there are also indications that despite an increased basal activity of 
mutated PKCγ, there might be a deficit to recruit downstream targets resulting in a 
certain loss of function (Verbeek et al., 2008). After viral transfection of a mutated form 
of PKCγ in vivo LTD was shown to be impaired and there were indications that the 
mutant PKCγ may interfere with normal endogenous PKC activity in a dominant 
negative manner (Shuvaev et al., 2011). Furthermore, another typical feature of 
mutated PKCγ proteins is an increased protein aggregation which may cause Purkinje 
cell death by ER-stress (Seki et al., 2005, 2007). In a recent study it was shown that 
the disaccharide trehalose can inhibit PKCγ aggregation and improves survival and 
development of Purkinje cells in an in vitro model (Seki et al., 2010). Taken together, 
the mechanism by which the mutations in the PKCγ gene lead to Purkinje cell 
degeneration in SCA-14 are still rather unclear (Sakai et al., 2011). Until today, only 
one transgenic mouse model of SCA-14 has been published (Zhang et al., 2009). In 
these mice the H101Y mutation was transgenically expressed under the control of a 
universal CMV promoter. The authors report an altered morphology and loss of 
Purkinje cells, but the documentation of these findings in the article is incomplete. In 
this study we present a novel SCA-14 mouse model with Purkinje cell specific 
expression of the PKCγ mutation S361G which is located in the kinase domain and 
was shown to confer an increased constitutive activity as tested by in vitro assays 
(Adachi et al., 2008). We find that in PKCγ-S361G transgenic mice there is evidence 
for both an increased PKCγ activity in vivo and for pathological changes typical for 
cerebellar disease thus linking the increased and dysregulated activity of PKCγ tightly 
to the development of cerebellar disease.  
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  Materials and Methods 
Real time quantitative PCR 
RNA was purified from the cerebellum of control and PKC-C mice at different ages 
using the RNeasy Mini-kit (Qiagen) following the instructions of the manufacturer. Real 
time quantitative PCR was performed on a StepOne real-time PCR system (Applied 
Biosystems, Zug, Switzerland) using the manufacturer’s Syber green master mix. The 
following primers were used: human (transgenic) PKCγ, forward 
gaaacagaagacccgaacgg, reverse: cgccttgagcagctccgagacg; mouse (endogenous) 
PKCγ, forward: caaaacagaagacaaagacc, reverse: ggccttgagtagctctgagaca; GAPDH, 
forward: aactttggcattgtggaagg, reverse: acacattgggggtaggaaca. Reactions were 
quantified by relative standard curve system and the cycle threshold method using the 
SDS2.2 software (Applied Biosystems, Foster City, CA). A relative quantitation value 
(RQ) for each sample from the triplicates of that sample was calculated for each gene. 
The data were analyzed with GraphPad Prism software. 
 
Western blot analysis 
Control and PKC-C mice of different ages were sacrificed by an overdose of 
pentobarbital, then the cerebellum was quickly dissected and frozen in liquid nitrogen. 
Samples were homogenized in RIPA buffer (SigmaAldrich, Buchs, Switzerland) with 
phosphatase and protease inhibitors. Protein concentrations were determined using a 
NanoDrop instrument (ThermoScientific, Reinach, Switzerland) and 100 µg of each 
sample were subjected to SDS-PAGE. The separated proteins were transferred to a 
nitrocellulose membrane using a semidry blotting machine (Bio-Rad, Cressier, 
Switzerland). After blotting, membranes were blocked with 5% BSA in TBS for 1 h and 
incubated with appropriate primary antibodies. After washing with TBS-T membranes 
were incubated with HRP-labelled secondary antibodies for 1 h. After washing bound 
antibodies were visualized with ECL2 Western blotting substrate (Pierce, Thermo 
Scientific, Reinach, Switzerland) and quantified using a C-Digit Western Blot scanner 
and software (LI-COR Biosciences, Bad Homburg, Germany).  
 
Immunohistochemistry and Histology 
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Immunohistochemistry was performed as described previously (Gugger et al., 2012). 
For the analysis of the cerebellar sections control and PKC-C transgenic mice were 
sacrificed by perfusion with 4% paraformaldehyde and the cerebellum was sectioned 
on a cryostat at 20µm. Sections were incubated free floating with the following 
antibodies: rabbit anti-calbindin D28K and mouse monoclonal anti-Parvalbumin 
(1:1000, Swant, Marly, Switzerland), mouse monoclonal anti-NeuN (1:500, Millipore, 
Zug, Switzerland), rabbit anti-GFAP (1:1000, Dako, Baar, Switzerland), rabbit anti 
vGlut1 (1:1000, Synaptic Systems,Heidelberg, Germany), rabbit anti-PKCγ (1:1000, 
Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-GFP (1:500, Abcam, 
Cambridge, UK). Organotypic slice cultures were fixed after 9-11 days in vitro in 4% 
paraformaldehyde overnight at 4°C. All reagents were diluted in 100 mM phosphate 
buffer (PB), pH 7.3. Cryoections or slices were incubated in blocking solution (0.1 - 
0.3% Triton X-100, 3% normal goat serum) for a minimum of 30 minutes in order to 
permeabilize the tissue and block non-specific antigen binding. Primary antibodies 
were added in fresh blocking solution and incubated overnight at 4°C. The staining 
was visualized with anti-mouse and anti-rabbit AlexaFluor 488 and 568 2nd antibodies 
(1:500, Molecular Probes, Eugene, OR). After washing in PB, secondary antibodies 
were added in PB containing 0.1% Triton X-100 in order to prevent non-specific antigen 
binding for at least 1 hour at room temperature. For cresyl violet staining cryostat 
sections were collected on Superfrost slides (Menzel, Braunschweig, Germany) and 
were stained with 0.125% cresyl violet to show the cellular pattern of the cerebellum. 
Stained slices or sections were mounted on glass slides and coverslipped with Mowiol 
(SigmaAldrich, Buchs, Switzerland). Cultures and sections were viewed on an 
Olympus AX-70 microscope equipped with a Spot digital camera. Recorded images 
were adjusted for brightness and contrast with Photoshop image processing software. 
 
  Results 
Transgene expression in PKCγ–S361G (PKC-C) transgenic mice 
We have aimed at creating a mouse model of SCA-14 by introducing a mutated human 
PKCγ gene carrying a mutation found in an affected family. We have chosen the 
S361G mutation (Chen et al., 2005) located in the kinase domain of the PKCγ gene. 
This mutation was shown to increase the kinase activity of PKCγ in a cell based assay 
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using CHO cells (Adachi et al., 2008). Five founders (for simplicity called PKC-C mice) 
were originally identified from 64 mice and were double tested by PCR genotyping with 
a second pair of primers (Fig. 10A). The identity and completeness of the transgene 
was checked and confirmed by DNA sequencing. In order achieve a Purkinje cell 
specific expression using the Tet-off system, the selected transgenic founder mice 
were crossed with Pcp2-tTA transgenic mice (Zu et al., 2004) which express the Tet-
Transactivator under a Purkinje cell specific promoter. In the offspring double 
transgenic mice were identified by PCR genotyping (Fig. 10B). Expression of the 
transgene was indicated by the presence of the GFP reporter included in the 
transfected construct, and was only observed in mice double transgenic for Pcp2-tTA 
and PKC-C (Fig. 10C and 10D). The expression of the mutated PKCγ protein cannot 
be directly assayed because no antibody specific for human PKCγ protein is available. 
Therefore, we have analyzed the presence of the mutated human mRNA by real time 
quantitative PCR (qPCR), (Fig. 10E) and the amount of total PKCγ protein as detected 
by Western blotting with the polyclonal anti-PKCγ antibody (Fig. 10F). No signal was 
obtained in qPCR for the mutated human PKCγ mRNA confirming the specificity of the 
used primers. In PKC-C mice mRNA expression of the mutated human PKCγ mRNA 
was present but only reached approximately 50% of the value of the endogenous 
normal PKCγ mRNA in P12 postnatal animals. In adult animals expression of the 
mutated human PKCγ mRNA declined slightly compared to the GAPDH control but 
because the mRNA of the endogenous PKCγ mRNA became expressed much 
stronger the mutated mRNA only constituted 15-20% of the endogenous mRNA in 
adult animals (Fig. 10E). The findings from qPCR were confirmed by Western blot 
analysis of total PKCγ protein in the cerebellum of control and PKC-C mice (Fig. 10F). 
In P12 PKC-C mice, PKCγ protein was increased to approximately 175% of control 
mice, but this increase had disappeared in 3 month and 12 month old adult mice (Fig. 
10F). These findings indicate that the human mutated PKCγ protein is specifically 
present in Purkinje cells of PKC-C mice but only constitutes about 30-50% of the total 
PKCγ protein in postnatal mice and much less in adult mice. The results shown in this 
manuscript are based on studies with founder 3 which had a solid GFP expression in 
Purkinje cells. Parts of the experiments were reproduced in founders 2 and 6 with very 
similar findings (data not shown).  
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Fig. 10 Generation of transgenic mice    
A The genotype of the founders was confirmed by PCR with a second pair of primers 
for human mutated PKC𝛾𝛾 transgenic mice. A 585bp band is detected in all positive 
founders but not in control.  1, DNA ladder; 2-6, 5 different founders; 7, negative control. 
B  Double transgenic mice expressing the mutated PKC𝛾𝛾 protein were identified by 
PCR. These mice show the 585bp band for mutated PKC𝛾𝛾 and Pcp2-tTA (472bp) band. 
1, DNA ladder; 2, PKC𝛾𝛾+, 3,  PKC𝛾𝛾+ Pcp2-tTA +, 4, negative mouse, 5, PKC𝛾𝛾+ Pcp2-
tTA +, 6, Pcp2-tTA +, 7, PKC𝛾𝛾+. C, D In double transgenic mice (C) the GFP marker 
was expressed specifically in Purkinje cells, while no GFP expression was found in 
control mice (D). Scale bar in D = 100 µm. E The expression of the mutated PKC𝛾𝛾 
mRNA was analyzed by quantitative RT-PCR. Light grey bars: Expression of 
endogenous PKC𝛾𝛾 mRNA in PKC-C mice, dark grey bars: Expression of mutated 
human PKC𝛾𝛾 mRNA. In P12 postnatal animals the mutated PKC𝛾𝛾 mRNA constituted 
approximately 50% of the endogenous normal PKC 𝛾𝛾  mRNA, in adult animals 
expression of endogenous mRNA became stronger and the mutated PKC𝛾𝛾 mRNA 
constituted only 15-20% of the endogenous PKC𝛾𝛾 mRNA. F  Quantitation of Western 
blots for total PKC𝛾𝛾 protein in the cerebellum of control and PKC-C mice. Light grey 
bars: Expression of total PKC𝛾𝛾 protein in control mice, dark grey bars: Expression of 
total PKC𝛾𝛾 protein in PKC-C mice. In P12 postnatal PKC-C mice total PKC𝛾𝛾 protein 
was increased by approximately 75% compared to control mice, in adult PKC-C mice 
total PKC𝛾𝛾 protein expression was similar to control mice. 
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  Discussion 
We have generated a novel SCA-14 mouse model with Purkinje cell specific 
expression of the PKCγ mutation S361G. This mutation was identified in 2005 (Chen 
et al., 2005) and is located in the kinase domain of the PKCγ protein. In a cellular assay 
system, this mutation was shown to confer an increased constitutive PKC activity 
(Adachi et al., 2008). We find that in PKCγ-S361G transgenic mice (here called PKC-
C mice) there is evidence for both an increased PKCγ activity in vivo and for 
pathological changes typical for cerebellar disease thus linking the increased and 
dysregulated activity of PKCγ tightly to the development of cerebellar disease.  
In human patients affected with the SCA-14 mutation used in this study, the major 
clinical and neuroimaging findings were a cerebellar ataxia, dysarthria and a cerebellar 
atrophy confirmed by MRI scans (Chen et al., 2005). In contrast, we did not find an 
overt cerebellar atrophy in the PKC-C mice. There are several possible explanations 
for this apparent difference. First, the age of onset of symptoms and the cerebellar 
atrophy in the human patients was between 5 and 60 years of age, with a mean of 28 
years of age. It may be difficult to replicate the cerebellar atrophy in the mouse with a 
life span of 1 to 2 years. Furthermore, the expression levels of the mutated transgenic 
PKCγ protein in the PKC-C mice are rather moderate. The expression level of the 
transgenic mRNA constitutes less than 50% of the mRNA of the normal endogenous 
PKCγ and a moderate increase of total PKCγ protein could only be found in young 
postnatal mice. Taken together these findings suggest that the fraction of the mutated 
PKCγ protein is around 30-50% of total PKCγ protein in young postnatal mice and will 
be less in older animals. In heterozygous SCA14 patients the expression of the 
transgene should be around 50% of the total protein throughout life and would be 
substantially higher compared to PKC-C mice. It is well conceivable that the expression 
level found in the PKC-C mice could be sufficient for causing functional changes in 
Purkinje cells but too low for causing Purkinje cell degeneration and death throughout 
the cerebellum.  
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  Cerebellar slice culture and dissociated cerebellar culture 
  Cerebellar slice culture 
The model system of cerebellar slice cultures is extensively used in neurobiology and 
electrophysiology studies. Initially organotypic slice cultures were developed with 
explant cultures of various neuroanatomical origins (Gähwiler et al., 1997 ). Since then, 
slice cultures have become an attractive alternative in addition to acute slices, and the 
spectrum of possible culturing methods, as well as the type of applications with which 
they have been used, have been considerably expanded. 
In organotypic slice cultures, a complete slice of tissue is kept in culture. This has the 
advantage that the natural microenvironment of the neurons with cell-cell interactions 
and the local neuronal networks is preserved (Dupont et al., 2006). This provides the 
possibility for various kinds of studies, like cellular development, synaptogenesis, 
repair after lesions, or electrophysiology. Slice cultures from the nervous system, 
however, can only be obtained from immature tissue, as survival of neurons critically 
depends on their stage of development. For example, Purkinje cells are extremely 
sensitive to axotomy at the age around P5 in mice and do not survive in slice cultures 
prepared during this period (Dusart et al., 1997). In general, slice cultures give best 
results when taken from developing nervous tissue before myelination. 
Some special measures have to be taken to ensure a sufficient supply with nutrients 
and oxygen to all cells in the typically 0.3 – 0.5 mm thick slice cultures. In the technically 
simplest method, the static slice culture, which allows cerebellar slices to be cultured 
for several weeks, the slices are placed on top of a membrane which is permeable to 
all ingredients of the culture medium (Stoppini et al., 1991). The membrane is held by 
a culture insert and placed over the medium, which is drawn through the membrane 
into the slice culture by capillary forces. In this culture, the top of the culture is at the 
interface between culture medium and air, which allows both nutrients and oxygen to 
reach the whole culture (Kapfhammer and Gugger, 2012). 
 
  Results of cerebellar slice culture 
Organotypic cerebellar slice cultures were cultured for 7 days. Starting at the 3rd day 
in vitro, some of the cultures were treated with PMA (50 nM), a phorbol ester which is 
stimulating PKC, until the cultures were fixed. PMA has been shown previously to 
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inhibit and limit Purkinje cell dendritic development (Metzger F., 2000). As control we 
added EtOH/DMSO which was used for diluting PMA. 
Purkinje cells in the slices were visualized by immunostaining with anti-Calbindin D28K 
which is a Purkinje cell marker (Fig. 11A).In the control slices, Purkinje cells developed 
large and highly branched dendritic trees. In Purkinje cells treated with PMA, the 
morphology of the dendritic tree was completely changed (Fig. 11B). The dendritic tree 
was very small and stunted, the branches appeared thickened with only few short side 
branches. The area covered by the dendritic tree was markedly reduced. A similar 
morphology was present in cultures derived from mPKCγ transgenic mice. The 
dendritic tree of the Purkinje cells from these mice was greatly reduced in size and the 
branching was markedly reduced (Fig. 11C). The morphology was very similar and 
indistinguishable from that of PMA treated control Purkinje cells suggesting that the 
mutated PKCγ-S361G from transgenic mice had an increased PKC activity. Moreover, 
when Purkinje cells derived from mPKCγ transgenic mice were treated with PMA, the 
dendritic tree of the Purkinje cells was further reduced in size and almost no branching 
could be detected (Fig. 11D). A quantitative analysis of Purkinje cell dendritic tree size 
is shown in Fig. 11E. For statistical analysis the area covered by the dendritic trees of 
at least 20 different Purkinje cells was measured. Statistical analysis of the data was 
done with Graph Pad Prism software. Results are typically presented as bar graphs. 
The statistical analysis showed clear statistically significant differences between the 
size of the dendritic tree of Purkinje cells from the control condition compared to PMA 
treatment or Purkinje cells derived from mPKCγ transgenic mice with or without PMA 
treatment (Fig. 11E). No statistically significant differences were found between control 
Purkinje cells treated with PMA and Purkinje cells from mPKCγ transgenic mice. 
Interestingly, the dendritic size of PMA-treated Purkinje cells from mPKCγ transgenic 
mice was further reduced compared to untreated Purkinje cells from mPKCγ 
transgenic mice or PMA-treated control Purkinje cells. This finding suggests that the 
mPKCγ does mediate a strong but not maximal stimulation of PKC activity, which can 
be further boosted by PMA treatment. 
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Fig. 11 Purkinje cell morphology 
and dendritic size of mPKCγ 
transgenic mice and control mice 
(A) Immunofluorescence staining of 
cerebellar slice cultures after one 
week in vitro. Cultures from control 
mice showed expanded dendritic trees. 
(B) Purkinje cells from control cultures 
treated with the PKC activator PMA 
developed only very small dendritic 
trees. (C) The dendritic tree of Purkinje 
cells from mPKCγ transgenic mice 
was also small with few side branches. 
(D) PMA treatment of Purkinje cells 
from mPKCγ transgenic mice further compromised dendritic tree development. (E) 
Quantification of the total dendritic area of Purkinje cells. The reduction of dendritic 
size of Purkinje cells from mPKCγ transgenic mice and PMA-treated control cultures 
versus untreated control cultures was statistically significant with p < 0.05. Error bars 
indicate the SEM. 
E 
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  Dissociated cerebellar culture 
In contrast to slice cultures, in dissociated cell cultures, cells are taken out of their 
tissue environment and can be studied in isolation. Dissociated Purkinje cells 
preparations maintained in an in vitro environment with simplified cellular and 
biochemical conditions can facilitate molecular analyses of neuronal development. 
Pharmacological manipulation of Purkinje cells is also possible in cultures maintained 
with a serum free, chemically defined medium. Because of these advantages, 
dissociated cultures of cerebellar neurons have been utilized for example in the search 
for granule neuron (GN)-derived trophic factors which support the survival of 
developing Purkinje cells (Baptista et al., 1994; Morrison et al., 1998). 
A disadvantage of dissociated cerebellar cultures is the relatively low survival rate of 
Purkinje cells in serum free, hormone supplemented Eagle’s basal medium, in 
particular as long term culture over two weeks and longer is needed. Furuya et al. 
(1995) found that the use of Dulbecco’s modified Eagle medium : F-12 nutrient based 
medium (DFM) significantly improves the long term survival of dissociated rat Purkinje 
cells. Later, Tabata et al. (2000) further modified this method for mouse Purkinje cells. 
Mouse Purkinje cells cultured according to their method differentiated through several 
morphological and electrophysiological stages similar to those seen in Purkinje cells in 
vivo. Various aspects of Purkinje cell biology, including their morphological 
development, electrophysiological properties, sub-cellular organization, and 
relationships with other cell types have been investigated using these dissociated 
cerebellar cultures (Matsuda et al., 2010; Okubo et al., 2001 ; Tanaka et al., 2006; 
Uemura et al., 2010). 
Recently, Wagner et al., (2011) showed that transfection by electroporation using a 
novel plasmid containing the promoter sequence of the Purkinje cell specific gene L7 
provides an efficient and simple method to achieve the expression of multiple 
exogenous cDNAs in cultured Purkinje cells.  
The dissociated cerebellar cultures are heterogeneous, containing granule neurons, 
interneurons and glial cells in addition to Purkinje cells. Remarkably, the expression of 
cDNAs with pL7 plasmids is highly specific for Purkinje cells. In contrast, expression 
from plasmids utilizing a β-Actin promoter is observed mainly in neurons other than 
Purkinje cells (Wagner et al., 2011). Similarly, CMV promoter-based plasmids led to 
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high level cDNA expression in cells other than Purkinje cells. These differences 
highlight the value of novel pL7-plasmids for achieving Purkinje cell transfection. 
We obtained the pL7 plasmid from Dr. Wagner and established the transfection of 
Purkinje cells in dissociated cerebellar cultures in order to be able to evaluate the 
effects of different transfected genes for Purkinje cell dendritic development. 
 
  Results of dissociated cerebellar culture 
Purkinje cell dendritic development in dissociated cultures 
We observed the dendritic development of Purkinje cells in these cultures for 18 days. 
With this dissociated culture system, we could follow the development of Purkinje cells 
as a single cell. The time point for terminating the cultures can be chosen based on 
visualizing the living Purkinje cells and their dendritic trees.  
At DIV 4, Purkinje cell dendrites start to develop but the cells still have multiple thin 
perisomatic processes. At DIV 8, Purkinje cells have formed a primary dendrite and 
start rapid dendritic expansion. At around DIV 14-18, Purkinje cells have developed a 
rather elaborated highly branched dendritic tree (Fig. 12). An advantage of this culture 
system is that we could follow the dendritic development of Purkinje cells over time 
and also we could maintain the cultures for more than 4 weeks. 
 
Fig. 12 Development of Purkinje cell in Dissociated cerebellar culture 
Immunofluorescence staining of dissociated cerebellar cultures in each point in vitro. 
Cultures were stained with anti-Calbindin D-28K (1:1000). 
 
Purkinje cell dendritic development in dissociated cultures from mPKCγ transgenic 
mice 
As shown above, Purkinje cells from control mice developed elaborated branched 
dendritic arbors after a culture period of 14-18 days. In contrast, Purkinje cells from 
mPKCγ transgenic mice developed only very small dendritic trees.  
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Fig. 13 Immunofluorescence staining analysis of dissociated cerebellar culture 
of mPKCγ transgenic mice and control mice 
(A) Immunofluorescence staining of dissociated cerebellar culture after two weeks in 
vitro. Cultures from control mice treated with EtOH/DMSO showed expanded dendritic 
trees. (B) Purkinje cells from control cultures treated with the PKC activator PMA 
developed a small dendritic tree with only very few processes. (C) Cultures from control 
mice without any treatment showed large expanded dendritic trees.  (D) The dendritic 
tree of Purkinje cell from mPKCγ transgenic mice was very small and very similar to 
the dendritic tree of PMA-treated control. (E) Quantification of the total dendritic area 
of Purkinje cells. The reduction of dendritic size of PMA-treated cultures or Purkinje 
cells from mPKCγ transgenic mice versus control cultures was statistically significant 
with p < 0.05. Error bars indicate the SEM. 
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These findings are comparable to those obtained in organotypic slice cultures. The 
morphology of Purkinje cells from mPKCγ transgenic mice was similar to that of control 
Purkinje cells treated with the PKC activator PMA (Fig. 13A-D, previous page). The 
statistical analysis showed clear statistically significant differences of the size of the 
dendritic tree of Purkinje cells between the control condition and PMA treatment or 
Purkinje cells derived from mPKCγ transgenic mice (Fig. 13E). 
From these data two important conclusions emerge:  
First, dissociated cultures yield exactly the same results with respect to the Purkinje 
cell dendritic tree as organotypic slice culture showing that this culture method is 
appropriate for studying Purkinje cell dendritic development. 
Second, Purkinje cells from mPKCγ transgenic mice showed a gain of function 
phenotype of PKCγ biological activity. With the consistent results from these 
experiments, dissociated cerebellar cultures are proven to be an appropriate system 
to analyse Purkinje cell dendritic morphology after gene manipulation experiments. 
 
 Transfection approach for Purkinje cells 
  Biolistic transfection 
In order to optimize the transfection parameters, we performed transfections with 
several conditions (Table. 1 and 2). 
Table. 1 Condition of biolistic transfection 1 
The same GFP-vector was transfected with the different parameters at DIV 3 to 
cerebellar slices. Total transfected cell number and transfected Purkinje cell number 
are shown for 8 cerebellar slices on one culture insert transfected together with the 
same conditions. 
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Table. 2 Condition of biolistic transfection 2 
GFP-vector was transfected with different conditions at DIV 4 or DIV 7 to cerebellar 
slices. Transfected cell number and transfected Purkinje cells number are shown for 8 
cerebellar slices on one culture insert transfected together with the same conditions. 
 
We first used the original barrel provided by Biorad for bombardment (“wide barrel”), 
it’s a rather wide barrel and makes it difficult to target a specific region on the culture 
insert. We also used another barrel which is narrower (“narrow barrel”) and allows to 
target specific regions on the culture inserts (O'Brien and Lummis, 2006). Also we 
compared bombardments at different times in vitro (from DIV 3 to DIV 7) and with two 
different amounts of Gold particles. The results are shown Fig. 14 and 15. In some 
cases we could get several transfected Purkinje cells (Fig. 15) but it was rather rare 
and often we only got few transfected Purkinje cells per slice. 
 
Wide barrel VS Narrow barrel 
With the wide barrel (pressure 200 Psi), we got several transfected Purkinje cells in 
one well with 8 cerebellar slices (at DIV 3; 3-8 Purkinje cells, at DIV 4; 0-5 Purkinje 
cells, at DIV 7; 2-12 Purkinje cells). With the narrow barrel (80 Psi to 150 Psi), we got 
slightly fewer transfected Purkinje cell compared to the wide barrel (at DIV 3; 1or2 
Purkinje cells, at DIV 4; 0-8 Purkinje cells, at DIV 7; 1-3 Purkinje cells), but the 
difference was small.  
 
Shooting day 
We did the transfections at DIV 3, DIV 4 and DIV 7 independently and could not see 
any difference in the transfection rate.  
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We also tried several types of Gold particles and again no clear difference was found 
for different particle sizes or particle types (data not shown). 
In all the experiments we have done we could get only a small number of transfected 
Purkinje cells insufficient for doing an analysis of the size and morphology of the 
Purkinje cell dendritic tree. For this reason we did not further pursue this method for 
Purkinje cell transfection in slice cultures.  
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Fig. 14 Immunostaining of GFP-transfected Purkinje cells 
Immunofluorescence staining of cerebellar slices after one week in vitro. After fixing, 
cerebellar slices were stained with anti-GFP and anti-Calbindin D28K antibodies. (A-
C) Result with 1.6 µm (12.5 mg) Bio-Rad Gold, 200 Psi wide barrel at DIV 4. (D-F) 
Result with 1.6 µm (6.0 mg) Bio-Rad Gold, 80 Psi Narrow barrel at DIV 3. (G-I) Result 
with 1. 6 µm (6.0 mg) Bio-Rad Gold, 150 Psi Narrow barrel at DIV 3. 
 
 
Fig. 15 Immunostaining of GFP-transfected Purkinje cells 
Immunofluorescence staining of cerebellar slices after 9 days in vitro. After fixing, 
cerebellar slices were stained with (A) anti-GFP and (B) anti-Parvalbumin antibodies. 
Result with 1.6 µm (12.5 mg) Bio-Rad Gold, 200 Psi wide barrel at DIV 7.  
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  Magnetofection 
Results 
In order to find the optimal conditions for transgene expression with Magnetofection 
(Buerli et al., 2007; Hughes et al., 2001; Krotz, 2003; Plank et al., 2003; Plank et al., 
2011) we tested several time points of transfection as shown in Fig. 16.  
We tested the transfection efficiency for transfections performed at DIV 5 or at DIV 14. 
At both time points, the magnetofection procedure didn’t compromise the survival of 
the Purkinje cells (Fig. 16A-C). However, at both time points we only got few 
transfected cells, and only a very low number of transfected Purkinje cells. Furthermore, 
in the transfected cells the expression of the transgene was very weak as seen by the 
low intensity of GFP staining (Fig. 16D-I). Therefore, we didn’t continue this method 
further. 
  
Fig. 16 Immunostaining of GFP-transfected dissociated cerebellar cells 
(A-C) Immunofluorescence staining of dissociated cerebellar cells after 48 hours 
transfection with NeuroMag. Plasmid was transfected to dissociated cerebellar cells at 
DIV 5. At DIV 7, cells were fixed and stained with anti-GFP and anti-Calbindin D28K 
antibodies. (D-I) Immunofluorescence staining of dissociated cerebellar cells after 72 
hours transfection with NeuroMag. Plasmid was transfected to dissociated cerebellar 
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cells at DIV 14. At DIV 17, cells were fixed and stained with anti-GFP and anti-Calbindin 
D28K antibodies.  
  Effectene 
We tried transfections with Effectene at DIV 10 (Fig. 17A-F) and DIV12 (Fig. 17G-L). 
As a result of transfection at DIV 10, we found several transfected cells but no Purkinje 
cells (Fig. 17A-F). Very rarely we found GFP-transfected Purkinje cells (Fig. 17J-L) but 
the transfection rate was very low and transgenic GFP expression was weak. We 
therefore decided not to use this method for further experiments.  
 
Fig. 17 Immunostaining of dissociated cerebellar cells 
(A-F) Immunofluorescence staining of dissociated cerebellar cells after 24 hours 
transfection with Effectene. Plasmid was transfected to dissociated cerebellar cells at 
DIV 10. At DIV 11, cells were fixed and stained with anti-GFP and anti-Calbindin D28K 
antibodies. (G-I) Immunofluorescence staining of dissociated cerebellar cells without 
any transfection after 24 hours treated with Effectene. (J-L) Plasmid was transfected 
to dissociated cerebellar cells at DIV 12 with Effectene. At DIV 13, cells were fixed and 
stained with anti-GFP and anti-Calbindin D28K antibodies.  
  Conclusion 
85 
 
 
We tried 3 different transfection methods using various commercially available 
reagents. Using these three methods, we could obtain a certain number of transfected 
Purkinje cells. The best results were obtained using the Gene gun but still the achieved 
transfection efficiency was not sufficient for evaluating the dendritic development of 
transfected cells. 
A possible explanation for the poor transfection efficiency might be that the CMV 
promoter contained in the expression plasmid does not support gene expression in 
Purkinje cells very well. Therefore, we had to reconsider the expression vector itself. 
Recently, Wagner et al. showed that with a Purkinje cell specific expression vector 
based on the L7 promoter long term transfections of Purkinje cells could be achieved 
after electroporation (Wagner et al., 2011). Therefore, we decided to try electroporation 
with the vector based on the L7 promoter from Wagner (Wagner et al., 2011).  
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 Phenotype of other PKC gamma mutations 
The following section contains unpublished results. 
 Transgenic mice which carry human PKCγ S361G mutation (mPKCγ) showed 
severe inhibition of dendritic in dissociated cerebellar culture 
In a previous study, we have reported that the catalytic domain mutation caused severe 
inhibition of Purkinje cell dendritic development in organotypic cerebellar slice culture 
and in vivo (Ji et al., 2014). In order to confirm that a similar inhibition of Purkinje cell 
dendritic development could be seen in dissociated cerebellar cultures we made such 
cultures from mPKCγ transgenic mice. The cultures were fixed at DIV14 and stained 
with Calbindin-D28K, a marker protein for Purkinje cells. As expected, Purkinje cells 
from mPKCγ transgenic mice had small dendritic tree with few branch points, similar 
to Purkinje cells treated with the PKC activator PMA (Fig. 18). We performed PMA 
treatment during either from P4-P11 or from P7-P14, both showed a similar 
morphology (data not shown). These findings in dissociated cerebellar cultures 
correlate well with those in organotypic cerebellar slice cultures and demonstrate that 
an increased PKC activity caused inhibition of Purkinje cell dendritic development in in 
the dissociated cerebellar culture system. Using dissociated cerebellar cultures, we 
now tested whether mutant PKCγ constructs expressed via a L7 promoted-based 
vector would inhibit dendritic development in Purkinje cells. 
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Fig. 18 Increased PKC activity reduces Purkinje cell dendrites in dissociated 
primary culture. 
(A) Purkinje cells with normal dendritic expansion in dissociated primary culture. (B) 
PMA (15 nM, 10 days) treated Purkinje cell with greatly reduced dendrites. (C) Purkinje 
cells from mPKCγ transgenic mice also have greatly reduced dendrites. Scale bar in 
H = 50 µm. (D) Quantitative analysis of Purkinje cell dendritic tree size. Data are shown 
as the mean ± S.D of at least 20 Purkinje cells. 
 
SCA14 mutations for expression in Purkinje cells 
To date, over 30 mutations in PKCγ have been found in SCA14 families (Fig. 19A). 
Many of them are concentrated on C1B domain while some mutations are found 
throughout the coding regions of the PRKCG gene. In order to study the effects on 
Purkinje cell dendritic morphology of mutations in different domains of PKCγ , we 
constructed plasmids containing three C1B mutations, one deletion in the C2 domain 
(which is not reported in a SCA14 family but thought to be constitutive active 
(Rotenberg et al., 1998)) and two mutations in the  catalytic domain (Fig. 19B).    
88 
 
 
We have used a L7-based plasmid (a gift of Dr. Wolfgang Wagner in Hamburg) for the 
subsequent experiments because it allows expression of the transgene selectively in 
Purkinje cells (Baader et al., 1998; Wagner et al., 2011; Zhang et al., 2001). In order 
to observe the transfection and expression of PKCγ easily, the mutated PKCγ 
constructs are constructed as GFP fusion proteins (Fig. 19C).  
 
 
Fig. 19 PKCγ protein domains with SCA14 mutations and the construct used for 
the experiments 
(A)Thirty two point mutations and deletions which were found in SCA14 families. 
(B)Five point mutations and one deletion which we chose for experiments. (C)Plasmid 
for expression of exogenous genes in Purkinje cells. Each mutation or deletion was 
constructed as GFP fusion protein. 
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 Purkinje cells transfected with PKCγ carrying C1 or C2 domain mutations 
developed normal dendritic trees  
First, in order to see the effect of a transgenic expression of wild type PKCγ (WT PKCγ), 
a WT PKCγ-GFP fusion plasmid was transfected to dissociated cerebellar cells. The 
transfection resulted in the continuous presence of the WT PKCγ–GFP fusion protein 
over several days as seen by GFP fluorescence. In the transfected Purkinje cells we 
found a small change of dendritic morphology with a thickening of the dendrites.  
However, quantitative analysis only showed a slight reduction of the dendritic tree size 
which didn’t reach statistical significance. The amount of WT PKCγ–GFP fusion protein 
overexpression achieved with the L7-based vector is thus sufficient to have a small 
inhibitory effect on Purkinje cell dendritic development (Fig. 20A, F).  
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Fig. 20 Purkinje cells transfected with PKCγ WT or C1B and C2 mutant 
constructs 
(A) Purkinje cells transfected with WT PKCγ in dissociated primary culture. At DIV 14, 
cells were fixed and stained by anti-CalbindinD28K (red) and anti-GFP antibodies 
(green). (B) Purkinje cells transfected PKCγ G118D. (C) Purkinje cells transfected 
PKCγ S119P. (D) Purkinje cells transfected PKCγ V138E. (E) Purkinje cells transfected 
PKCγ Δ260-280. Scale bar in H = 50 µm. (F-K) Purkinje cell dendritic area was 
measured with image J and statistically analyzed with Graph pad prism. Data are 
shown are the mean ± S.D of at least 20 Purkinje cells. 
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It can serve as a reference to see whether the other constructs would confer an 
increased biological activity compared to the WT PKCγ construct.    
Next, three of C1B mutations and one deletion in C2 domain were transfected by the 
same procedure as for WT PKCγ. Fig. 20B-E and Fig. 20G-K show the Purkinje cell 
morphology for all C1B and C2 mutations. None of these mutant constructs had a 
strong effect on dendritic tree development in Purkinje cells. C1B mutations transfected 
cells showed almost the same morphology compared to that of GFP control transfected 
cells (data not shown), i.e. there were not even the small qualitative changes present 
that were seen with transfection of WT PKCγ. This observation would be compatible 
with a reduced biological activity of the C1B mutations. The Purkinje cells transfected 
with the C2 mutation were more like WT PKCγ transfected Purkinje cells and also 
showed some thickening of the dendrites (Fig. 20E). Statistical analysis showed no 
significant changes of the dendritic area, similar to transfections of WT PKCγ. 
 
 Purkinje cells transfected with PKCγ carrying catalytic domain mutations 
showed inhibition of dendritic development  
As shown above, Purkinje cells in dissociated cultures from PKCγ S361G transgenic 
mice show a sever reduction of dendritic development. When we transfected Purkinje 
cells with a construct carrying the same S361G mutation they developed again only a 
very small dendritic tree with few side-branches (Fig. 21A) identical to that of mPKCγ 
S361G transgenic mice (Fig. 18). We tested another mutation in the catalytic domain, 
F643L which causes SCA14 with cognitive decline and atrophy of the vermis in human 
(Stevanin et al., 2004). Purkinje cells transfected with the F643L construct also showed 
a strong reduction of dendritic development with few side branches (Fig. 21B). On 
quantitative evaluation, the reduction of dendritic size was less pronounced compared 
to S361G but still dramatic and highly significant (Fig. 21C and 21D). These results 
indicate mutations in the catalytic domain of PKCγ have a higher PKC activity 
compared to WT PKCγ and negatively regulate dendritic growth of Purkinje cells. 
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Fig. 21 Purkinje cells transfected with PKCγ catalytic domain mutants. 
(A) Purkinje cells transfected with PKCγ S361G in dissociated primary culture. (B) 
Purkinje cells transfected with PKCγ F643L. Scale bar in H = 50 µm. (C and D) 
Purkinje cell dendritic area was measured with image J and statistically analyzed with 
Graphpad prism. Data are shown as the mean ± S.D of at least 20 Purkinje cells. 
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 Mutant PKC gamma signalling related proteins 
The following section is based on the work published in the Molecular Neurobiology, 
2015, Print ISSN 0893-7648, DOI; 10.1007/s12035-015-9444-3. Some text, figures, 
figure legend numbering and title numbering were modified to fit this thesis. All the 
experiments described in the manuscript were carried out E.S., and the writing of the 
manuscript was done together with J.P.K., W.W. provided the L7-based expression 
plasmid,  
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  Abstract 
Purkinje cell dendritic development is severely compromised after chronic activation of 
protein kinase C (PKC). In a recent transgenic mouse of model spinocerebellar ataxia 
14, the S361G mutation of the PKCγ-gene was expressed in Purkinje cells. Purkinje 
cells from these mutant mice in organotypic slice cultures have the same stunted 
dendritic tree as Purkinje cells after pharmacological activation of PKC. Because the 
transgene is exclusively present in Purkinje cells, cerebellar tissue from these mice is 
an attractive starting material for searching genes which might be interacting with PKCγ 
in Purkinje cells for inducing the stunted dendritic growth. We have performed a micro 
array analysis and identified several candidate genes with an increased mRNA 
expression in the PKCγ-S361G transgenic Purkinje cells. Out of these candidates we 
have further studied carbonic anhydrase 8 (CA8). We show here that CA8 mRNA and 
protein expression is strongly induced in PKCγ-S361G transgenic Purkinje cells. 
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Overexpression of CA8 in Purkinje cells in dissociated cultures strongly inhibited 
Purkinje cell dendritic development and produced a dendritic phenotype similar to 
PKCγ-S361G. There was no evidence for a direct binding of CA8 to either PKCγ or the 
type 1 IP3 receptor. Knock-down of CA8 with miRNA did not alter Purkinje cell dendritic 
development and did not protect Purkinje cells in dissociated cultures from the stunted 
dendritic growth induced by PKCγ-S361G or by PKC activation. Our results indicate 
that CA8 is a novel important regulator of Purkinje cell dendritic development and that 
its expression is controlled by PKCγ activity. 
 
  Introduction 
The signalling molecule PKC plays an important role for long term depression of 
Purkinje cells (Ito et al., 2014) and has a strong negative impact on Purkinje cell 
dendritic growth and development (Kapfhammer, 2004; Metzger and Kapfhammer, 
2003; Schrenk and Kapfhammer, 2002). Increased PKC activity is likely to affect the 
long term calcium equilibrium of the Purkinje cells. Blockade of voltage gated calcium 
channels could partially protect Purkinje dendrites cells from the stunted growth seen 
with increased PKC activity (Gugger et al., 2012) and Purkinje cells from Moonwalker 
(Mwk) mutant mice with increased calcium influx through TRPC3 channels also show 
a stunted dendritic morphology (Becker et al., 2009). Similarly, inhibition of the Plasma 
Membrane calcium-ATPase 2 (PMCA2) affected Purkinje cell dendritic growth (Huang 
et al., 2010; Sherkhane and Kapfhammer., 2013). These findings demonstrate the 
involvement of the calcium equilibrium for regulating Purkinje cell dendritic growth but 
still very little is known about the downstream molecular interactions after PKC 
activation in Purkinje cells leading to the reduced dendritic growth. Interestingly, one 
form of spinocerebellar ataxias, SCA 14, is caused by point mutations in the PKCγ 
gene (Chen et al., 2012; Pandolfo et al., 2005) and that at least some of the missense 
mutations may confer a gain of function phenotype with a constitutive activation of 
PKCγ (Adachi et al., 2008; Verbeek et al., 2005). We have recently created a 
transgenic mouse model of SCA 14 by introducing a transgene carrying the S361G 
mutation of the PKC-gene specifically into Purkinje cells. This mutation is located in 
the catalytic domain (Chen et al., 2005) and was shown previously to confer an 
increased catalytic activity as tested by in vitro assays (Adachi et al., 2008). PKCγ-
95 
 
 
S361G transgenic mice have pathological changes typical for cerebellar disease and 
have an increased PKCγ activity in vivo reflected by the reduced dendritic development 
typically seen with increased PKC activity (Ji et al., 2014). Purkinje cells from these 
mutant mice thus show both an increased PKCγ activity and a severe dendritic 
reduction. Because the transgene is exclusively activated in Purkinje cells, cerebellar 
tissue from these mice is an attractive starting material for searching other genes which 
might be interacting with PKCγ for inducing the stunted dendritic growth. We have 
performed a gene chip micro array analysis and identified several candidate genes 
with an increased mRNA expression in the PKCγ-S361G transgenic Purkinje cells. Out 
of these candidate genes we have further studied CA8 which was shown previously to 
be involved in Purkinje cell function and cerebellar disease (Hirasawa et al., 2007; Jiao 
et al., 2005). We show here that CA8 mRNA and protein expression is strongly induced 
after PKC activation and that overexpression of CA8 in cultures of dissociated Purkinje 
cells strongly inhibits Purkinje cell dendritic development. However, we found no 
evidence of a binding of CA8 to either PKCγ or the type 1 IP3 receptor. Knock-down 
of CA8 protein expression by miRNA transfection did not protect Purkinje cells in 
dissociated cultures from the stunted dendritic growth after increased PKCγ activity. 
Our results indicate that CA8 is an important regulator of Purkinje cell dendritic 
development and that its expression is controlled by PKCγ activity.  
 
  Materials and Methods 
Plasmid Construction 
Plasmid L7-GFP was previously described (Wagner et al., 2011). CMV-CA8 and CMV-
PKCγ plasmids were from Origene (Rockville, MD, USA). Restriction sites were added 
to the CA8 and PKCγ genes by polymerase chain reaction (PCR) using the following 
primers: Forward primer for CA8: 5’CAG GAT CCA GCG GCC GCA TGG CTG ACC 
TGA GCT TC3’, Reverse primer for CA8: 5’CCC TTG CTC ACC ATG GCC TGA AAG 
GCC GCT CGG A3’, Forward primer for PKCγ: 5’CAG GAT CCA GCG GCC GCA 
TGG CTG GTC TGG GCC CC 3’, Reverse primer for PKCγ: 5’CCC TTG CTC ACC 
ATG GCC ATG ACG GGC ACA GGC A3’. These PCR products were incubated with 
the L7-GFP vector in the presence of the restriction enzymes, NotI and NcoI (New 
England BioLabs, Massachusetts, USA) in suitable buffer. After 30min incubation at 
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37°C, DNA fragment and linearized vector were fused using in-Fusion HD Cloning Kits 
(Clontech, Mountain View, CA). The constructed expression vectors were confirmed 
by DNA sequencing (Microsynth, Balgach, Switzerland).  
 
Organotypic Slice Cultures 
Animal experiments were carried out in accordance with the EU Directive 2010/63/EU 
for animal experiments and were reviewed and permitted by Swiss authorities. 
Cultures were prepared from B6CF1 (CB6) mice or PKCγ-S361G transgenic mice  as 
described previously (Kapfhammer JP, 2010). Briefly, mice were decapitated at 
postnatal day 8 (P8), their brains were aseptically removed and the cerebellum was 
dissected in ice-cold preparation medium (minimal essential medium (MEM) with 1% 
glutamax (Life Technologies, Zug, Switzerland), pH 7.3). Sagittal sections 350 µm thick 
were cut on a McIllwain tissue chopper under aseptic conditions. Slices were separated, 
transferred onto permeable membranes (Millicell-CM, Merck-Millipore, Zug 
Switzerland) and incubated on a layer of Neurobasal medium (97% Neurobasal 
medium, 2% B27 supplement, 1% glutamax, pH 7.3) in a humidified atmosphere with 
5% CO2 at 37°C. The medium was changed every 2-3 days for a total of 5 days for 
microarray analysis and of 7 days for protein analysis and immunostaining. 
 
Microarray analysis 
Starting material for the microarray analysis were cerebellar slice cultures from PKCγ-
S361G transgenic mice versus control mice. After 5 days in vitro (DIV 5), organotypic 
cerebellar slices were washed, harvested and submerged in RNAlater (Life 
Technologies, Zug, Switzerland) solution for storage. The slices from one litter deriving 
from 3-4 mouse pups were collected and used for RNA purification. Purified total RNA 
was amplified by in-vitro transcription and converted to sense-strand cDNA. 
Fragmented cDNA samples were then hybridized to GeneChip Mouse Gene 1.0 ST 
Arrays (Affymetrix, Santa Clara, CA, USA). Procedures were carried out as described 
by the manufacturers and the analysis was done in the LSTF core facility of the 
University of Basel by Dr. Philippe Demougin. Raw data were processed and analyzed 
using Partek Genomics suite (version 6.12.0907). Transcripts were considered to be 
changed if the p-value was smaller than 0.05. After filtering, 1045 genes were retained. 
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We then set the threshold at a fold change exceeding 1.25 for being specifically 
expressed and 98 genes were retained.  
 
Reverse transcriptase-quantitative PCR (RT-qPCR) 
Total RNA was extracted from organotypic cerebellar slices harvested at DIV 5-7 and 
cDNA was synthesized with RT-qPCR using oligo (dT) primers (Applied Biosystems, 
Foster City, CA). For gene expression analysis, RT-qPCR reactions were conducted 
in a total volume of 20 μl comprising 10 μl of Mastermix with SYBR green (Applied 
Biosystems, Foster City, CA), 0.5 μl of each primer (1.0 μM), 0.3 μl of sample cDNA, 
and 8.5 μl ultrapure water. Real-time PCR reactions were run on a Real time PCR 
system (Applied Biosystems, Foster City, CA) under the following reaction conditions: 
1 cycle of [95°C for 10 min], 40 cycles of [94°C for 15 s → 65°C for 60 s], and 1 cycle 
of [95°C for 15 s → 72°C for 30 s → 95°C for 15 s]. Oligonucleotide primers were 
designed using the Primer3 software (http://bioinfo.ut.ee/primer3/). The primer 
sequences are given in supplementary methods. Reactions were quantified by relative 
standard curve system and the cycle threshold (Ct) method using the SDS2.2 software 
(Applied Biosystems, Foster City, CA). A relative quantitation value (RQ) for each 
sample from the triplicates of that sample was calculated for each gene. The data was 
analyzed as RQ for the gene of PKCγ transgenic mice/ RQ for control mice. For each 
comparison a minimum of 3 independent experiments were done with unrelated RNA 
samples. 
 
Western Blot analysis 
Tissue slices were harvested with a cell scraper. Samples were then 
homogenized in RIPA buffer with phosphatase inhibitor (phosphor STOP, 
Roche, Basel Switzerland) and protease inhibitor (cOmplete Protease Inhibitor 
Cocktail Tablets, Roche, Basel Switzerland). Homogenates were sonicated for 
5 seconds a total of 5 times and cleared by centrifugation at 14,000 × g for 15 
min at 4 °C. Protein concentrations were determined with Nano drop 
(ThermoScientific, Reinach, Switzerland). Western blotting analysis was 
performed by standard protocols. Membranes were blocked with 5% BSA in 
TBS for 1 hour and incubated with appropriate Primary antibodies. Rabbit anti-
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ITPR1 (Cell signaling, Massachusetts, USA 1:1000), Rabbit anti-CA8 (Novus 
Biologicals, Colorado, USA 1:2000), Rabbit anti-PKCγ (Santa Cruz 
Biotechnology, Santa Cruz, CA, 1:1000), Rabbit anti-Fam40b (AVIVA, San 
Diego, USA, 1:1000), Rabbit anti-Plekhd1 (Thermo Scientific, Reinach, 
Switzerland, 1:1000), Rabbit anti-Homer3 (Abgent Inc., San Diego, CA, USA 
1:1000) , mouse anti-mGluR1 (BD Biosciences, Franklin Lakes, NJ, USA 
1:1000) or anti-βActin (Millipore Zug Switzerland, 1:1000) was used. After 
washing with TBS-T, membranes were incubated with HRP-labelled secondary 
antibodies for 1 hour. After washing, bound antibodies were visualized with 
ECL2 Western blotting substrate (Pierce, Thermo Scientific, Reinach, 
Switzerland) and quantified using a C-Digit Western Blot scanner and software 
(LI-COR Biosciences, Bad Homburg, Germany). For each comparison a 
minimum of 3 independent experiments were done with unrelated protein 
samples. 
 
Immunoprecipitation 
Cerebellar slice cultures at DIV 7 were used as starting material. Slice cultures 
were harvested with a cell scraper. Samples were then homogenized in RIPA 
buffer with phosphatase inhibitor and protease inhibitor as described in 
Western Blot analysis. Homogenates were sonicated for 5 sec a total of 5 times 
and cleared by centrifugation at 14,000 × g for 15 min at 4°C and protein 
concentrations were determined and 100 µg of each sample were used for 
immunoprecipitation. Before using, Protein G was washed twice at 12000 × g 
for 10 sec with PBS. Lysate was incubated with 50 µl Protein G for 30 min at 
4°C and lysate was washed twice at 12000 × g for 10sec with PBS. 1 µg 
antibody, 50 µl pre-washed Protein G and 50 µl PBS were added to the lysate 
and rotated at 4°C for overnight. Tubes were then centrifuged at 4°C for 2 min 
at 3000 × g and washed with 1ml PBS 4°C for 2 min at 3000 × g four times. 
SDS-PAGE and Western blot were done as described. A minimum of 3 
independent immunoprecipitation experiments with unrelated protein samples 
were done per condition. 
Immunohistochemistry 
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At DIV 7, slices were fixed in 4% paraformaldehyde overnight at 4°C. All reagents were 
diluted in 100 mM phosphate buffer (PB), pH 7.3. Slices were incubated in blocking 
solution (0.5% Triton X-100, 3% normal goat serum) for 1 hour at room temperature. 
Two different primary antibodies were simultaneously added to the slices in fresh 
blocking solution and incubated overnight at 4°C. After washing in PB, secondary 
antibodies were added to the slices in PB containing 0.1% Triton X-100 for 2 hours at 
room temperature. For the analysis of protein expression in Purkinje cells, mouse anti-
Calbindin D-28K (Swant, Marly, Switzerland 1:1000) and polyclonal Rabbit anti-GFP 
(Abcam, Cambridge, UK 1:1000), Rabbit anti-CA8 (Novus Biologicals, Colorado, USA 
1:2000), mouse anti-ITPR1 (Abcam, Cambridge, UK 1:100), rabbit anti-ITPR1 
(Millipore, Zug Switzerland, 1:2000) or Rabbit anti-PKCγ (Santa Cruz Biotechnology, 
Santa Cruz, CA, 1:1000) were used as primary antibodies and goat anti-mouse Alexa 
568 (Molecular Probes, Eugene, OR, 1:1000) and goat anti-rabbit Alexa 488 
(Molecular Probes, Eugene, OR, 1:1000) were used as secondary antibodies to 
visualize Purkinje cells. Stained slices were mounted on cover slips with Mowiol 
(Sigma-Aldrich, Buchs, Switzerland). Cultures were viewed on an Olympus AX-70 
microscope equipped with a Spot digital camera. Recorded images were adjusted for 
brightness and contrast with Photoshop image processing software. 
 
Histology  
Mice were deeply anesthetized, perfused through the aorta with 4% 
paraformaldehyde and cryoprotected with 30% sucrose overnight. Brains were 
embedded in tissue freezing medium (OCT), frozen and sectioned using a Leica 
cryostat CM1900. Sagittal sections (25 µm) were examined by 
immunohistochemical staining. 
 
Plasmid transfection of Purkinje cells in dissociated cerebellar cultures  
Dissociated cerebellar cultures were prepared from mice essentially as 
described (Wagner et al., 2011) except that the cells were obtained from 
postnatal day 0 (P0) mice. The transfection of the cells was performed using a 
Nepa21 electroporator (NEPAGENE, Japan) according to manufacturer's 
instructions. 100 μl of the Opti-MEM (Life Technologies, Zug, Switzerland) 
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solution was mixed with the plasmid DNA to be transfected. This mixture was 
then used to suspend the cerebellar cell pellet. The cell suspension was 
transferred into one of the cuvettes provided in the kit and subjected to the 
optimized electroporation program. After transfection, cells were plated in glass 
chambers that had been coated with poly-L-lysine containing 90% v/v DFM, 1% 
N-2 Supplement, 1% Glutamax and 10% v/v FBS (all from Life Technologies, 
Zug, Switzerland), pH was adjusted to 7.2-7.4. Two hours after transfection, 
0.8 ml DFM, containing 1% N-2 Supplement, 1% Glutamax at 37°C was added 
to each dish. After that, half of medium was changed once or twice a week. 
After 14-18 days, cells were fixed in 4% paraformaldehyde for 1 hour at 4°C 
and processed for immunohistochemistry as described. A minimum of 3 
independent transfection experiments using different dissociated cultures were 
done for each plasmid. 
 
Knockdown of CA8 expression 
miRNAs were designed and generated by Life Technologies, Zug, Switzerland to 
target CA8 (for details see supplementary methods). Each miRNA was cloned into the 
BLOCK-iT™ Pol II miR RNAi expression vector according to the instructions of the 
manufacturer and then sequenced (Microsynth, Balgach, Switzerland). In order to test 
the knockdown efficacy, the different miRNA vectors together with a CA8 expression 
vector were transfected into HeLa cells using Lipofectamin 2000 (Life Technologies, 
Zug, Switzerland). The most efficient pcDNA6.2-GW/miRNA expression vectors 
containing CA8-specific miRNAs were sub cloned to pL7 in order to transfect miRNA 
to Purkinje cells. In order to monitor miRNA transfection, a GFP reporter was included 
in the miRNA vectors. Dissociated cerebellar cultures cells were electroporated using 
Nepa21 (NEPAGENE, Japan) according to manufacturer's instructions and cultured 
as described. A minimum of 3 independent transfection experiments using different 
dissociated cultures were done for each plasmid. 
 
Statistical analysis of Purkinje cell dendritic tree size 
The quantification of Purkinje cell dendritic tree size and counting of branch points from 
organotypic slice cultures or dissociated Purkinje cell cultures was done as previously 
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described (Gugger and Kapfhammer., 2012). Purkinje cells which had a dendritic 
tree isolated from its surroundings were selected for analysis. An image analysis 
program (Image Pro Plus or ImageJ) was used to trace the outline of the Purkinje cell 
dendritic trees yielding the area covered by the dendritic tree. Over 20 cells per 
experimental condition originating from at least 3 independent experiments were 
acquired and analysed using GraphPad Prism software (San Diego, USA). The 
statistical significance of differences in parameters was assessed by a non-parametric 
Mann-Whitney’s test. Confidence intervals were 95%, statistical significance was 
assumed when p<0.05. 
 
  Results 
Up-regulated genes in PKCγ-S361G transgenic mice identified by Gene chip analysis 
We have previously reported that PKCγ-S361G mice carrying a human SCA 14 allele 
with Purkinje cell specific expression showed an increased PKCγ activity in Purkinje 
cells leading to abnormal morphology of Purkinje cells, a phenotype which is very 
similar to the one found after pharmacological treatment of PKC stimulator. In contrast 
to pharmacological stimulation, the increased PKC activity in PKCγ transgenic is 
Purkinje cell specific, offering the possibility to search for downstream targets of PKCγ-
S361G signaling which might be involved in the inhibition of Purkinje cell dendritic 
growth. 
In order to search for transcripts with altered expression in Purkinje cells of PKCγ-
S361G transgenic mice we used the Affymetrix Gene Chip Mouse Gene 1.0 ST Array 
comparing samples of cerebellar slice cultures from PKCγ transgenic mice to control 
mice. The micro array analysis was performed twice using 2 independent samples from 
different culture experiments. We could identify 98 genes which were up-regulated and 
17 genes which were down-regulated in PKCγ-S361G transgenic mice based on a 
change of more than 1.25 fold (the complete microarray data sets are available from 
the authors on request). The rather moderate changes in expression of most 
transcripts could be explained by the fact that the Purkinje cells population is very small 
and only comprises around 0.1% of the total cells of the cerebellum of adult rodents 
(Tomomura et al., 2001). We focused on up-regulated genes because our previous 
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studies had shown that PKCγ-S361G transgenic mice had an increased activity of PKC 
and we searched for candidates which might be involved in PKC signaling.  
Out of the 98 up-regulated genes, we selected eight genes for further analysis based 
on their expression level in Purkinje cells in situ and their presumed function (Table. 3). 
A brief description of the main features of the eight candidate genes is given in the 
Supplementary Table 1. The expression of the mRNA of the eight candidate genes 
was verified using the Allen brain atlas. The in situ hybridisation data from the Allen 
Brain Atlas (http://mouse.brain-map.org/) confirm that all of the 8 selected candidate 
genes are strongly expressed in Purkinje cells. For several of these genes an important 
role for Purkinje cell differentiation and function has already been suggested 
(Supplementary Table. 1). 
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Gene  p-value Fold change 
Bcl11a  0.036643 1.412 
CA8  0.023265 1.63062 
Chn1   0.011644 1.47505 
Fam40b 0.045992 1.92428 
Klhl4   0.025187 1.9327 
Lhx1  0.007259 1.36811 
Plekhd1   0.000103 1.38 
Ywhah (14-3-3eta) 0.024979 1.29995 
 
Table. 3 Gene chip micro array results of candidate genes.  
For the 8 selected candidate genes the induction of mRNA expression in PKCγ-
S361G transgenic mice compared to control mice (Fold change) and the p-values of 
for the significance of the change are shown. 
 
 
Fig. 22 Gene chip and quantitative RT-PCR data for cerebellum of PKCγ-S361G 
transgenic mice and control mice 
(A) Induction of the expression of the 8 selected candidate genes as found in the 
gene chip assay (B) Quantitative RT–PCR confirmed that all candidates are up-
regulated in PKCγ-S361G transgenic mice. 
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RT-qPCR analysis and Western blotting confirms the upregulation of candidate 
genes 
In order to confirm the GeneChip micro array results (Fig. 22A), we performed RT-
qPCR assays using cerebellar slice cultures. As expected, all of the candidate genes 
were up-regulated in the cerebellar slice cultures from PKCγ-S361G transgenic mice 
(Fig. 22B). In order to confirm the increased expression of candidates on the protein 
level, we performed Western blot analysis. After 7 days of culture (DIV 7), cerebellar 
slice cultures of control mice and PKCγ-S361G transgenic mice were collected and 
candidate proteins were detected with Western Blotting. At DIV7 there is a strong 
reduction of the dendritic expansion of Purkinje cells in slice cultures from PKCγ-
S361G transgenic mice (Ji et al., 2014). In PKCγ-S361G transgenic mice, the PKCγ-
S361G protein expression level is higher than that of control (Fig. 23A). Notably, fold 
change of PRKCG gene in GeneChip micro array was around 1.6 (data not shown). 
Within the candidates, the protein expression of CA8, Fam40b and Plekhd1 was 
induced in PKCγ-S361G transgenic mice (Fig. 23B, C). CA8 was more than 5 times 
up-regulated while Fam40b and Plekhd1 were only slightly up at around 1.3 of control 
levels. As for the other candidates, either we could not see a strong difference in 
protein expression or no antibody suitable for Western blot analysis is available so far. 
Therefore, further analysis was restricted to CA8, Fam40b and Plekhd1.   
 
RT-qPCR analysis and Western blotting confirms the upregulation of candidate 
genes 
In order to confirm the GeneChip micro array results (Fig. 22A), we performed RT-
qPCR assays using cerebellar slice cultures. As expected, all of the candidate genes 
were up-regulated in the cerebellar slice cultures from PKCγ-S361G transgenic mice 
(Fig. 22B). In order to confirm the increased expression of candidates on the protein 
level, we performed Western blot analysis. After 7 days of culture (DIV 7), cerebellar 
slice cultures of control mice and PKCγ-S361G transgenic mice were collected and 
candidate proteins were detected with Western Blotting. At DIV7 there is a strong 
reduction of the dendritic expansion of Purkinje cells in slice cultures from PKCγ-
S361G transgenic mice (Ji et al., 2014). In PKCγ-S361G transgenic mice, the PKCγ-
S361G protein expression level is high er than that of control (Fig. 23A).  
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Fig. 23 Western Blot analysis of cerebellum of PKCγ-S361G transgenic mice and 
control mice  
(A) Protein expression of PKCγ is increased in the cerebellum of PKCγ-S361G 
transgenic mice.  βActin was used as a loading control. (B) Western Blot results of 
CA8, Fam40b and Plekhd1. βActin as loading control. (C) Quantitation of Western Blot 
data. Signal intensity of each candidate was normalized with βActin. Data were from 
three independent experiments and signal intensity of samples from control mice was 
set to one. 
 
Notably, fold change of PRKCG gene in GeneChip micro array was around 1.6 (data 
not shown). Within the candidates, the protein expression of CA8, Fam40b and 
 
CA8 is specifically and strongly expressed in Purkinje cells  
To determine the expression pattern of CA8 in brain, we performed 
immunohistochemical analysis on mid-sagittal brain sections of P14 wild-type mice and 
PKCγ-S361G transgenic mice. Purkinje cells were identified by staining for Calbindin-
D28K together with CA8. We found that CA8 was specifically expressed in Purkinje 
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cells and that the staining intensity was higher in PKCγ-S361G transgenic mice (Fig. 
24A, B). Further we performed immunostaining in organotypic slice cultures. CA8 was 
again most strongly expressed in cultures derived from PKCγ-S361G transgenic mice 
(Fig. 24C, D). These results suggest that CA8 is specifically expressed in Purkinje cells 
and that the expression level is induced by the PKCγ-S361G transgene. 
 
 
Fig. 24 Immunofluorescence staining analysis of cerebellum of PKCγ-S361G 
transgenic mice and control mice  
(A-F) Immunofluorescence staining of frozen section from P14 control mice in A-C and 
from PKCγ-S361G mice in D-F with anti-Calbindin-D28K (A, D) and with anti-CA8 (B, 
E). Merged images in (C, F). 
(G-L) Immunofluorescence staining of cerebellar slice cultures after one week in vitro.  
Cultures from control mice in G-I and from PKCγ-S361G mice in J-L stained with anti-
Calbindin-D28K (G, J) and with anti-CA8 (H, K). Merged images in (I, L).  
Note the strong induction of anti-CA8 immunostaining in PKCγ-S361G cerebellum. 
Scale bar in H = 50 µm. 
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Immunostaining for Fam40b and Plekhd1 with commercially available antibodies did 
not give satisfactory results and showed either no staining or only poor staining 
intensity on sections or organotypic cerebellar slice cultures. Therefore, we didn’t 
further analyze these candidates and focused on CA8. 
 
The inositol 1, 4, 5-trisphosphate receptor 1 (ITPR1) is also induced in PKCγ-S361G 
transgenic mice 
CA8, 10, and 11 are called CARPs because they lack classical carbonic anhydrase 
enzymatic activity due to the missing catalytic zinc coordinating residues (Sjöblom et 
al., 1996). Thus their biological functions are still unclear. Hirota et al. showed that  
Fig. 
25 ITPR1 is induced in PKCγ-S361G transgenic mice  
(A) Quantitative RT–PCR showing upregulation of ITPR1 but not ITPR2 and ITPR3 in 
PKCγ-S361G. (B) Western Blot results of ITPR1 from cerebellum of control and PKCγ-
S361G transgenic mice. βActin as loading control. (C) Quantitation of Western Blot 
data. Signal intensity was normalized with βActin. (D, E) Anti-ITPR1 immunostaining 
of cerebellar slice cultures after one week in vitro. Note the strong induction of anti-
ITPR1 immunostaining in PKCγ-S361G slices (E) versus control slices (D).  Scale bar 
in E = 50 µm. 
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CARPs bind to ITPR1 using a yeast hybrid system and also found abundant co-
expression and co-localization of CARP and ITPR1 in Purkinje cells (Hirota et al., 2003). 
The ITPR1 functions as a ligand-gated ion channel that releases Ca2+ from intracellular 
stores (Banerjee and Hasan, 2005). We analyzed the ITPR1 expression level in PKCγ-
S361G transgenic mice. Although we had not identified ITPR1 as a candidate in our 
GeneChip micro array because the p-value was above 0.05 (p-value 0.052 and fold 
change was 1.42), ITPR1 mRNA was induced in PKCγ-S361G transgenic mice when 
tested with RT-qPCR (Fig. 22A). Western Blotting analysis confirmed that ITPR1 
protein is strongly up-regulated in PKCγ-S361G transgenic mice (Fig. 25B, C). 
Immunofluorescence staining results showed specific expression in Purkinje cells 
which was increased in PKCγ-S361G transgenic mice (Fig. 25D, E). 
 
No evidence for a binding between CA8 and ITPR1 in cerebellar Purkinje cells 
The co-expression of ITPR1 and CA8 in Purkinje cells and the induction of both 
proteins by increased PKCγ activity raise the question about a direct interaction of 
ITPR1 and CA8 in Purkinje cells. Binding of CA8 to ITPR1 has been previously shown 
using a GST pull-down assay with recombinant proteins but it is not known whether 
such an interaction also occurs endogenously in Purkinje cells. In order to identify an 
interaction in Purkinje cells, we have carried out co-immunoprecipitation using lysates 
from cerebellar slice cultures. Using this assay, we were unable to detect an interaction 
between ITPR1 and CA8 (Fig. 26) in cerebellar tissue. 
Furthermore, no interaction of CA8 and ITPR1 was detected using the Duo-link 
proximity ligation assay (data not shown). Our data do not support the idea of an 
interaction of CA8 and ITPR1 in cerebellar Purkinje cells. 
 
CA8 overexpression in Purkinje cells inhibits Purkinje cell dendritic development 
In order to characterize the functions of CA8 on dendritic development of Purkinje cells, 
we performed transfection experiments in dissociated cerebellar cell cultures with a 
Purkinje cell specific expression vector based on the L7 promoter (Wagner et al., 2011). 
The L7 promoter plasmid was transfected by electroporation and efficiently and 
selectively mediated expression of the transfected genes in Purkinje cells at a high rate 
and with a continued expression for more than three weeks.  
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Fig. 26 Co-Immunoprecipitation for CA8, ITPR1, PKCγ and Homer3. 
At DIV7, cerebellar slices were lysed (see Methods) and subjected to co-
immunoprecipitation analysis. Western blots with the antibodies indicated at the left 
margin of co-immonoprecipitates from the antibodies indicated in the top line. 
Immunoprecipitation was only observed for the protein of the antibody used, and no 
co-immunoprecipitation of other proteins was found. 
 
We first transfected a plasmid containing the mutated PKCγ-S361G construct that was 
used for the generation of the PKCγ-S361G transgenic mice (Ji et al., 2014). Control 
Purkinje cells in these cultures transfected with a GFP plasmid showed a well-
developed branched dendritic tree (Fig. 27C) which was indistinguishable from that of 
non-transfected Purkinje cells (Fig. 27A). In contrast, Purkinje cells transfected with 
the PKCγ-S361G plasmid developed only very small dendritic trees with little branching 
(Fig. 27D). This morphology was indistinguishable from that of Purkinje cells derived 
from m PKCγ transgenic mice (Fig. 27B). This finding confirms that the dissociated 
cultures are useful for studying some aspects of Purkinje cell dendritic development 
and that the PKCγ mediated inhibition of Purkinje cell dendritic growth is present in the 
dissociated cultures. We then transfected a plasmid containing the CA8 gene inducing 
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Fig. 27 Morphology of Purkinje cells after PKCγ-S361G and CA8 transfection 
after 2 weeks in vitro. Immunostaining with anti-Calbindin-D28K (A, B) or anti-
GFP (C-F). 
(A) Purkinje cells from control mice in dissociated culture with expanded dendritic 
trees. (B) Purkinje cell from PKCγ-S361G transgenic mice with very small dendritic 
trees. (C) Purkinje cells transfected with a control GFP vector with normal dendritic 
expansion. (D) Purkinje cells transfected with a PKCγ-S361G-GFP vector with small 
dendritic trees similar to those of PKCγ-S361G transgenic mice. (E) Purkinje cells 
transfected with a control GFP with normal dendritic expansion. (F) Purkinje cells 
transfected with a CA8-GFP vector also with small dendritic trees. Scale bar in H = 
50 µm. (G-I) Quantification of the total dendritic area of Purkinje cells in the 
transfection experiments. The analysis shows that Purkinje cells transfected with 
PKCγ-S361G (H) or CA8 (I) had very small dendritic trees similar to those of Purkinje 
cells from PKCγ-S361G transgenic mice (G).  The number of measured cells (n) was 
20 for all experiments, and the results were statistically significant with p<0.0001 in 
all conditions. Error bars represent the SEM. 
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an overexpression of CA8 in the transfected Purkinje cells. CA8 overexpression 
resulted in a strong inhibition of Purkinje cell dendritic development compared to 
control Purkinje cells (Fig. 27E) with a morphology of the dendritic tree in transfected 
cells (Fig. 27F) very similar to that after transfection of the PKCγ-S361G containing 
plasmid (Fig. 27D). Quantitative measurements of the size of the Purkinje cell dendritic 
tree with the different transfections confirm that both PKCγ-S361G and overexpression 
of CA8 lead to a severe and similar reduction of the size of Purkinje cell dendritic trees 
(Fig.  27G-I). Our findings show that CA8 overexpression has similar effects on 
Purkinje cell dendritic development as a strong activation of PKCγ and suggests that 
PKCγ and CA8 may be acting in the same or related signaling pathways within Purkinje 
cells. 
 
miRNA-mediated suppression of CA8 protein does not protect from reduction of 
dendritic growth  by increased activity of PKC 
Our finding that overexpression of CA8 reduces dendritic growth raises the question 
whether CA8 might be part of a signaling complex which converts increased PKC 
activity into reduced dendritic growth. We have therefore aimed at suppressing the 
expression of CA8 protein in Purkinje cells by miRNA transfection. In order to knock 
down CA8 protein expression in Purkinje cells, we used two different miRNAs, mi327 
and mi616, which were selected based on their knockdown efficiency in HeLa cells 
and which were cloned into the L7 promoter plasmid together with a GFP reporter (for 
details see supplementary methods). mi327 and mi616 transfected Purkinje cells 
showed a greatly reduced CA8 expression as revealed by immunohistochemistry (Fig. 
28D, F, H) compared to control miRNA transfected  (Fig. 28A) or non-transfected cells.  
Purkinje cells with a CA8 knockdown displayed a rather normal morphology with no 
significant reduction of the size of the dendritic tree (Fig. 28C). When CA8 knockdown 
was combined with stimulation of PKC activity with phorbol-12-myristate-13-acetate 
(PMA), the CA8 knock down didn’t provide any protection from the reduction of the 
dendritic tree seen under these conditions (Fig. 28E, F). A similar result was obtained 
when CA8 knockdown was done in Purkinje cells from PKCγ-S361G transgenic mice. 
The CA8 knockdown did not rescue the dendritic tree form the severe reduction typical 
for this condition (Fig. 28G, H). A quantitative evaluation of the dendritic tree sizes is 
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shown in Fig. 28I confirming the qualitative findings. These data indicate that the 
signaling from PKCγ to the control of dendritic growth in Purkinje cells does not require 
a strong contribution of CA8 protein function. 
Fig. 28 Morphology of Purkinje cells after CA8 miRNA-mediated knockdown 
after 2 weeks in vitro.  
Immunostaining with anti-GFP (A, C, E, G, I, L) or anti-CA8 (B, D, F, H, K, M). 
(A, B) Control miRNA-GFP-transfected Purkinje cells express the GFP reporter (A), 
show normal CA8 immunostaining (B) and a normal morphology. (C, D) A Purkinje 
cell transfected with CA8 miRNA-GFP expresses GFP and shows a normal 
morphology (C). A non-transfected Purkinje cell is well stained in the anti-CA8 
immunostaining whereas the CA8 miRNA-GFP-transfected Purkinje cell (arrow) is 
almost not visible. (E, F) Treatment with the PKC stimulator PMA dramatically 
reduced dendritic growth. (E) Anti-GFP immunostaining, (F) Anti-CA8 
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immunostaining. Transfection with CA8 miRNA-GFP strongly reduced the CA8 
immunostaining but did not protect from the PMA-induced dendritic reduction.  
(G, H) Purkinje cell from a PKCγ-S361G transgenic mouse with strongly reduced 
dendrites. (G) Anti-GFP immunostaining, (H) Anti-CA8 immunostaining. Transfection 
with CA8 miRNA-GFP strongly reduced the CA8 immunostaining but did not protect 
from the dendritic reduction. Scale bar in H = 50 µm. 
(I) Quantification of the dendritic area of Purkinje cells in the CA8 miRNA-GFP 
transfection experiments. The analysis shows that transfection with CA8 miRNA-GFP 
could not rescue the dendritic tree size after stimulation with PMA (labeled WT+PMA) 
or in PKCγ-S361G transgenic Purkinje cells (labeled Tg). The data include control 
experiments with transfections of a control miRNA-GFP plasmid for which no images 
are shown in (A-H). The number of measured cells (n) was 20 for all experiments, 
and the reduction of the dendritic tree in the experiments with either PMA treatment 
or PKCγ-S361G transgenic mice was statistically significant with p<0.0001 in all 
conditions irrespective of the presence of miRNA. Error bars represent the SEM. 
 
 
  Discussion 
Using a transgenic mouse model expressing a constitutive active form of PKC 
specifically in Purkinje cells, we have identified several candidate genes which might 
be involved in the stunted dendritic growth of Purkinje cells seen after PKC activation. 
One of these candidate genes, CA8, has a greatly increased mRNA and protein 
expression after PKC activation. Overexpression of CA8 in cultures of dissociated 
Purkinje cells strongly inhibited Purkinje cell dendritic development. Knock-down of 
CA8 protein expression by miRNA transfection did not protect Purkinje cells in 
dissociated cultures from the stunted dendritic growth after increased PKCγ activity. 
Our results show that CA8 is an important regulator of Purkinje cell dendritic 
development and that its expression is controlled by PKCγ activity.  
 
Genes with increased mRNA expression in Purkinje cells with activated PKCγ 
Increased activity of PKC in Purkinje cells results in a dramatic reduction of dendritic 
outgrowth and in the formation of a greatly reduced dendritic tree. The downstream 
signalling events converting the activation of PKC to reduced dendritic growth are still 
very unclear. We have used a transgenic mouse model expressing a mutant PKCγ 
with increased catalytic activity specifically in Purkinje cells resulting in stunted 
dendritic growth (Ji et al., 2014) as starting point for searching for genes with an 
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increased expression in such Purkinje cells using a gene chip approach. We have 
identified many candidate molecules although the observed upregulation was typically 
only in the range of 1.5 -1.2 x the original expression. The rather moderate changes in 
expression of most transcripts could be explained by the fact that the Purkinje cell 
population is very small and only comprises around 0.1% of the total cells of the 
cerebellum of adult rodents (Tomomura et al., 2001). When we confirmed the 
increased expression of some of the candidates by RT-qPCR we actually found factors 
of 2 and more (Fig. 22). All of the selected candidate molecules are expressed in 
Purkinje cells and have the potential to be involved in PKC signaling and Purkinje cell 
dendritic development (see supplementary table. 1). We decided to focus the further 
analysis on CA8 because it was the only candidate molecule for which commercially 
available antibodies gave satisfactory results in Western blotting and 
immunohistochemistry, both of which was required for further analysis of a potential 
function in Purkinje cell dendritic development. 
CA8 is a carbonic anhydrase lacking enzymatic activity (Sjöblom et al., 1996). In the 
wdl mouse, mutant with a 19-base-pair deletion in CA8 gene, the loss of function of 
CA8 results in ataxia (Jiao et al., 2005) and synaptic changes in the cerebellum 
(Hirasawa et al., 2007) which are associated with alterations in calcium signalling 
(Lamont et al., 2015). CA8 knockdown in zebrafish resulted in abnormal cerebellar 
development and ataxia (Aspatwar A,2013). Mutations in the human CA8 gene were 
identified which are associated with cerebellar ataxia and mild cognitive retardation 
(Kaya et al., 2011; Türkmen et al., 2009) and antibodies directed against CA8 have 
been identified as a cause of Purkinje cell degeneration and cerebellar ataxia in 
paraneoplastic syndromes (Höftberger et al., 2014). While through these studies there 
is a strong association of CA8 mutations with Purkinje cell death and cerebellar ataxia 
only little is known about CA8 function in Purkinje cells. Our finding that CA8 mRNA is 
approximately two-fold increased and that its protein shows a 6-fold increase in 
Purkinje cells of PKCγ-S361G transgenic mice suggests that it may be involved in the 
signalling events downstream of PKC activation. In view of the reported interaction 
between CA8 and ITPR1 (Hirota et al., 2003), we have now shown that ITPR1 is 
strongly induced in Purkinje cells from PKCγ-S361G transgenic mice. Mutations in 
ITPR1 are causing spinocerebellar ataxia (Schorge et al., 2010; van de Leemput et al., 
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2007) linking the final outcome of disturbances of PKCγ, CA8 and ITPR1 and 
suggesting that these proteins may interact functionally for the control of Purkinje cell 
synaptic function and dendritic development. 
 
PKCγ, CA8 and ITPR1 do not co-immunoprecipitate 
CA8 was previously identified as a protein binding to ITPR1 in a yeast two hybrid 
screen and the interaction was confirmed with a GST-pulldown assay (Hirota et al., 
2003). In a recent report CA8 was shown to modulate pain sensation in sensory 
neurons by inhibiting ITPR1-mediated signalling and calcium release (Zhuang et al., 
2015). Although the ITPR1 was not originally identified as being upregulated in our 
gene chip screening (because the p-value was slightly above 0.05) we have confirmed 
that it is also increased with an almost 5-fold increased protein expression in Purkinje 
cells with activated PKC. In the classical signalling pathway, both PKCγ and the ITPR1 
are activated in parallel via DAG and IP3. It is an interesting finding that a chronic 
activation of PKC induces a strong induction of the protein expression of ITPR1 and 
the presumed interacting protein CA8. The activation of the PKC pathway thus induces 
an induction of its parallel pathway which is activated by IP3. This could mean that 
these pathways are not only linked by the common activation by DAG and IP3 but that 
PKC activation by itself can recruit the parallel IP3 pathway. The exact mechanism of 
this interaction still needs to be determined. It is well known that the IP3 receptor is a 
target of PKC phosphorylation and that phosphorylation changes the IP3-induced 
calcium release (Vermassen et al., 2004). Our finding suggest that PKC-mediated 
phosphorylation of the ITPR1 may eventually increase the protein expression of this 
receptor. 
Despite the parallel rise of protein expression of ITPR1 and CA8 in Purkinje cells of 
PKCγ-S361G transgenic mice and the finding that an interaction between these two 
proteins was identified in a yeast two hybrid screen and by a GST-pulldown assay 
(Hirota et al., 2003) we could not show a co-immunoprecipitation of CA8 and ITPR1 in 
Purkinje cells. Neither ITPR1 nor PKCγ co-immunoprecipitated with CA8. Similarly, in 
the Duolink proximity assay no evidence for a close interaction was found (data not 
shown). Of course we cannot exclude that this failure to demonstrate a direct binding 
was due to technical limitations, but both proteins are solidly expressed and we have 
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tried different immunoprecipitation protocols, none of which was showing co-
immunoprecipitation (data not shown). Therefore, the exact nature of the interaction 
between PKCγ, CA8 and ITPR1 in Purkinje cells still needs to be studied further. 
 
CA8 and Purkinje cell dendritic development 
The strong upregulation of CA8 with activation of PKCγ raises the possibility that CA8 
is directly or indirectly involved in the stunted growth of the Purkinje cell dendritic tree 
seen with constitutive activation of PKCγ in PKCγ-S361G transgenic mice. We have 
addressed this issue by overexpressing CA8 in dissociated Purkinje cell cultures. The 
dissociated culture system is of course less complex and more artificial compared to 
organotypic slice cultures, but it allows to reliably transfect Purkinje cells by 
electroporation and the use of an L7-based Purkinje cell specific expression vector 
(Wagner et al., 2011). Purkinje cells derived from PKCγ-S361G transgenic mice 
show a much reduced dendritic development in such cultures, and also transfection of 
a PKCγ-S361G plasmid resulted in a strong reduction of dendritic outgrowth (Fig. 27) 
indicating that the dissociated culture does indeed reflect the changes of dendritic 
outgrowth originally seen in organotypic slice cultures. When Purkinje cells were 
transfected with a CA8 plasmid resulting in CA8 overexpression a similar stunted 
dendritic growth was observed as seen after overexpression of PKCγ or of the mutated 
PKCγ-S361G (Fig. 27). This finding shows that CA8 function does have an inhibitory 
effect on Purkinje cell dendritic growth and that it is likely that PKCγ and CA8 are both 
part of a common or related signalling pathway eventually controlling dendritic 
outgrowth and retraction. If CA8 was a downstream effector of PKC activation a loss 
of function of CA8 should reduce the effects of PKCγ on the Purkinje cell dendrites. To 
this end we have used transfection of miRNA in order to suppress CA8 expression. 
After transfection with miRNA, protein expression of CA8 was reduced to a degree that 
cells were only weakly detected by immunohistochemistry (Fig. 28) confirming an 
efficient suppression of CA8 protein expression by the miRNA. Despite this marked 
reduction of CA8 expression, activation of PKC with PMA still showed the typical 
stunted dendritic growth indicating that CA8 is not required for this effect. There was 
also no rescue of the stunted dendritic tree by CA8 knockdown in Purkinje cells derived 
from PKCγ-S361G transgenic mice. While these findings leave open the possibility that 
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the small residual amount of CA8 protein present in Purkinje cells with CA8 knockdown 
is sufficient for mediating the effects of PKCγ activation they make it very unlikely that 
CA8 is the dominant mediator of PKCγ activation. They leave open the possibility that 
CA8 may be more loosely associated with PKCγ signalling or that its function might be 
redundant with another yet to be identified mediator of PKCγ activation. 
 
Conclusions 
In this study we have identified CA8 and the ITPR1 as two genes with strongly 
increased expression in Purkinje cells with chronic activation of PKCγ. We could not 
find evidence for a direct interaction of CA8 with the ITPR1 but show that 
overexpression of CA8 in Purkinje cells results in a phenotype with stunted dendritic 
growth similar to that seen after activation or overexpression of PKCγ. Although CA8 
is probably not a direct mediator of PKCγ for the effects on dendritic growth, it is likely 
to be part of a larger signalling network including PKCγ and the ITPR1 which controls 
synaptic function and dendritic growth of Purkinje cells. 
 
Acknowledgement:  
We thank Dr. John A. Hammer 3rd (National Heart, Lung and Blood Institute, NIH, 
Bethesda, MD, USA) for providing the pL7-mGFP plasmid and Markus Saxer for 
technical assistance. Dr. Phillipe Demougin from the Life Science Training facility 
(LSTF) of the University of Basel performed the microarray experiments. This work 
was supported by the University of Basel and the Swiss National Science Foundation 
(31003A-116624). 
  
118 
 
 
Supplementary material for 
Carbonic anhydrase related protein 8 expression is controlled by PKCγ activity and 
regulates Purkinje cell dendritic growth 
 
Etsuko Shimobayashi, Wolfgang Wagner and Josef P. Kapfhammer 
 
Supplementary methods: 
 
Primer sequences for RT-qPCR 
The following primer sequences were used:  
Chn1 (forward: tcagccatgtgactttgagc, reverse: tccatcgtcctgattcttcc),  
Klhl4 (forward: ttgctccaggctttctgact, reverse: caacagcatctcgaggaaca),  
CA8 (forward: tcagttgagttcaggcaacg, reverse: tgcttggaaaaactgcctct),  
Bcl11a (forward: tcccatcgagatgaaaaagg, reverse: gctgctgggctcatctttac),  
Fam40b (forward: gtacagcctcccccagtaca, reverse: cacgtcaatgcctagcttca),  
Lhx1 (forward: tagcccgcttgagactgatt , reverse: gagcgacagggcaattagag)   
Plekhd1 (forward: ggcctcctatctttccttgg, reverse: tacaaccatccacgactcca) and  
Ywhah (forward: ggctctgcttgacaagttcc, reverse: gcctcagaagcttcaaccac).  
As endogenous control GAPDH was selected. 
GAPDH (forward: aactttggcattgtggaagg, reverse: acacattgggggtaggaaca)  
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Supplementary Table 1 
B-cell CLL/lymphoma 
11A (Bcl11a) 
Bcl11 (also known as Evi9, Ctip1) encodes a C2H2 zinc 
finger transcription factor that acts as a transcriptional 
regulator (John et al., 2012). Bcl11 is involved in 
neuronal differentiation and the formation of sensory 
circuits (Jiao et al., 2005). 
Carbonic anhydrase-
related proteins 8 (CA8) 
CA8 is a carbonic anhydrase which is lacking the 
enzyme activity of carbonic anhydrase. A 19 bp deletion 
of CA8 in waddles (wdl) mice causes an ataxic 
phenotype with a side-to-side" waddling gait (Lim et 
al.,1992). CA8 is strongly expressed in Purkinje cells.  
Chimerin (chimaerin) 1 
(Chn1) 
Chn1 belongs to Rho GTPase-activating protein family 
and within the cerebellum the mRNA of Chn1 was 
detected only in Purkinje neurons (Andrews et al., 
2007). Chn1 is a member of the “Duane's retraction 
syndrome 2 related genes” in which mutations cause 
familial isolated Duane syndrome (Buttery et al., 2006). 
The diacylglycerol-binding protein alpha1-chimaerin 
(Chnα1) regulates dendritic morphology (Goudreault et 
al., 2009). 
family with sequence 
similarity 40, member B 
(Fam40b) 
Fam40b as well as Fam40a have recently been isolated 
as part of a striatin-interacting phosphatase and kinase 
(STRIPAK) complex contains the PP2A catalytic 
(PP2Ac) and scaffolding (PP2A A) subunits (Bai SW, 
2011). Interestingly, Fam40a and Fam40b are well 
conserved from fungi and amoebae to humans and 
involved in cell cytoskeletal organization and migration 
in human cells (Chen et al., 2008). Their detailed 
function is not yet known. 
Kelch-like family 4 
(Klhl4) 
Klhl4 belongs to actin-binding protein (ABP) Kelch-like 
family. Klhl1 is involved in T-type Ca-channels and 
SCA-8 (Aromolaran et al., 2010; He et al., 2006) and 
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Klhl4 is a constitutive neuronal ABP localized to the 
soma and dendritic arbors. Its deletion in Purkinje 
neurons results in dendritic atrophy and motor 
insufficiency (Hayes et al., 2001).  The exact function of 
Klhl4 is yet unknown. 
 
LIM homeobox protein 1 
(Lhx1) 
Lhx1 encodes a LIM-homeo domain transcription factor. 
Lhx1 and the closely related protein Lhx5 previously have 
been detected in Purkinje cells in rodents (Zhao et al., 
2007). Recently, Lhx1 and Lhx5 were shown to play 
essential roles in the differentiation of neurons throughout 
the developing central nervous system. Mutant mouse 
embryos lacking the function of these genes showed a 
defective Purkinje cell differentiation in the developing 
cerebellum (Rippey et al., 2013).  
pleckstrin homology 
domain containing, family 
D (Plekhd1) 
Plekhd1 is an uncharacterized gene that has an N-
terminal Pleckstrin homology (PH) domain (Meuillet et al.,  
2011). PH domains are generally involved in intracellular 
signaling by binding to phospho-tyrosine and polyproline 
sequences, Gβγ subunits of heterotrimeric G proteins, and 
phosphoinositide (PI) and recruitment of their target 
proteins to the cell membrane (Martin et al.,1994). 
According to data from the Allen Brain Atlas Plekhd1 
mRNA in the cerebellum is strongly and specifically 
expressed in Purkinje cells. 
Tyrosine 3-
monooxygenase/tryptoph
an 5-monooxygenase 
activation protein, eta 
(Ywhah) 
Ywhah encodes 14-3-3 protein eta chain gene. 14-3-3 is 
abundant in the brain and it is known that 14-3-3 proteins 
participate in neuronal development and cell growth 
control (Ubl et al., 2002). 14-3-3 eta chain might be 
involved in preventing neuronal cell death in several ways 
(Metzger and Kapfhammer, 2000; Wetsel et al., 1992). 
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Table. 4 Sequence of miRNA oligomer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.29 Immunofluorescence staining analysis and Western Blotting analysis of 
Car8miRNA transfected Hela cells. 
(A) Control is Car8-GFP transfected Hela cells. mi327, mi616 and mi686 are 
transfected with Car8-GFP. Cells were fixed after 72hr transfection. (B) WB results 
showed Car8 expression level was reduced in miRNA transfected cells. (C) Each 
Car8 expression was calculated and analyzed with Graphpad prism.  
 
 
miRNA Oligo Sequence (5'-3')
mi327-Top TGC TGA CTT CAT ACA GCT CAA ACT CCG TTT TGG CCA CTG ACT GAC GGA GTT TGC TGT ATG AAG T
mi327-Bottom CCT GAC TTC ATA CAG CAA ACT CCG TCA GTC AGT GGC CAA AAC GGA GTT TGA GCT GTA TGA AGT C
mi616-Top TGC TGA AGA GGG TCT GGT AAT AAA GTG TTT TGG CCA CTG ACT GAC ACT TTA TTC AGA CCC TCT T
mi616-Bottom CCT GAA GAG GGT CTG AAT AAA GTG TCA GTC AGT GGC CAA AAC ACT TTA TTA CCA GAC CCT CTT C
mi686-Top TGC TGA TAT CCA GGT AAC TCC TTC GCG TTT TGG CCA CTG ACT GAC GCG AAG GAT ACC TGG ATA T
mi686-Bottom CCT GAT ATC CAG GTA TCC TTC GCG TCA GTC AGT GGC CAA AAC GCG AAG GAG TTA CCT GGA TAT C
mi327
mi616
mi686
βActi
 
Car
 
G
FP
  
 C
ar
8 
 C
ar
8+
m
i3
27
 
 C
ar
8+
m
i6
16
 
 
 
mi32
 
mi61
 
mi68
 
Ct
 
A 
B C 
122 
 
 
5. Discussion 
  Gene transfection of Purkinje cells with electroporation  
 
In the study with several point mutations in PKCγ, we have analyzed the effect of 
several PKCγ mutations on the dendritic growth of Purkinje cells. To achieve Purkinje 
cell transfection with the different mutant constructs, we first performed lipofection, 
magnetofection (Jenkins et al., 2011 ; Sapet et al., 2011) and biolistic gene transfection 
with gene gun (Haag et al., 2012; Smith-Hicks et al., 2010). Although these transfection 
systems worked well for cell lines or some neural cells, we couldn’t get satisfying 
transfection rates for Purkinje cells. Thus we performed electroporation for cerebellar 
cells in dissociated cultures. When we used expression plasmids with the CMV 
promoter, we did get a good overall number of transfected cells in the culture, but only 
very few transfected Purkinje cells. Only when we used with the plasmid with the L7 
promoter (Wagner et al., 2011), we got a sufficient number of transfected Purkinje cells 
and no transgene expression in cells other than Purkinje cell. Furthermore, in our 
experiments the L7 promoter-plasmid yielded adequate expression levels for more 
than two weeks, which helped to investigate the effects of PKCγ mutants throughout 
Purkinje cell dendritic development. 
The morphology of Purkinje cell dendrites changes drastically during postnatal 
cerebellar development (Armengol et al., 1991; Tanaka et al., 2006). In the first 
postnatal week, Purkinje cells have several primary dendrites. In the second postnatal 
week, most Purkinje cells lose all of their primary dendrites except one, which rapidly 
elongates and branches in the sagittal plane to elaborate the typical dendritic tree 
(Sotelo et al., 2009) which forms numerous synapses with climbing fibers and parallel 
fibers (Rossi et al.,1995). Previous research showed that the final morphology of 
Purkinje cell dendrites is achieved both through extension and through retraction of 
dendritic processes (Tanaka et al., 2006). Therefore, our approach made it possible to 
observe the influence of several types of mutant PKCγ proteins on extension and 
retraction of Purkinje cell dendrites from postnatal 0 to the second and third postnatal 
week. In our experiments, we always use P0 mice because when we used cerebella 
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from P1 or older mice, the dendritic development of Purkinje cells was reduced and 
more variable.  
 
  The domain location of SCA14 mutations determines their effect on 
dendritic growth of Purkinje cells 
 
We had expected that most PKCγ mutants would have a similar effect on dendritic 
growth of Purkinje cells as most PKCγ mutants have an increased enzymatic activity 
in cell based assays (Adachi et al., 2008; Verbeek et al., 2005). Earlier studies have 
shown that activation of PKCγ negatively regulates the development of the Purkinje 
cell dendritic tree in rodent cerebellar slice cultures (Metzger et al., 2003; Schrenk et 
al., 2002). Our previous finding that Purkinje cells in S361G PKCγ transgenic mice 
have shown a strong reduction of dendritic development is a proof for a biologically 
relevant activation of PKC (Ji et al., 2014). Therefore, it is conceivable that every PKCγ 
mutation which have an increased enzymatic activity would negatively regulate 
dendritic development of Purkinje cells similar to S361G mutant. However, we found 
that none of several tested PKCγ mutations located in the C1B domain showed an 
inhibitory effect on dendritic growth of Purkinje cells although increased enzymatic 
activities of these PKCγ mutants (S119P, G128D and V138E) were demonstrated 
before (Adachi et al., 2008; Seki et al., 2009). On the other hand, there are indications 
that the C1B domain PKCγ mutants H101Y, S119P and G128D could disrupt the 
association of endogenous PKCγ with other binding proteins, such as 14-3-3 proteins, 
resulting in an inactivation of endogenous PKCγ (Lin D et al., 2007). Recently, 
Jezierska et al. (2014) suggested that alterations in the conformation of the C1B 
domain might affect PKCγ mutant autophosphorylation levels and might lead to a 
decreased kinase activity. In addition, Adachi et al. had shown that 14 types of C1B 
mutants failed to regulate Ca2+ influx into CHO cells while the catalytic domain mutants 
S361G and F643L had an increased inhibitory effect of Ca2+ entry compared to WT 
PKCγ (2008). This finding is in agreement with our results that S361G and F643L 
mutants have an increased biological activity compared to WT PKCγ. Our results 
suggest that the catalytic domain mutants S361G and F643L have an increased 
catalytic activity resulting in dendritic growth inhibition of Purkinje cells while C1B 
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mutants didn’t show increased biological activity probably due to inactivation of 
endogenous PKCγ or decreased kinase activity. In the C2 domain deletion, we found 
the same minor morphological changes as with transfection of WT PKCγ. Further 
investigations with SCA14 mutants in the C2 domain are needed in order to better 
understand the consequences of mutations in this domain for PKCγ biological activity. 
Taken together, our results suggest that SCA14 is likely not to be caused by a simple 
pathological mechanism but that several different pathways may be involved 
depending on the position of the point mutations or deletions. In this study, we found 
that SCA14 mutations could be divided into two types, one type with a point mutation 
in the kinase domain (S361G and F643L) which has an increased biological activity 
resulting in reduced Purkinje cell dendrites, the other type with a point mutation in the 
C1B domain has normal or decreased biological activity (perhaps by inactivation of 
endogenous PKCγ), and has no effect on Purkinje cell dendritic development. Further 
experiments are necessary to investigate that how these different effects on 
biological activity are involved in the pathogenesis of SCA14 and cerebellar 
dysfunction. 
 
  General discussion 
  PKC isoforms expressed in Purkinje cells 
As stated in the introduction, PKC has several isoforms and PKCγ is the dominant 
classical isoform in Purkinje cells. However, the α- and β-isoform might be also be 
expressed in Purkinje cells. PKCα is ubiquitously expressed in all cerebellar cells 
whereas PKCβ was reported to be mostly present in granule cells (Hirono et al., 
2001) but may also be expressed Purkinje cells (Gundlfinger et al., 2003).  
Do all isoforms have the same function on dendritic development of Purkinje cells? 
There are some evidences about the role of the different PKC isoform for dendritic 
development of Purkinje cells. Gundlfinger et al (2003) showed that PKCα is 
expressed in Purkinje cells while PKCβ is not expressed in Purkinje cells under 
normal culture conditions. PKCα deficient mice showed rather normal dendritic 
development. The lack of PKCα might be compensated by PKCγ because PKCγ is 
dominantly expressed in Purkinje cells. On the other hand, Purkinje cells from PKCγ 
deficient mice showed a slightly more complex dendritic tree (Schrenk et al., 2002)  
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indicating that PKCγ has a dominant effect on dendritic tree development. But if 
PKCα is activated by phorbol ester treatment it does inhibit dendritic development in 
the absence of PKCγ (Gundlfinger et al., 2003). These findings are best explained by 
assuming that under normal conditions PKCγ is the functional relevant isoform and 
that PKCα is rather forming a reserve pool. Taken together, in Purkinje cells PKCγ 
and PKCα are expressed and PKCγ is the major isoform responsible for dendritic 
development under normal conditions. 
PKC is also well known as a key protein for the induction of cerebellar long term 
depression (LTD). LTD is produced by associative activation of PF and CF (Kim and 
Thompson,1997), which results in co-activation of AMPA receptor and PLCβ in 
Purkinje cells (Linden and Connor,1995). Co-activation of AMPA receptors and 
mGluR1 activate phospholipase Cβ (PLCβ) coupled to heterotrimeric G-proteins 
Gq/G11, leading to hydrolysis of phosphatidylinositol 4, 5-bisphosphate (PIP2) to 
inositol 1, 4, 5-trisphosphate (IP3) and diacylglycerol (DAG). This will result in an 
increased intracellular Ca2+ concentration by release of Ca2+ from IP3R-mediated 
stores and TRPC3-mediated Ca2+ influx. Increased Ca2+ concentration in the 
cytoplasm and DAG activate PKC (Ohtani et al., 2014). There are several PLCβ 
isoforms in Purkinje cells (dominantly PLCβ1, 3 and 4) and within PLCβ isoforms 
PLCβ3 and PLCβ4 are crucial for mGluR1 induced LTD (Hirono et al., 2001). There 
are some studies about the relevant PKC isoform for the expression of LTD. In a first 
publication no change was seen in LTD in PKCγ deficient mice (Chen et al., 1995), 
which indicates that PKCγ is less important for LTD compared to other PKC isoforms. 
Furthermore, PLC (β3 and β4) activation caused translocation of PKCα and PKCβ 
but not PKCγ (Hirono et al., 2001). In further studies it was shown that the PDZ 
ligand in PKCα is of crucial importance for the induction of LTD (Leitges et al., 2004). 
On the other hand, as mentioned in the introduction, the PKC inhibitor peptide (PKC 
19-36) completely blocks LTD in wild-type mice but not in PKCγ deficient mice 
(Hémart et al., 1995). While it is evident that PKCγ is not required for the induction of 
LTD, it may still have a modulatory role. 
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  SCA14 mutations and inhibition of Purkinje cell dendritic development  
In this thesis I have focused on mutant PKCγ and Purkinje cell dendritic 
development. The findings that on the one hand PKCγ deficient mice have an 
enlarged dendritic tree and on the other hand PKC activation causes severe dendritic 
growth inhibition indicate that PKC has a negative influence on dendritic 
development. This links increased PKC activity to Purkinje cell dysfunction and 
SCA14.  
An important question to answer will be whether SCA14 mutations will cause 
dendritic growth inhibition and pathogenesis by the same mechanisms? 
There is some evidence that many or even all SCA14 related mutant PKCγ proteins 
might have increased kinase activity (Adachi et al., 2008; Verbeek et al., 2005). But 
there are also data showing that mutant PKCγ failed to recruit downstream targets 
resulting in a certain loss of function (Verbeek et al., 2008). In order to study the 
biological relevance of SCA14 and PKCγ mutations for Purkinje cells dendritic 
development, we generated transgenic mice expressing a mutated PKCγ with the 
S361G point mutation from SCA14. We found that this mutant PKCγ caused severe 
dendritic reduction of Purkinje cells in organotypic slice cultures. Furthermore, these 
transgenic mice showed mild ataxia in the absence of cerebellar degeneration, which 
supports the idea that increased kinase activity of PKCγ inhibits Purkinje cell dendritic 
growth and links it to SCA pathogenesis. On the other hand, we also have created 
additional SCA14 related mutant PKCγ transgenic mice. One mouse line is carrying 
the missense mutation G118D (in the C1 regulatory domain) and the second line a 
deletion of amino acids 260-280 in the C2 domain. The G118D mutation is a SCA14 
mutation in human (van de Warrenburg et al., 2003) and this mutation increased the 
intrinsic kinase activity of PKCγ (Verbeek et al., 2005). The 260-280 deletion has no 
direct relation to SCA14 so far, but the same deletion in PKCα was shown to have an 
increased kinase activity (Rotenberg et al., 1998). Interestingly, Purkinje cells from 
either of these two transgenic mouse lines develop normal dendritic trees in 
cerebellar slice cultures indicating that there is no biologically relevant increase of 
PKC activity in Purkinje cells. In order to address the effects of SCA14 related 
mutations more systematically, we generated expression vectors for several PKCγ 
mutations and transfected them to Purkinje cells in dissociated cerebellar cultures 
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(Material and Methods). This in vitro assay confirmed that C1 domain mutations 
(including G118D mutation) and the 260-280 deletion didn’t affect dendritic 
development. In contrast, an additional kinase domain mutation found in SCA14 
patients mediated again a severe inhibition of dendritic development in Purkinje cells. 
This would be in agreement with the finding of Adachi et al. that in CHO cells the C1 
domain mutants failed to regulate Ca2+ influx while kinase domain mutants showed 
an increased inhibition of Ca2+ entry into the cells (2008). These findings suggest that 
there may be diverse mechanisms leading to pathogenesis in SCA14. While for 
mutations in the kinase domain Purkinje cell dysfunction is likely to be linked to 
increased PKC activity, this seems not to be the case in C1 domain mutations which 
rather show a functional deficiency of PKC. The common aspect of the two 
mechanisms may be that both interfere with the regulated function of the PKCγ – 
IP3R pathway, the dysfunction of which is tightly linked to the development of the 
ataxic phenotype (Schorge et al., 2010). This is further discussed in the following 
paragraph.  
 
  Car8, IP3R and PKCγ 
In this study we found that Car8 and IP3R1 are both upregulated in mutant PKCγ 
transgenic mice. Interestingly, Car8, IP3R1 and PKCγ proteins are all known to be 
strongly and specifically expressed in Purkinje cells. The common function among 
them is that they are involved in calcium influx and regulate calcium homeostasis in 
Purkinje cells. Disruption of intracellular calcium homeostasis in Purkinje cells is 
thought to be a key mechanism in the pathogenesis of SCA and at the same time 
known to control Purkinje cell dendritic development. The dendritic tree size reduction 
in cerebellar Purkinje cells in slice cultures can be achieved by chronic activation of 
mGluR1 (Sirzen-Zelenskaya et al., 2006). This reduction of Purkinje cell dendritic 
development after chronic activation of mGluR1 could be partially rescued by 
inhibition of T-type and P/Q-type calcium channels (Gugger et al., 2012), indicating 
that Ca2+ influx through T-type and P/Q-type channels is important for mediating 
dendritic growth inhibition. Inhibition of the plasma membrane Ca2+-ATPase2 
(PMCA2) activity by carboxyeosin also resulted in an inhibition of Purkinje cell 
dendritic growth (Sherkhane and Kapfhammer, 2013). Interestingly, it is known that 
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PMCA2 co-immunoprecipitates with mGluR1, Homer 3 and IP3R1, which indicates 
that Ca2+ pump PMCA2, mGluR1, Homer 3 and the IP3R1 are forming a complex 
and regulate each other (Kurnellas et al., 2007). Little is still known about the further 
downstream signaling events eventually interfering with Purkinje cell dendritic 
development.  
Another mutation affecting the Ca2+ homeostasis in Purkinje cells is found in 
Moonwalker (Mwk) mice which have a gain of function point mutation in the TRPC3 
channel. Mwk mice develop cerebellar ataxia (Becker et al., 2009) and also have 
abnormal dendritic arborization during cerebellar development (Sekerkova et al., 
2013). Interestingly, TRPC3 knockout mice showed a normal dendritic development 
(Gugger et al., 2012), highlighting the importance of the increased Ca2+ entry in the 
Mwk mutation. Adachi et al. showed that PKCγ with a C1 domain mutation (G128D) 
failed to inhibit Ca2+ entry through the TRPC3 channel. Dulneva et al. showed that 
CaMKIV is hyper-phosphorylated in the Mwk cerebellum and might be one candidate 
for the downstream regulation of dendritic outgrowth (2015). One of the downstream 
targets of CaMKIV is RORα which is a key factor for Purkinje cells development at an 
early stage (Dulneva et al., 2015 and Boukhtouche et al., 2006). In this thesis I also 
aimed at identifying downstream targets of PKCγ and by a gene array approach and 
we identified Car8 and IP3R1 as potential candidates for PKCγ downstream 
signaling. We could confirm that Car8 is involved in Purkinje cell dendritic 
development but in our experiments Car8 knock down couldn’t rescue the PKCγ 
mediated in inhibition of dendritic growth. Car8 is thus unlikely to be a direct 
downstream target of PKCγ; alternatively there could be several parallel signaling 
pathways related to dendritic growth and Car8 might only be part of one of them. The 
exact function of Car8 function is still rather unclear but its importance is evident from 
the strong ataxic phenotype found in mice deficient for Car8 (Jiao et al., 2005) and 
humans (Türkmen et al., 2009). There is evidence that Car8 is modulating IP3R1 
function (Hirota et al., 2003) and that the ataxic phenotype could be in part explained 
by a loss of the precise regulation of IP3R1 activity and that this could also contribute 
to the abnormal dendritic development of Purkinje cells. We also identified IP3R1 as 
a candidate for downstream signaling of PKCγ. IP3R1 is the dominant IP3 receptor in 
Purkinje cells and may be also one of the key proteins in the pathogenesis of SCAs 
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(Schorge et al., 2010; Tada et al., 2016). Purkinje cells from IP3R1 knock-out 
(IP3R1KO) mice have a normal or only slightly changed morphology (Hisatsune et 
al., 2006; Matsumoto and Kato, 2001). On the other hand, these mice are ataxic 
(Matsumoto et al.,1996). In humans two SCA subtypes are associated with the IP3R1 
gene: SCA15/16 is caused by deletions or missense mutations in the IP3R1 gene 
(Ganesamoorthy et al., 2009; Novak et al., 2010; van de Leemput et al., 2007) and 
SCA29 is caused by missense mutations in IP3R1 (Sasaki et al., 2015). In both 
diseases there is a dominant inheritance and it is not entirely clear whether the 
disease is brought about by a pure loss of function of the IP3R1 (Iwaki et al., 2008). It 
is possible that the different missense mutation may cause IP3R1 dysfunction in 
several ways, and the signalling pathway downstream of the mutant IP3R1 could be 
changed in several ways. IP3R1 is also known to be an upstream protein of PKCγ, 
therefore there might be some feedback mechanism in the IP3R1- PKCγ signaling 
cascade in Purkinje cells. Once calcium homeostasis is destroyed, these proteins 
can be either up- or down-regulated and become causative for abnormal dendritic 
development and ataxia. Further work will be needed to reveal the exact molecular 
interactions responsible for the expression of the dendritic phenotype and the 
development of ataxia. 
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